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ABSTRACT
An immunological mechanism to account for the regulation of peripheral
self-reactive T cells, which escape central tolerance in the thymus, during the
primary activation of naïve, foreign antigen-specific T cells remains to be
established.  Contemporary models of primary T cell activation that attempt to
describe how this occurs differ significantly in the cellular interactions necessary for
naïve CD4+ T helper cell activation.  It is generally accepted that most CD8+ T cells
are dependent upon CD4+ T helper cells for their activation.
The Infectious Non-Self and Danger Models of CD4+ T cell activation
propose that interaction of a naïve T cell with an appropriately armed dendritic cell is
sufficient, whereas the Two-step, Two-signal Model proposes additional cellular
interactions are necessary.  The major goal of this thesis was to establish and utilize
an in vitro experimental system that would allow one to begin to delineate which
model most validly describes the cellular interactions required for generation of
primary immune responses from naïve T cells.   Employing a population of naïve T
cells uncontaminated with any partially or fully activated cells is essential for such a
study.
The results presented in this thesis show, that when thymocytes are employed
as a source of responding naïve T cells, cellular interactions, in addition to
interaction with bone marrow derived dendritic cells, are required for the activation
of naïve thymic T cells.  The primary activation of thymic T cells to generate CD4+
IL-2 producing cells, and CD8+ IFN-g producing cells and cytotoxic T cells upon
stimulation with splenic allogeneic stimulator cells is critically dependent upon the
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presence of a syngeneic population of radiation resistant, CD4+ T cells found in the
spleen of normal mice.  Additionally, when such cells are present as a source of
“help” for thymocytes, allogeneic bone marrow derived dendritic cells fail to
stimulate the generation of optimal cytotoxic and cytokine responses from naïve
thymic T cells. However, they do stimulate thymocytes to cycle and up regulate the
ligand for the costimulatory molecule CD40, CD40L.    The results presented within
also show that the optimal activation of naïve thymic T cells to generate CD4+ IL-2
producing cells, and CD8+ IFN-g producing cells and cytotoxic T cells, requires the
presence of allo-MHC bearing Ig+ B220+ B cells.  The removal of B220+ cells by
magnetic cell sorting from the allogeneic spleen reveals that the generation of CD8+
cytotoxic T cells and IFN-g producing cells from thymocytes is markedly reduced
compared to unsorted allogeneic spleen cells.  However, IL-2 and IL-4 cytokine
producing cells are still detectable.  Potential reasons for the generation of the latter
cytokine producing cells are discussed. The results presented in this thesis have
revealed insights into the cellular interactions involved in the activation of naïve
thymic T cells.
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11.0.  INTRODUCTION
1.1. The Basic Foundations of Immunity
1.1.1. Brief Historical Background
The discipline of immunology, which is defined as the science that deals with
the immune response and its humoral and cell-mediated aspects (Merriam-Webster,
2004), had its beginnings in the realization that exposure to an attenuated form of an
infectious organism or to a related, non-pathogenic organism, could protect an
individual from serious infection upon encounter with a more virulent strain of a
pathogen (Clark, 1983; Silverstein, 1999). Since Jenner’s demonstration in the
1700’s of the generation of immunological protection against smallpox with pre-
exposure or vaccination with cowpox virus, people have wanted to understand how
vaccination results in the generation of protective immunity, and how this immunity
is mediated. The field of immunology thus arose.
At the turn of the 20th century, attempts to delineate the protective immunity
induced upon vaccination led to the early identification of two types of immune
response.  Metchnikoff attributed a major role for phagocytic cells in the defense
against pathogens (Metchnikoff, 1968), while at the same time Ehrlich proposed
antibody was more important (Ehrlich, 1900; Silverstein, 1999). The debate about
2which arm of immunity was the most essential for providing immunological
protection ensued for almost 50 years.
It was the realization that both humoral and cellular immune responses are
essential parts of the body’s specific immune defense against infectious organisms
that sparked the beginnings of a modern era of cellular immunology (Clark, 1983;
Silverstein, 1999). People wanted to understand what cells were responsible for
mediating protection, where they originated, and more importantly how they
recognized foreign and not self-antigens. In the 1940’s and 50’s, Burnet and
Talmage formulated the Clonal Selection Theory to provide a rationale for how
antibody is produced and how tolerance towards self is achieved (Baxter & Hodgkin,
2002; Burnet, 1959; Jerne, 1955; Silverstein, 2002; Talmage & Pearlman, 1963).
Though originally describing the precursor of antibody-producing cells, the Clonal
Selection Theory correctly predicted that antibody-producing cells express only a
single type of specificity, and the population as a whole thus represents a large
repertoire of potentially selectable entities envisaged free of virtually all self-reactive
clones.
According to Burnet, antibody-producing cells capable of responding against
self-tissues are deleted early in prenatal life (Burnet, 1957, 1959).  This model of self
non-self discrimination was supported by the experiments of Owen with non-
identical dizotic twin cattle that were mutually tolerant of each other’s blood cells
(Owen, 1945), and the demonstration by Billingham, Brent, and Medawar that adult
mice would accept foreign skin grafts if they had been injected in utero with cells
from the donors (Billingham, Brent, & Medawar, 1953).  According to Lederberg’s
3proposal, survival versus deletion of immune cells was temporal, and depended on
the maturity of the cell and not the developmental state of the animal.  Immature
cells capable of responding against self-tissues become tolerant upon encounter with
antigen and only mature cells are activatable (Lederberg, 1959, 1988). It became
evident from Landsteiner’s work with hapten-carrier conjugates that the nature of
antigen was also important in determining the immunological outcome of
administering an antigen (Landsteiner, 1945). Neither Burnet’s nor Lederberg’s
model of self-non-self discrimination could explain how non-immunogenic haptens
could be made immunogenic by conjugation to an immunogenic carrier.  In order to
accommodate all of these findings, Talmage and Pearlman proposed that antigens
alone, in non-conjugated forms, result in the induction of tolerance, whereas,
aggregates, that possibly associate with complement, deliver additional non-specific
stimuli that result in clonal expansion and antibody production (Talmage &
Pearlman, 1963).
The cells responsible for mediating immunological protection, and how they
recognize antigen, self or foreign, were largely unknown when these models were
formulated. Results indicating that circulating lymphocytes are the
immunocompetent cells capable of mediating graft rejection and tuberculin
immunity came from the experiments of Gowans and Medawar, and Chase,
respectively (Billingham, Brent, & Medawar, 1954; Chase, 1945; Ellis, Gowans, &
Howard, 1969).  The demonstration that circulating lymphocytes are absent from
mice thymectomized within a day of birth, and the subsequent susceptibility of these
mice to infectious organisms and their inability to reject allogeneic tissue grafts
4indicated that the thymus could be essential for immunological function (Claman &
McDonald, 1964; Claman & Talmage, 1963; Miller, 1964; Miller, Mitchell, &
Weiss, 1967; Mitchell & Miller, 1968b).  From experiments originally designed to
identify whether the origin of antibody producing cells was thymus or bone marrow
dependent it became evident that different cells of the immune system interact with
one another to result in the generation of immune responses (Claman, Chaperon, &
Selner, 1968; Claman, Chaperon, & Triplett, 1966a, 1966b). The experiments of
Miller with semiallogeneic mice confirmed these findings (Mitchell & Miller,
1968a), and the work of Rajewsky & Rottlander, and Mitchison with hapten carrier
conjugates, demonstrated that cellular collaboration is involved in the generation of
immune responses (Mitchison, 1966; Rajewsky & Rottlander, 1967; Rajewsky,
Schirrmacher, Nase, & Jerne, 1969).  The ability to break tolerance to self-antigens
by conjugation of that antigen to immunogenic carriers (Weigle, 1964) or by
challenge with cross-reactive antigens could not be easily explained by either
Burnet’s or Lederberg’s models of self non-self discrimination.
It was at this time that Bretscher and Cohn put forth the two-signal model of
lymphocyte activation (Bretscher & Cohn, 1970; Bretscher & Cohn, 1968).  This
model was originally put forth to describe the activation of antibody producing cells,
but was generalized to also apply to cellular responses.  Bretscher and Cohn
postulated that a free antigenic determinant binding to an antigen-receptor would
generate a paralytic signal within a cell, whereas, aggregation of two or more
determinants by a “carrier antibody” would induce a second signal that would cause
cellular activation (Bretscher & Cohn, 1968). In 1970, the cells capable of inducing
5second signals for cell activation were predicted to be the thymus dependent
lymphocytes (Bretscher & Cohn, 1970).  The experiments of Lafferty focusing on
transplant rejection indicated that the lymphocytes mediating rejection need to
recognize a cosignal in addition to an antigenic difference (Lafferty, Walker,
Scollary, & Killby, 1972).  The cells involved in delivering the additional stimulus to
lymphocytes were of heamatopoietic origin and needed to be metabolically active in
order to deliver the “second” signal (Lafferty, Bootes, Dart, Radovich, & Talmage,
1976; Lafferty, Misko, & Cooley, 1974).  Lafferty modified Bretscher and Cohn’s
two-signal model and suggested a stimulator cell that is bound to the responsive
lymphocyte by means of an antigen-bridge provides signal two via a conformational
change in an unidentified surface receptor-ligand combination; once activated, he
postulated that the lymphocytes no longer require recognition of this second signal.
The discovery that the immune response genes which determine immune
responsiveness encode the Major Histocompbatibity Complex molecules, and that T
lymphocytes from different strains of mice recognize antigen in the context of these
molecules (Doherty & Zinkernagel, 1975; McDevitt & Sela, 1965; Rosenthal &
Shevach, 1973), opened up the possibility that reactivity against allografts and
normal T cell behavior were similar. Lafferty and Cunningham subsequently
suggested that T cells that saw antigen in the context of a self-MHC for autologous
reactions, and allo-MHC for alloreactions, trigger the stimulatory cell to provide an
additional stimulatory or costimulatory signal (Lafferty & Cunningham, 1975).
According to their model, recognition of antigen by the T cell without recognition of
the MHC would fail to result in the delivery of a second costimulatory signal.
6Evidence in accord with the prediction that antigenic stimulation of mature
lymphocytes in the absence of costimulatory signals induces a state of
unresponsiveness and that the presence of additional costimulatory signals results in
lymphocyte activation came from the work of Jenkins & Schwartz and Nossal
(Jenkins & Schwartz, 1987; Nossal & Pike, 1980). The cell involved in delivering
the “second signal” had since been identified as an antigen-presenting cell capable of
digesting and displaying peptides derived from whole antigens in the context of
MHC antigens on their surface (Harding, Leyva-Cobian, & Unanue, 1988; Unanue,
1984).  Jenkins and Schwartz found that viable antigen presenting cells were
required for the full activation of cloned lymphocytes, and that killed or fixed
antigen-presenting cells failed to deliver the required costimulatory signals to T
lymphocytes (Jenkins, Ashwell, & Schwartz, 1988).  They proposed a new version
of Bretscher and Cohn’s two-signal model where antigen alone seemed to lead to an
inert state, and antigen in the presence of costimulation from viable antigen-
presenting cells leads to activation (Schwartz, Mueller, Jenkins, & Quill, 1989).
The observations of Jenkins and Schwartz were instrumental in the
delineation of how the activation of lymphocytes occurs upon recognition of antigen
(Jenkins, Pardoll, Mizuguchi, Quill, & Schwartz, 1987).  In conjunction with the
characterization of the T cell receptor (TCR) (Hayday et al., 1985; Marrack et al.,
1983), these observations paved the way for the contemporary era of immunology. A
vast amount of knowledge has been gained since, particularly in regards to the
different cell types involved in mediating immunity, the events that lead to their
development, how they recognize antigen, and the means by which protective, and in
7some instances, non-protective immune responses, are generated (Abbas, Lichtman,
& Pober, 2000; Paul, 1999).   However, the means by which the immune system
discriminates peripheral self from non-self to selectively generate immune responses
against foreign antigens remained enigmatic.  This central question in immunology is
the focus of this thesis work.  In order to properly discuss how the immune response
potentially discriminates peripheral self from non-self during the generation of
primary immune responses, one must consider current wisdom as to how the cells of
the immune response function.
1.1.2. A Brief Synopsis of Modern Day Knowledge of the
Immune System: Innate and Adaptive
The immune system of higher vertebrates is now known to be composed
primarily of three cell types, which are granulocytes, monocytes, and lymphocytes
(Abbas et al., 2000; Clark, 1983; Paul, 1999). The immunological protection
provided by these cells can be divided in two separate types of immunity that are
referred to as innate and adaptive immunity.  The innate response provides an
individual with constitutive and pre-existing protection (Medzhitov, 2001). Non-
antigen-specific immune cells, such as neutrophils, cells of the monocyte lineage,
and NK cells mediate this protection (Bendelac, Bonneville, & Kearney, 2001).  By
contrast, the adaptive response is acquired, and is mediated by lymphocytes that bear
clonally distributed, antigen-specific receptors (Abbas et al., 2000; Clark, 1983; Paul,
1999). The antigen-specific cells that mediate adaptive immunity include antibody-
producing B-lymphocytes, ab TCR expressing CD4+ T helper, and CD8+ cytotoxic
8T lymphocytes. As Burnet and Talmage correctly predicted (Burnet & Fenner, 1949;
Talmage, 1980; Talmage & Pearlman, 1963), the expansion of antigen-specific cells
after a primary encounter with a foreign antigen enables the adaptive immune
response to respond more rapidly if the antigen is encountered again.
The cells of the innate immune response lack the capacity to remember a
previous encounter with foreign antigen.  However, the cells of the innate immune
response play an integral role in the defense against infectious organisms (Medzhitov
& Janeway, 1998).  They are essential for maintaining tissue integrity, lowering
infectious burdens, and are key cells involved in maintaining the homeostasis of
antigen-specific T lymphocytes of adaptive immune responses (Hoebe, Janssen, &
Beutler, 2004; Holt & Sly, 1999; Moretta, 2002).  For example, cells such as gd T
lymphocytes (Hoebe et al., 2004; Kaufmann, 1996) are important for mediating the
repair of tissue damage caused by inflammation, and antigen-presenting cells are
essential for providing homeostatic survival signals to antigen-specific CD4+ and
CD8+ T lymphocytes (Dai & Lakkis, 2001; Holt & Sly, 1999).
More important to the initiation of adaptive responses are the antigen-
presenting cell functions of monocyte derived macrophages and dendritic cells
(Guermonprez, Valladeau, Zitvogel, Thery, & Amigorena, 2002; Steinman, 1991;
Unanue, 1984).  These cells are the primary antigen-presenting cells that
phagocytose and process protein antigens into antigenic peptides.  Antigenic peptides
are presented on the surface of antigen presenting cells in the context of protein
antigens encoded by a region called the major histocompatibility region located on
chromosome 14 in mice and chromosome 6 in man (Abbas et al., 2000; Clark, 1983;
9Paul, 1999).  This region, which contains the immune response genes that can
determine whether particular strains of mice can respond to simple or limiting doses
of more complex foreign antigens, encodes protein products referred to as Major
Histocompatibility Complex antigens (McDevitt & Sela, 1965; Mozes, McDevitt,
Jaton, & Sela, 1969; Rosenthal & Shevach, 1973).  Antigenic-peptides bound in a
groove of MHC Class II or Class I molecules are presented to ab CD4+ and CD8+ T
cells, respectively (Davis et al., 1998).   Inhibition of antigen processing prevents the
recognition of antigen by T cells, and prevents the generation of protective immune
responses (Guery, Sette, Leighton, Dragomir, & Adorini, 1992; Jenkins & Schwartz,
1987). The homeostatic and antigen presentation roles of antigen presenting cells are
thus essential to the initiation and mediation of protective primary and secondary
immune responses.
The antigen-specific cells of the adaptive immune response that mediate
primary and secondary immune responses are antibody producing B cells, ab TCR
expressing CD4+ and CD8+ T lymphocytes (Abbas et al., 2000; Clark, 1983; Paul,
1999).  As mentioned previously, these lymphocytes display clonally distributed
receptors that enable the recognition of a vast array of foreign antigens (Blackman,
Kappler, & Marrack, 1988; Litman, Anderson, & Rast, 1999; Reth, 1992). The
ability of the adaptive immune response to recognize a universe of potential antigens
is the result of genetic recombination as was originally visualized by Lederberg
(Lederberg, 1959). During B and T cell development, recombination events, referred
to as V (D) J joining, occur in genes encoding the regions of the B and T cell
receptors (Abbas et al., 2000; Clark, 1983; Paul, 1999).  The resulting lymphocyte
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population that develops is composed of an array of cells, each bearing receptors of a
unique antigen-specificity.
B cells bear immunoglobulin receptors on their cell surface (Abbas et al.,
2000; Clark, 1983; Paul, 1999).  Recognition of antigen by this receptor can result in
cross-linking and the internalization of receptor-antigen complexes, and in the
presence of the appropriate cooperative interactions with thymus dependent
lymphocytes, B cells are stimulated to up-regulate surface molecules, produce
growth factors called cytokines, and can be stimulated to terminally differentiate into
plasma cells that primarily secrete immunoglobulin (Hodgkin & Basten, 1995;
Lanzavecchia, 1990; Lanzavecchia & Bove, 1985; Rush & Hodgkin, 2001). The
antibody produced by B cells participates in the immunological protection against
pathogens that are found extracellularly, of which circulating Influenza virus is a
prime example (Lafferty & Oertelis, 1961). Binding of antibody to circulating virus
particles can neutralize the ability of the virus to infect cells, and can prevent it from
becoming an intracellular pathogen that is inaccessible to circulating antibody.
Binding of antibody to extracellular pathogens can also hasten their removal.
Phagocytic cells bear Fc receptors, which bind to portions of the antibody not bound
to antigen (Abbas et al., 2000; Clark, 1983; Paul, 1999). When antigen becomes
adsorbed to surface bound immunoglobulin it can either be internalized and
processed or can be transferred to other lymphocytes (Batista, Iber, & Neuberger,
2001; Batista & Neuberger, 2000).  Opsinization of foreign antigens by antibody,
such as virus, thus hastens the ability of innate immune cells to process and present
antigenic peptides to CD4+ and CD8+ T cells.
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B cells also function as antigen-presenting cells.  However, their primary
means of antigen uptake is immunoglobulin receptor mediated (Brocke, Armandola,
Garbi, & Hammerling, 2003; Brocke, Garbi, Momburg, & Hammerling, 2002;
Bryant & Ploegh, 2004; Hodgkin & Basten, 1995; Lanzavecchia & Bove, 1985).  B
cells, as compared to antigen presenting cells such as macrophages, have a 100-1000
fold lower capacity to pinocytose, and a 10-50 fold lower capacity to adsorb antigens
(Chesnut, Colon, & Grey, 1982).  Antigen-specific B cells achieve maximal
efficiency in presenting antigen to T cells by a combination of specific antigen-
uptake by the B cell receptor, and efficient antigen-targeting of antigens taken up by
the B cell receptor to antigen processing and MHC loading compartments (Brocke et
al., 2003; Brocke et al., 2002; Bryant & Ploegh, 2004; Watts, 1997).  These qualities
enable an antigen specific B cell to present antigen to T cells at 1000 fold lower
concentrations than non-specific antigen-presenting cells that can acquire antigen by
active macropinocytosis of much larger fluid volumes (Sallusto, Cella, Danieli, &
Lanzavecchia, 1995; Unanue, 1984; Watts, 1997) or by adsorption of antigen via a
range of endocytosis receptors (Steinman, Hawiger, & Nussenzweig, 2003; Watts,
1997).  The latter antigen presenting cells are hence the primary antigen presenting
cells that endocytose apoptotic cells.
ab bearing CD4+ and CD8+ T cells of the adaptive immune response bear
clonally distributed T cell receptors that recognize small fragments of degraded
proteins (Abbas et al., 2000; Clark, 1983; Paul, 1999).  In order for adaptive immune
responses to be initiated, these peptide fragments must be presented to T cells in the
context of MHC molecules (Goldrath & Bevan, 1999).  The ab T cell receptors of
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CD4+ T cells recognize peptides in the context of MHC class II molecules, and the
receptors of CD8+ T cells recognize peptides in the context of MHC Class I (Cantor
& Boyse, 1975; Davis et al., 1998; Doherty & Zinkernagel, 1975; Rosenberg,
Mizuochi, Sharrow, & Singer, 1987; Swain, Dialynas, Fitch, & English, 1984).  All
cells of the body posses the processing machinery to present endogenously derived
peptides on their cell surface in the context of MHC Class I antigens. It is primarily
specialized cells, the antigen presenting cells, briefly introduced, that possess the
antigen uptake and processing machinery to present exogenously acquired antigens
on MHC Class II antigens (Abbas et al., 2000).  Other cells, such as endothelial cells,
can be stimulated by inflammatory stimuli to up regulate expression of MHC class II
antigens, but their ability to actively acquire antigen is minimal.
Peptides derived from exogenous phagocytosed antigens are primarily
presented to CD4+ T cells on MHC Class II, whereas intracellular antigens, such as
those produced during virus infection are primarily presented to CD8+ T cells on
MHC Class I (Goldrath & Bevan, 1999; Marrack et al., 2001).  A cross-presentation
pathway of antigen-presentation occurs in some antigen-presenting cells, most
commonly in dendritic cells, whereby exogenous antigens taken up by defined
endocytic surface receptors, such as FcgR and defined integrins, gain access to the
MHC Class I presentation pathway (Bevan, 1976; Kurts, Cannarile, Klebba, &
Brocker, 2001; Kurts et al., 1996; Sigal, Crotty, Andino, & Rock, 1999; Srivastava,
2002).  Presentation of the exogenously acquired antigens appears to be an activation
dependent process (Albert, Jegathesan, & Darnell, 2001; Delamarre, Holcombe, &
Mellman, 2003). Recycled endogenous derived peptides presented on MHC class I
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can also gain access to the Class II presentation pathway (Adorini et al., 1991;
Gromme et al., 1999).
MHC class II restricted, CD4+ T cells have two immunological roles once
activated.  Upon recognition of MHC Class II presented peptides, they mediate
cellular immune responses by producing inflammatory cytokines, such as IFN-g,
which triggers the activation of macrophages (Blanden, Lefford, & Mackaness,
1969; Coffman & Mosmann, 1991; Unanue, 1984; Wheelock, 1965).  The activation
of macrophages by CD4+ T cells initiates the recruitment of additional non-specific
cells of the innate response, and results in the expression of an immune response
termed Delayed Type Hypersensitivity (Blanden et al., 1969; Mackaness & Blanden,
1967).
Activated antigen-specific CD4+ T cells also orchestrate the generation of
antigen-specific immune cells (Swain, 1999).  The ability of CD4+ T cells to
orchestrate immune responses by innate and adaptive immune cells is commonly
referred to as T cell help (Husmann & Bevan, 1988; Mitchison, 1971).  It is now
known that CD4+ T cells are the thymus dependent cells required in Claman’s
experiments for the optimal production of antibody from helper-dependent B cells
(Claman et al., 1966b; Miller & Mitchell, 1969).  After specific recognition of a
peptide-MHC Class II complex presented on surface of a B cell, CD4+ T cells help
B cells differentiate into antibody producing cells by producing B cell growth factors
or cytokines (Croft & Swain, 1995; Hodgkin & Basten, 1995; Kehry & Hodgkin,
1993; Lanzavecchia, 1990; Rush & Hodgkin, 2001), and via the ligation of surface
antigens CD4+ T helper cells trigger the initiation of intracellular signaling pathways
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within the B cell that allow for clonal expansion (DeFranco, 1999; Kehry &
Hodgkin, 1993; Rush & Hodgkin, 2001).
In addition to providing antigen-specific B cell help, CD4+ T cells also help
another type of thymus dependent lymphocyte, the CD8+ T cells, differentiate into
cytotoxic T lymphocytes (Cantor & Boyse, 1975; Keene & Forman, 1982; Pilarski,
1977; Pilarski, Al-Adra, & McKenzie, 1980).  CD8+ cytotoxic T cells are potent
antigen-specific cells of the adaptive immune response that play a large role in the
rejection of allogeneic tissue grafts and the defense against viruses (Doherty &
Zinkernagel, 1975; Plata, Cerottini, & Brunner, 1975; Plata, Jongeneel, Cerottini, &
Brunner, 1976; Rosenberg et al., 1987).  Upon recognition of a foreign peptide-MHC
Class I complex, activated CD8+ T cells release short-range proteins, such as
perforin, that lyse the targeted cell (Lieberman, 2003; Trambas & Griffiths, 2003).
Much like the help for B cells, CD4+ T cells provide help for CD8+ T cells by
providing essential differentiation factors, such as the cytokine IL-2 (Dai,
Konieczny, & Lakkis, 2000; Smith, 1984; Teh & Teh, 1980), and again via the
ligation of surface receptors they trigger the initiation of intracellular signaling
pathways within the CD8+ T cell that allow for clonal expansion (Weiss, 1999).  In
contrast to the CD4+ T help for B cell activation that is provided directly, help for
CD8+ T cell activation in mice is delivered indirectly through an MHC Class II and
Class I expressing, antigen-presenting cell (Bennett, Carbone, Karamalis, Miller, &
Heath, 1997; Ridge, Di Rosa, & Matzinger, 1998).  The antigen-presenting cell
bridge between CD4+ T helper cells and CD8+ T cells is essential for the generation
of primary and secondary antigen-specific cellular responses (Shedlock & Shen,
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2003; Sun & Bevan, 2003). Some CD8+ T cell responses can be generated in the
absence of CD4+ T cells, such as those generated against LCMV, Sendai, and some
strains of influenza virus (Homann, McGavern, & Oldstone, 2004; Wong & Pamer,
2003; Wu & Liu, 1994). In general, these responses fail to be sustained in the
absence of appropriate CD4+ T cell help (Bourgeois, Veiga-Fernandes, Joret, Rocha,
& Tanchot, 2002; Hunziker, Klenerman, Zinkernagel, & Ehl, 2002; Janssen et al.,
2003; Shedlock & Shen, 2003; Sun & Bevan, 2003; Zhan, Corbett, Brady,
Sutherland, & Lew, 2000), and hence memory CD8+ T cell responses are impaired.
1.1.3. The Anatomical Organization and Development of Cells of
the Immune System
In order to provide the best possible defense against a pathogen when the skin
or mucosal barriers are broken, immune cells are in sentinel locations beneath the
skin and mucosal tissues, and possess the potential to circulate throughout the body
via an extensive system of vessels and immune organs (Gowans, 1959; Gowans &
Steer, 1980; Merad et al., 2002; Steinman, 1991).  This network is called the
lymphatic system.  It parallels the circulatory system, collecting any fluid that has
leaked from the circulatory system into interstitial spaces.  The draining lymphatic
fluid and the infectious pathogens it potentially contains are collected and delivered
to immune related organs (Abbas et al., 2000; Clark, 1983).
The first lymphoid organ encountered is a lymph node.  Lymph nodes are
distributed throughout the body and are central for the entrapment and recognition of
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foreign antigens by cells of the immune response (Clark, 1983; Harris, Harris, Beale,
& Smith, 1954; N. J. Warner, A. Szenberg, & F. M. Burnet, 1962).  Antigens may
enter the lymph nodes in one of two ways, either suspended in lymphatic fluid or as
an engulfed antigen harbored inside a migrating antigen presenting cell (Steinman,
1991).  Antigen presenting dendritic cells are specialized for this task (Guery &
Adorini, 1995).  Upon antigen uptake, they undergo a differentiation step that
enables them to extravasate from peripheral tissues, and transmigrate through the
lymphatic vessels to the draining lymph nodes (Romani et al., 1989; Sallusto &
Lanzavecchia, 2000; Steinman et al., 2003).  Draining lymph nodes are the first site
where the innate and previously unexposed adaptive cells of the immune system
come together for the generation of primary antigen-specific immune responses.
While antigens are being presented to antigen-specific CD4+ and CD8+ T cells in
the lymph nodes, the cells of the innate immune response are recruited to the site of
infection and attempt to contain pathogenic microorganisms by creating an
inflammatory environment (Rosenberg & Gallin, 1999).
A second site where innate and adaptive immune cells come together is the
spleen (Picker & Siegelman, 1999).  In contrast to lymph nodes that are fed by the
lymphatic vessels, the spleen receives circulating lymphocytes through the blood
(Clark, 1983). The spleen is composed of two sections.  The red pulp is composed of
RBCs that are destined for removal, and the white pulp is composed of lymphocytes
(Abbas et al., 2000).
There are additional lymphoid tissues and organs of the immune system;
however, unlike the lymph nodes and spleen, two of these organs, the bone marrow
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and thymus, are not involved in the entrapment and recognition of foreign antigens
for the generation of immune responses. The major function of these organs is the
generation and development of immune cells (Claman, Chaperon, & Hayes, 1969;
Miller, 1964; Picker & Siegelman, 1999).
All of the red blood cells and white cells found in the blood and lymph are
generated from pluripotent, hematopoetic stem cells in the bone marrow (Abbas et
al., 2000; Ikuta, Uchida, Friedman, & Weissman, 1992). In addition to being the
major site for hematopoesis in higher vertebrates, the bone marrow is also the
primary site where B cell development occurs (Hardy & Hayakawa, 2001; Howard,
Hunt, & Gowans, 1972). Only one species, the avian species, possesses a separate
organ where B cell development occurs.  This organ is called the Bursa of Fabricus
and it is located at the lower end of the intestine (Glick, Chang, & Jaap, 1956;
Warner & Szenberg, 1964).  Its removal at the time of birth results in a complete
lack of antibody producing cells (Szenberg, 1970); hence the coining of the term B
cell.
Another lymphoid organ, the thymus, is similar to the Bursa of Fabricus in
that it also involutes with age (Picker & Siegelman, 1999).  However, the thymus is
the site of T lymphocyte development rather than B cell development (Miller, 1964).
The unique environment of the thymus positively selects progenitor T cells that bear
T cell receptors that can recognize self-MHC complexes (Jameson, Hogquist, &
Bevan, 1995).  The recognition of Class II complexes leads to the development of
self-MHC restricted CD4+ T cells, and the recognition of Class I MHC complexes
leads to the development of self-MHC restricted CD8+ T cells from CD4+CD8+
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double positive thymocytes.  Positive selection of self-restricted CD4+ and CD8+ T
cells occurs in the cortical regions of the thymus (Anderson, Moore, Owen, &
Jenkinson, 1996; Laufer, DeKoning, Markowitz, Lo, & Glimcher, 1996).  When
these thymocytes migrate into the medullary regions of the thymus, cells that bear T
cell receptors that are specific for, and possess high affinity for, peptides derived
from ubiquitous self-antigens seen in the context of self-MHC are removed from the
developing lymphocyte pool by the induction of apoptosis (Palmer, 2003).  The
result of T cell development in the thymus is thus a pool of single positive, self-
MHC restricted, CD4+ and CD8+ T cells that express a diverse array of ab T cell
receptors that primarily recognize peptides derived from foreign antigens (Bevan,
Hogquist, & Jameson, 1994).  While originally describing tolerance induction of
antibody producing cells, Burnet and Lederberg correctly predicted that the removal
of a vast array of self-reactive lymphocytes, ab TCR bearing CD4+ and CD8+ T
cells in today’s terminology, is essential for tolerance towards self (Burnet, 1959;
Lederberg, 1959).  The deletion of self-reactive clones in the thymus during T cell
development is referred to as central tolerance.  However, this mechanism of self-
tolerance induction does not remove all of the CD4+ and CD8+ T cells capable of
recognizing self-antigens. A number of T cells with specificity for organ specific
antigens that are not abundantly expressed in the thymus escape clonal deletion and
are present in the peripheral T cell pool (Bouneaud, Kourilsky, & Bousso, 2000;
Fowell & Mason, 1993; Goldrath & Bevan, 1999; Jiang et al., 2003; Kuchroo et al.,
2002; Lesage et al., 2002).
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Developing B cells are also subject to self-tolerance mechanisms (Goodnow,
Adelstein, & Basten, 1990).  However, unlike T cells that must recognize self-
peptide in the context of MHC antigens, helper cell dependent B cells undergo
apoptosis when immunoglobulin receptor ligation by antigen occurs in the absence
of T cell help (Bretscher, 1975; Fulcher et al., 1996; Goodnow, Crosbie, Jorgensen,
Brink, & Basten, 1989).  This can occur in the bone marrow, or in the periphery
(Chung, Silverman, & Monroe, 2003). The majority of B cells with immunoglobulin
receptors for ubiquitous self-antigens are lacking because of the absence of CD4+ T
helper cells with self-specificity (Goodnow et al., 1989). A minority of B cells
escape clonal deletion because they express immunoglobulin receptors specific for
self-antigens inaccessible to the B cell (Ferry, Jones, Vaux, Roberts, & Cornall,
2003). These B cells include those specific for self-antigens that are sequestered
inside of cells, which are also normally expressed at very low levels. The existence
of such cells in the periphery, and the possibility that cognate peripheral self antigen-
specific CD4+ T helper cells are also present leads one to question how the immune
system prevents their activation (Cook, Basten, & Fazekas de St Groth, 1998; Lesage
et al., 2002) and exemplifies the need for a mechanism to regulate T cell activation in
the periphery.
Thus, the immunological question that was a concern even in the days of
Ehrlich remains (Ehrlich, 1900); how are immune responses against foreign
antigens/pathogens selectively generated and responses against self, in modern
terms, peripheral self, circumvented?
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1.2. CD4+ T Helper Cells
1.2.1. CD4+ T cell Subsets
CD4+ T helper cells are the orchestrators of the antigen-specific immune
responses.  Modern knowledge that protective cellular and humoral immunity tend to
be mutually exclusive allows the division of activated CD4+ T helper cells into
distinct subsets (Mosmann & Coffman, 1989; Swain et al., 1991). While many
responses are mixed, CD4+ T cells that help in the generation of cytotoxic CD8+ T
cell responses, and delayed-type-hypersensitivity reactions generally belong to the
Th1 subset (Cher & Mosmann, 1987; Wong & Pamer, 2003).  Th1 responses are
effective at containing intracellular pathogens, of which M. tuberculosis and
Leishmania species are prime examples (Bretscher, Hamilton, & Ogunremi, 2002;
Sacks & Noben-Trauth, 2002).  Th1-type cytokines include IL-2, IFN-g, LT
(lymphotoxin), IL-12, and IL-18 (Lewkowich & HayGlass, 2002; Mosmann &
Coffman, 1989; Nakanishi, Yoshimoto, Tsutsui, & Okamura, 2001; Rempel, Wang,
& HayGlass, 1997; Seder, Gazzinelli, Sher, & Paul, 1993; Smeltz, Chen, Ehrhardt, &
Shevach, 2002).  In addition to aiding in the differentiation of CTLs, the secretion of
Th1-type cytokines activates macrophages, and natural killer cells of the innate
immune response (Hoebe et al., 2004).  On a molecular level, the commitment to the
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Th1 lineage is associated with the expression of the transcription factor T-bet
(Mullen et al., 2001; Robinson & O'Garra, 2002)
CD4+ T cells that help in the generation of humoral responses generally
belong to the Th2 subset (Mosmann & Coffman, 1989).  These responses are
effective in the defense against pathogens that are extracellular or have a significant
extracellular phase, which includes helminth parasites and circulating viruses,
respectively (Ahmed & Biron, 1999; Pearce, Scott, & Sher, 1999; Sher, Fiorentino,
Caspar, Pearce, & Mosmann, 1991).  Th2-type cytokines include IL-4, IL-5, IL-6,
IL-13, IL-9, and in some situations IL-10 (Mosmann & Coffman, 1989; Sher et al.,
1991; Swain et al., 1991; Swain, Weinberg, English, & Huston, 1990).  IL-4 is a
growth factor that promotes the proliferation of antibody-producing B cells, and
promotes mast cell activation (Pfeifer, McKenzie, Swain, & Dutton, 1987).  Other
Th2-type cytokines influence the class of antibody produced (Abbas et al., 2000).
Th2 lineage commitment is typically associated with the expression of the
transcription factor GATA-3 (Farrar et al., 2001; Robinson & O'Garra, 2002; Zhang,
Cohn, Ray, Bottomly, & Ray, 1997).
1.2.2. T cell Differentiation into Th1/Th2 Type Subsets
The more general knowledge that CD4+ T cells have different functions
depending on their cytokine profile led to their separation into distinct Th1 and Th2
subsets (Mosmann & Coffman, 1989).   In some cases, segregation of subsets
correlates with either resistance or susceptibility to infection (Bretscher, Ogunremi,
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& Menon, 1997; Hailu et al., 2001).  In general terms, intracellular pathogens are
best controlled by Th1 responses, whereas, extracellular pathogens are best
controlled by Th2 responses (Bretscher et al., 2002).  The realization that separate
subsets correlate with protective immunity spurred the development of a number of
experimental systems to delineate what factor(s) influence CD4+ T cell Th1/Th2
lineage commitment (Constant & Bottomly, 1997; Del Prete, 1998). The delineation
of such factors is important for an understanding of how CD4+ T cell differentiation
occurs in response to antigenic challenge.
Although the exact mechanisms governing the initial lineage instruction of
naïve CD4+ T cells is still unknown, a number of factors are believed to influence
lineage commitment.  The factors influence both in vitro and in vivo CD4+ T cell
differentiation (Murphy & Reiner, 2002; Seder & Paul, 1994).  They include the
cytokine milieu present at the initiation of responses, the dose of antigen used to
stimulate naïve CD4+ T cells, and the nature and the type of antigen presenting cell
that presents foreign antigen-derived peptides to naïve CD4+ T cells (Constant &
Bottomly, 1997; Hosken, Shibuya, Heath, Murphy, & O'Garra, 1995; Maldonado-
Lopez, Maliszewski, Urbain, & Moser, 2001; Moser & Murphy, 2000; Seder & Paul,
1994).  Initial research dealing with CD4+ T cell lineage commitment largely dealt
with how the cytokine milieu present at priming influences naïve CD4+ T cell
differentiation (HayGlass, Wang, Gieni, Ellison, & Gartner, 1996; Mosmann &
Coffman, 1989; Swain, Weinberg, English et al., 1990; Yang & HayGlass, 1993).
The influence of cytokines on the development of CD4+ T cell lineage
commitment, which follows the initial activation events, is well established.  The
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presence of IFN-g, IL-12, or IL-18 favors the generation of Th1 type responses,
whereas the presence of IL-4, IL-5, or IL-13 favors the generation of Th2 responses
(Bradley, Yoshimoto, & Swain, 1995; Seder, Paul, Davis, & Fazekas de St Groth,
1992; Smeltz et al., 2002; Swain, Weinberg, English et al., 1990).  Cross-regulation
is the modulation of established responses by the presence of cytokines.  The
presence of IL-12 stimulates the up regulation and maintenance of IFN-g receptors
on precursors destined to be Th1 type effectors, and suppresses the expression of IL-
4 (So, Park, & Lee, 2000; Trinchieri, 1995).  The presence of IL-4 down-regulates
the production of IL-12 by APC, such as dendritic cells, and suppresses IFN-g
production in precursors destined to become Th2 effectors (Murphy & Reiner, 2002;
Nelms, Keegan, Zamorano, Ryan, & Paul, 1999).
The demonstration of the importance of the cytokine milieu leads to the
question of how the differential production of Th1 and Th2 cytokines occurs when
naïve precursor CD4+ T cells encounter a foreign antigen.  It is evident from a
number of studies that the nature and dose of antigen plays a large role in T cell
activation and Th1 or Th2 lineage commitment (Adkins, Jones, Bu, & Levy, 2004;
Boonstra et al., 2003; Bretscher, Wei, Menon, & Bielefeldt-Ohmann, 1992; Hosken
et al., 1995; Menon & Bretscher, 1998; Parish, 1971; Power, Wei, & Bretscher,
1998; Sarzotti, Robbins, & Hoffman, 1996; Taylor-Robinson & Phillips, 1998).
However, there are some conflicting findings as to which dose of antigen
preferentially induces the production of a Th1 type or Th2 type cells.  Some report
that low doses of antigen preferentially stimulate the generation of Th2 type
responses, moderate doses preferentially stimulate Th1 type responses, while very
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high does favor the generation of Th2 type cells (Boonstra et al., 2003; Constant &
Bottomly, 1997; Hosken et al., 1995; Rogers & Croft, 1999).  Other studies provide
evidence that low doses of antigen, or infectious agents, lead to the generation of
Th1-type responses, and high doses the generation of Th2 responses (Adkins et al.,
2004; Bretscher et al., 1992; Menon & Bretscher, 1998; Parish, 1971; Power et al.,
1998; Sarzotti et al., 1996; Taylor-Robinson & Phillips, 1998).  The varied
conclusions made in regards to influence of different antigen doses may be reflective
of the marked differences in the experimental systems employed, such as the use of
normal versus TCR transgenic mice as host animals.
Precursor cell number can also influence the Th1/Th2-type nature of the
immune responses upon stimulation with antigen (Bretscher, 1983a; Harris et al.,
1954; Ismail & Bretscher, 2001; Liew, Millott, Lelchuk, Cobbold, & Waldmann,
1989; Titus, Ceredig, Cerottini, & Louis, 1985). For instance, in an in vivo model of
Leishmania, the partial depletion of CD4+ cells switches the immune response
normally generated in susceptible mice, which is Th2 in nature, to a protective one
that is predominately Th1 (Liew et al., 1989; Titus et al., 1985).  Further findings
demonstrate that the number of cells adoptively transferred to lethally irradiated mice
determines the Th1/Th2 phenotype of the response generated against SRBC
(Bretscher, 1983b; Ismail & Bretscher, 2001).  A threshold number of adoptively
transferred precursor cells is required for immune responses to be generated, and
once this threshold is reached, a low number of cells favors the development of Th1
responses, whereas, a high number favors the generation of Th2 type responses.
Hence, the number of naïve CD4+ T cells present upon antigen encounter, or
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alternatively, the number stimulated to proliferate upon exposure to antigen can also
influence the generation of immune responses and the subsequent Th1/Th2 lineage
commitment of the antigen-specific precursor, CD4+ T cells (Bretscher, 1983a;
Gerloni et al., 2000; Strutt & Bretscher, 2005; Tucker & Bretscher, 1982).
The proper regulation of CD4+ T cell lineage commitment to Th1/Th2
subsets is central to the development of protective immunity. Although the exact
mechanisms underlying lineage commitment and regulation of immune responses are
unknown, the decisive events are likely tightly associated with the events involved in
primary T cell activation.
1.2.3. Regulation of Immune Responses and T Regulatory Cells
A number of regulatory mechanisms brought about by the presence of
cytokines and inhibitory signals are known to influence T cell survival and
differentiation. These regulatory mechanisms include those that indirectly inhibit T
cell proliferative responses by down-regulating cytokine synthesis and accessory cell
functions of antigen presenting cells, such as the pleiotrophic effects of the auto-
regulated cytokine IL-10 (Fiorentino, Zlotnik, Mosmann, Howard, & O'Garra, 1991;
Moore, O'Garra, de Waal Malefyt, Vieira, & Mosmann, 1993; Sher et al., 1991).
They also include those mechanisms that regulate the phenotype of established
Th1/Th2 type responses, which includes the cytokines IL-12 and IL-4 (Mosmann et
al., 1991), whose affects were discussed in the previous section.  The effects of
inhibitory signals such as those induced by ligation of cell surface receptors, such as
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CTLA-4-B7 ligation, can also influence the generation of immune responses (Egen,
Kuhns, & Allison, 2002; Thompson & Allison, 1997).  Ligation of these surface
molecules, which will be discussed in more depth in section 1.3, can induce the
metabolism of tryptophan by the enzyme indolamine 2,3-dioxygenase, which is
produced by appropriately triggered antigen presenting cells, to result in the release
of metabolites that induce apoptosis in T cells (Grohmann et al., 2002; Leibson,
2004; Steinman et al., 2003).
Immune responses can also be regulated by distinct subsets of T cells that can
influence both the phenotype and magnitude of established immune responses
(Asherson, Colizzi, & Zembala, 1986; Chess & Jiang, 2004; Ramshaw, McKenzie,
Bretscher, & Parish, 1977; Shevach, 2002).  These cells were originally termed
suppressor cells, but in the modern literature, they are known as T regulatory cells. A
recently identified subset of regulatory cells, the CD25+ CD4+ T cell subset, may
also participate in the distinction of self from non-self (Fulcher et al., 1996;
Sakaguchi, Sakaguchi, Asano, Itoh, & Toda, 1995; Shevach, McHugh, Piccirillo, &
Thornton, 2001).
At least three distinct subsets of CD4+ T regulatory cells exist.  Tr-1
regulatory cells are associated with the secretion of high levels of IL-10 and TGF-
b, which again are cytokines that suppress a number of cell functions including the
indirect inhibition of T cell proliferation through suppression of the production of
cytokines and several accessory cell functions of antigen-presenting cells (Annacker
et al., 2001; Barrat et al., 2002; Fowler & Powrie, 1999; von Boehmer, 2003).  In
addition to the secretion of IL-10 and TGF-b, the second Th3 regulatory cells subset
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is also associated with the secretion of IL-4 (Seddon & Mason, 1999; von Boehmer,
2003).  The CD25+ CD4+ T cell subset is distinct from Tr-1 and Th3 cells in that the
repeated stimulation of CD4+ T cells with antigen in the presence of IL-10 and TGF-
b fails to lead to their generation (Jonuleit, Schmitt, Schuler, Knop, & Enk, 2000;
Shevach, 2002; von Boehmer, 2003). CD25+ CD4+ T regulatory cells are thought to
be generated in the thymus, require cell contact to mediate their suppressor
functions, and to date they have not been solidly associated with the secretion of
cytokines (Apostolou, Sarukhan, Klein, & von Boehmer, 2002; Jordan et al., 2001;
Nakamura, Kitani, & Strober, 2001; Shevach, 2002).  The most reliable marker for
CD25+CD4+ T cells is the expression of the transcription factor FOXP3 (Chen et al.,
2003; Fontenot, Gavin, & Rudensky, 2003; Hori, Nomura, & Sakaguchi, 2003).
The presence of CD25+ CD4+ T regulatory cells inhibits the generation of
autoimmune responses in experimentally generated lymphopenic environments
(Fowell & Mason, 1993; Sakaguchi et al., 1995). The possibility now exists that
CD25+ CD4+ T cells may play an essential role in the maintenance of peripheral
self-tolerance possibly through CTLA-4 triggered tryptophan metabolism
(Grohmann et al., 2002; Sakaguchi, 2004). Results indicate that the generation of
CD25+CD4+ T regulatory cells may occur by an unknown mechanism in the thymus
(Apostolou et al., 2002; Jordan et al., 2001).  However, in light of the fact that there
is uncertainty in the means by which these cells are activated and regulated in the
periphery, it may be premature to conclude that these cells participate in the
discrimination of immunological self from non-self (Belkaid, Piccirillo, Mendez,
Shevach, & Sacks, 2002; Fulcher et al., 1996; Pasare & Medzhitov, 2003; Yamazaki
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et al., 2003).  The observation that the removal of such cells from normal mice fails
to result in the generation of autoimmune disease reinforces this concern (McHugh
& Shevach, 2002; Shevach, 2002).  It may be reasonable to speculate that CD25+
CD4+ T cells function to regulate the homeostasis of peripheral naïve and memory T
cells (Annacker, Burlen-Defranoux, Pimenta-Araujo, Cumano, & Bandeira, 2000;
Bhandoola et al., 2002; Gavin & Rudensky, 2003; Ge, Palliser, Eisen, & Chen, 2002;
King, Ilic, Koelsch, & Sarvetnick, 2004; Murakami, Sakamoto, Bender, Kappler, &
Marrack, 2002)
1.2.4. T cell Differentiation into Memory Cells
Immunological memory is a hallmark of the adaptive immune response.
CD4+ T helper cells play a large role in the maintenance of these responses. CD4+ T
memory cells hasten the rate by which specific immune responses are orchestrated
upon a secondary encounter with a pathogen (Dutton, Bradley, & Swain, 1998).
The rapidity of memory responses is largely attributed to the clonal expansion
of antigen-specific CD4+ and CD8+ T cells, and antigen-specific B cells during the
generation of primary immune responses (Bradley, Duncan, Yoshimoto, & Swain,
1993; Leduc, Coons, & Connolly, 1955; Plata et al., 1975).  The majority of clonally
expanded and activated cells will die of exhaustion, competition for antigen
presented by antigen presenting cells, or because of withdrawal of required growth
factors after the clearance of antigen (Belkaid et al., 2001; Hunziker et al., 2002;
29
Kedl et al., 2000; Kundig et al., 1996; Sprent & Tough, 1994; Uzonna, Wei,
Yurkowski, & Bretscher, 2001).  A small population of the antigen-specific cells,
normally those that express high affinity receptors for the antigen in question,
survives as a memory subset (Kedl et al., 2000).  One sub-type of memory cells, the
effector memory cells, can traffic throughout the body through the lymphatic system,
and another, the central memory subset, is centrally located within the lymphoid
organs (Blander et al., 2003; Huehn et al., 2004; Sallusto, Lenig, Forster, Lipp, &
Lanzavecchia, 1999).
There is some debate in the literature as to whether the generation of memory
cells follows a linear path from naïve to effector to memory cell, or whether naïve T
cells directory differentiate into memory cell subsets (Kaech, Wherry, & Ahmed,
2002; Lanzavecchia & Sallusto, 2002; Swain, Agrewala, Brown, & Roman, 2002).
The most recent decisive factor reported to influence the memory cell fate of an
activated T cell is the activation status of antigen presenting cells (de Heusch et al.,
2004). However, it remains possible that both the linear and direct pathways lead to
memory T cell generation.  In order for the more revealing evidence to be obtained,
definitive surface markers on all subsets of T memory cells, particularly resting
memory T cells, must be identified (Ahmadzadeh, Hussain, & Farber, 2001;
Birkeland, Johnson, Trowbridge, & Pure, 1989; Goldrath, Bogatzki, & Bevan, 2000;
Hengel et al., 2003; Kelly & Scollay, 1990). While their definitive identification and
means of generation remain a topic of debate, memory CD4+ T helper cells are
undoubtedly essential for the mediation of protective cellular and humoral
immunological memory against infectious organisms.
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1.3. Naive T cell Activation
1.3.1.  The Signals Involved in T cell Activation
The activation of CD4+ T cells must be tightly regulated because these cells
are, for the most part, the guardians over the activation and establishment of
antigen specific immune responses, immunological memory, and tolerance towards
peripheral self.  As mentioned previously, Burnet, Talmage, and Lederberg have all
formulated models to provide a rationale for how the immune system discriminates
self-from non-self (Burnet, 1959; Lederberg, 1959; Talmage & Pearlman, 1963).  In
the context of modern knowledge of central tolerance and the importance of CD4+ T
cells in the generation and mediation of B cell and CD8+ T cell immune responses, it
is clear that the mechanisms that regulate the activation of CD4+ T cells are central
to the maintenance of tolerance towards peripheral self-antigens (Goldrath & Bevan,
1999; Hanahan, 1998).
The frequency of naïve T cells that exit the thymus and are specific for any
one antigen is initially small, in the order of magnitude of one in 104-105 cells
(Blattman et al., 2002; Goldrath & Bevan, 1999).  In order to orchestrate protective
immune responses, naïve T cells must selectively increase in number.  Since the
seminal observations of Jenkins and Schwartz, the initial expansion and activation of
T cells to generate effector T cells is now known to involve several complex
interactions between the T cell and the antigen-presenting cell presenting the relevant
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antigen (Abbas et al., 2000; Jenkins & Schwartz, 1987).  For CD4+ T cells,
activation results in the acquisition of the ability to secrete cytokines, replicate, and
differentiate into competent cells that help in the mediation of cellular and humoral
immune responses (Weiss, 1999). For CD8+ T cells, activation results in the ability
to secrete cytokines, replicate, and differentiate into mature cytolytically active cells.
The lack of the receipt of all of the appropriate signals during T cell activation can
lead to a period where the recently expanded T cells, CD4 or CD8+ T cells, are
refractory to further activation signals and are susceptible to activation induced cell
death (Kishimoto & Sprent, 1999; Kurts, Carbone et al., 1997; Kurts, Kosaka,
Carbone, Miller, & Heath, 1997; Nossal & Pike, 1980; Schwartz et al., 1989).
Recognition of peptide-MHC molecules, presented on the surface of antigen-
presenting cells, by the T cell receptor of a naïve T cell results in the generation of
the first signal required for T cell activation (Bretscher & Cohn, 1970; Jenkins &
Schwartz, 1987).  This signal results in the activation of various kinases and
phosphatases within the T cell and within the antigen-presenting cell (Schwartz et
al., 1989; Weiss, 1999).  The receipt of signal 1, which causes an influx in
intracellular calcium, results in the translocation of DNA-binding proteins into the
nucleus and the initiation of gene transcription (Abbas et al., 2000).  In a resting T
cell, signal 1 results in the expression a number of genes encoding immune related
encoding proteins including IL-2, the primary growth factor for most T cells (Smith,
1984).  Activation to cell division requires additional receptor-ligand interactions,
which were originally thought to be generated by the provision of IL-1 or recognition
of IL-2 by the IL-2 receptor (Malek, Ashwell, Germain, Shevach, & Miller, 1986;
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Manger, Weiss, Weyand, Goronzy, & Stobo, 1985; Smith, 1984).  It is now
generally accepted that a large number of accessory molecules participate in
costimulating the intracellular signals triggered by T cell receptor stimulation, in
either the presence or absence of IL-2 (Coyle & Gutierrez-Ramos, 2001; Croft &
Dubey, 1997; Weiss, 1999).
However, it remains unclear which accessory or costimulatory molecules are
essential for the generation of T cell responses because a number perform redundant
roles, act in concert, or function in a temporal fashion (Boussiotis, Freeman,
Gribben, & Nadler, 1996; Coyle & Gutierrez-Ramos, 2001; Croft & Dubey, 1997;
Lanier et al., 1995; Lenschow, Walunas, & Bluestone, 1996; Watanabe et al., 2003).
For example, the costimulatory molecules B7-1/CD80 and B7-2/CD86 that are
differentially expressed on antigen-presenting cells can both bind CD28 (Lanier et
al., 1995), a molecule constitutively expressed on the surface of T cells (Lenschow et
al., 1996).  The B7 molecules can also bind alternate receptors, such as CTLA4,
which is maximally expressed 48 to 72 hours after the initial activation of T cells
(Linsley, 1995).  Ligation of CTLA4 or alternative receptors that also bind B7, such
as PD-1 and BTLA, also negatively regulate the generation of T cell responses by
halting T cell proliferation and/or by inducing T cell apoptosis, possibly by inducing
the metabolism of tryptophan as introduced in section 1.2.3. (Boussiotis et al., 1996;
Carreno & Collins, 2002; Egen et al., 2002; Grohmann et al., 2002; Okazaki, Iwai, &
Honjo, 2002; Watanabe et al., 2003).  Members of the TNF/TNFR family of surface
molecules expressed on antigen-presenting cells have also been implicated as being
essential co-receptors for surface molecules on T cells, and these include CD40, 4-
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1BB, CD27, and Ox-40 (Croft & Dubey, 1997; Johnson-Leger, Christensen, &
Klaus, 1998; Ohshima et al., 1998; Rogers & Croft, 2000; Wen, Bukczynski, &
Watts, 2002; Wu et al., 1995).  In general, the B7-CD28 costimulatory interactions,
in addition to those interactions that are involved in stabilizing T cell-APC contact,
such as the ICAM-1-LFA ligation, are essential for primary CD4+ T cell activation
(Dubey, Croft, & Swain, 1995; Green et al., 1994; Harding, McArthur, Gross,
Raulet, & Allison, 1992; Jenkins, Taylor, Norton, & Urdahl, 1991), and CD40-
CD40L interactions are essential for CD8+ T cell activation (Bennett et al., 1998;
Borrow et al., 1998; Lanier et al., 1995; Shepherd & Kerkvliet, 1999; Sigal, Reiser,
& Rock, 1998).  Other interactions possibly function to allow responses to proceed
and develop efficiently once responses are initiated (Banchereau et al., 1994; Lee,
Haynes, Eaton, Swain, & Randall, 2002; Maxwell, Campbell, Kim, & Vella, 1999;
Wallin, Liang, Bakardjiev, & Sha, 2001).
T cell activation is thus a multi-step process, involving a cascade of
costimulatory events initiated after antigen-dependent T cell receptor ligation
(Carreno & Collins, 2002; Coyle & Gutierrez-Ramos, 2001; Croft & Dubey, 1997;
Lenschow et al., 1996).  Several phenotypic changes accompany the process of T
cell activation.  These include the up-modulation on the surface of the T cell the
expression of CD40L, the IL-2 receptor, CD69, and CD44 (Budd et al., 1987; Dutton
et al., 1998; Jaiswal, Dubey, Swain, & Croft, 1996; Minami, Kono, Miyazaki, &
Taniguchi, 1993; Swain et al., 1991), and the down-modulation of such surface
ligands as CD62L and CD45RB (Birkeland et al., 1989; Dutton et al., 1998; Gallatin,
Weissman, & Butcher, 1983).  The same molecules that are up/down modulated
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during activation can be down/up modulated during the differentiation pathway to
resting memory cells (Ahmadzadeh et al., 2001; Hengel et al., 2003; Kassiotis &
Stockinger, 2004; Ponta, Wainwright, & Herrlich, 1998). The early realization of
transitory expression of such markers has lead some to suggest “that there are no
markers of [T cell] memory, but only markers of activation” (Mitchison, 1992).
Of the antigen presenting cells of the immune system, being macrophages,
dendritic cells, and B cells, the dendritic cell is the most favored cell implicated in
participating in the initial activation of naïve T cells (Banchereau & Steinman, 1998;
Metlay, Pure, & Steinman, 1989; Unanue, 1984). Primed CD4+ T cells can help
resting B cells become efficient stimulator cells of naïve T cells (Ho, Cooke,
Goodnow, & Davis, 1994).  However, on a per cell basis they are generally
considered inferior in their capacity to stimulate naïve T cells (Cassell & Schwartz,
1994; Constant, Schweitzer, West, Ranney, & Bottomly, 1995; Lassila, Vainio, &
Matzinger, 1988; Steinman & Witmer, 1978; Tzehoval et al., 1983).  This view is
primarily based on the fact that B cells specific for any given antigen are relatively
rare, even in immunized animals.
Dendritic cells are the most favored cell implicated in participating in the
initial activation of naïve T cells because of their ability to sample peripheral
antigens, their ability to migrate into the T cell zones of the lymph nodes (Itano &
Jenkins, 2003; Reis e Sousa et al., 1997), and their constitutive expression of low
levels, and up-modulated expression of high levels of the costimulatory molecules
B7-1, B7-2, ICAM, LFA-3 and CD40 (Inaba et al., 1994; Larsen et al., 1994; Sporri
& Reis e Sousa, 2003).  To date, five different dendritic cell subtypes have been
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defined (Henri et al., 2001; Shortman & Liu, 2002; Vremec, Pooley, Hochrein, Wu,
& Shortman, 2000; Vremec & Shortman, 1997), and all are now believed to
originate from precursors found in the bone marrow (Shortman & Liu, 2002; Traver
et al., 2000; Wu et al., 2001). In general, all subtypes are believed to have a capacity
for initiating immune responses in their activated state (Shortman & Heath, 2001;
Shortman & Liu, 2002; Vremec et al., 2000), and the two major subtypes, the CD4-
CD8a+, and the CD4-CD8a- dendritic cells, have been demonstrated to be
functionally plastic in the stimulation of Th1/Th2 responses (Boonstra et al., 2003;
Guermonprez et al., 2002).  The spleen harbors three subtypes, which are the
CD4+CD8a-, the CD4-CD8a+, and the CD4-CD8a- dendritic cells (Vremec et al.,
2000; Vremec & Shortman, 1997).  The lymph nodes contain two additional
subtypes that are not normally found in the spleen, and these include the CD4-
CD8a-CD11b+ dendritic cells that also express moderate levels of CD205, and a
subtype of dendritic cells that express an array of myeloid markers including CD11b,
low CD8a, and high levels of CD205 that can be found in the skin-draining lymph
nodes (Henri et al., 2001; Shortman & Liu, 2002).  The latter is distinguished from
other subtypes of dendritic cells by high expression of langerin, a characteristic
marker of epidermal Langerhans cells (Henri et al., 2001).  Those dendritic cells in
an immature state, in general, fail to initiate immune responses and it has been
proposed that they have the potential to inactivate T cells.  One subtype, specifically
the CD8a expressing dendritic cells, may be specialized for this task.  However, to
date, a consensus has not been reached on this matter (Belz et al., 2002; Belz et al.,
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2004; Grohmann et al., 2003; Grohmann, Fallarino, Bianchi et al., 2001; Shortman &
Heath, 2001; Smith et al., 2003; Winkel, Kronin, Krummel, & Shortman, 1997).
1.3.2. Contemporary Models for the Control of the Delivery of Signal
Two
All contemporary models that attempt to describe the nature of events
involved in naive T cell activation agree that two signals are required (Bretscher,
1999; Janeway, 1989; Matzinger, 1994).  The provision of signal one alone, through
recognition of antigen by the T cell receptor without costimulation, fails to result in
the subsequent activation of the T cell.  The receipt of signal 1 alone can result in the
induction of a state of anergy, which may or may not be broken by the provision of
IL-2, or it may result in the induction of apoptosis (Guinan et al., 1999; Jenkins &
Schwartz, 1987; Kishimoto & Sprent, 1999; Schwartz, 2003).  Provision of signal
one in conjunction with a costimulatory signal two results in T cell activation
(Fulcher et al., 1996; Jenkins et al., 1991; Lenschow et al., 1996; Sperling et al.,
1996; Tao, Constant, Jorritsma, & Bottomly, 1997).  Hence, the regulation of the
expression of costimulatory molecules on antigen-presenting cells that collectively
result in the generation of signal two is of central importance to naive T cell
activation.  Competing contemporary models of naive T cell activation differ greatly
in the mechanisms by which the up-regulation of signal two is initiated and
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regulated.  Each model possesses particular strengths and weaknesses, which will be
discussed.
1.3.3. The Infectious Non-Self Model
To account for a need to preferentially activate T helper cells with foreign
antigen-specificity, C. Janeway Jr. proposed that the immune system has evolved to
specifically recognize the presence of infectious non-self (Janeway, 1989).  C.
Janeway Jr. postulated that the requirement in a number of experimental systems for
the presence of bacterial adjuvant to efficiently induce the generation of immune
responses against simple protein antigens is directly related to the generation of
signal two (Janeway, 1989).  He rationalized that recognition of bacterial products,
present in adjuvant, by a receptor present on the antigen presenting cells stimulates
the up-regulation of the molecules mediating the delivery of signal two.  In modern
terms, the recognition of pathogen-derived products by antigen-presenting cells
occurs through ligation of receptors more commonly referred to as Toll-like
receptors (Iwasaki & Medzhitov, 2004; Takeda, Kaisho, & Akira, 2003).  The
intracellular signaling pathways triggered by Toll-like receptor ligation result in the
up-regulation of costimulatory molecules B7.1 and B7.2 on the antigen-presenting
cell surface, and the expression and release of inflammatory mediators IL-1, IL-6,
and IL-8 (Agrawal et al., 2003; Fulcher et al., 1996; Iwasaki & Medzhitov, 2004;
Takeda et al., 2003).
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C. Janeway Jr. rationalized that self-antigens would fail to trigger the up-
modulation of costimulatory molecules on antigen-presenting cells, and therefore the
activation of any self-reactive T cells that escaped central tolerance mechanisms in
the thymus would fail to occur (Janeway, 1989).  He also rationalized that dendritic
cells, which constitutively express costimulatory molecules on their surface (Inaba et
al., 1994; Larsen, Ritchie, Pearson, Linsley, & Lowry, 1992), pose a particular threat
to self-tolerance, but dismissed these cells as participants in T cell activation because
of their inefficient antigen uptake (Janeway, 1989). In light of modern knowledge
that dendritic cells are in fact very potent antigen-presenting cells that take up
antigen in a differentiation dependent manner, mature activated dendritic cells have
in general lost their ability to acquire antigen (Banchereau & Steinman, 1998;
Romani et al., 1989; Steinman, 1991), it is difficult to rationalize a mechanism
within the context of this model that results in the preferential activation of foreign
antigen-specific T cells.   Of late, C. Janeway Jr. has stated “My personal opinion is
that autoimmunity would be nearly inevitable were it not for the action of regulatory
or suppressor T cells” (Janeway, 2001).  However, he also has stated “…virtually
always this distinction (self versus non-self) is made by the innate immune system,
which primes the adaptive immune system when a pathogen is present, but fails to
prime such responses in the absence of infection” (Janeway, 2001; Medzhitov &
Janeway, 2002). These statements bring to the fore two questions.  The first is which
mechanism, T regulatory cells or Toll-like receptor ligation, ultimately regulates
tolerance towards self-antigens in light of the recent knowledge that inflammatory
stimuli have been reported to bypass the action of suppressor cells (Grohmann,
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Fallarino, Bianchi et al., 2001; Pasare & Medzhitov, 2003; Yang, Huang, Huang, &
Pardoll, 2004), and the second is how immune responses against non-infectious
foreign antigens, such as RBCs and some allergens, are generated in the absence of
Toll-like receptor ligation?
1.3.4. The Danger Model
In order to account for the generation of immune responses in the absence of
products derived from infectious organisms, P. Matzinger proposed a model in which
the activation of antigen-presenting cells to express the costimulatory molecules
required for the generation of signal two occurs through the recognition of stressed
self (Matzinger, 1994).  The decision of whether or not to up-regulate signal two is,
according to P. Matzinger, in the hands of tissues.  She hypothesizes that the innate
immune response has evolved to respond to danger signals produced by tissue cells,
which are then relayed to cells of the adaptive immune response (Matzinger, 1994,
2002).  The release of products from stressed or necrotic cells, which are released
during inflammatory or infectious tissue damage, activates non-specific antigen
presenting cells to release pro-inflammatory cytokines, and up-regulate the
expression of costimulatory molecules (Gallucci, Lolkema, & Matzinger, 1999). She
states “there is no reason why antigen presenting cells should not respond to both
endogenous and exogenous signals” (Matzinger, 2002).
 The Danger Model proposes that the generation of signal one through TCR
recognition of antigen on antigen-presenting cells, and the provision of signal two by
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ligation of “danger” induced costimulatory molecules, results in the subsequent
activation of naïve, antigen specific CD4+ T cells (Matzinger, 1994, 2002).
A concern raised regarding the infectious non-self model of primary CD4+ T
cell activation is also applicable to the Danger Model.  It is not immediately evident
how the activation of peripheral self-reactive T cells is prevented.  P. Matzinger has
proposed that one does not need to account for a mechanism to prevent the activation
of peripheral self-reactive cells because they do not exist in the periphery (Matzinger
& Guerder, 1989; Ridge, Fuchs, & Matzinger, 1996).  She has proposed that the
majority of self-reactive T cells are eliminated in the thymus by central tolerance
mechanisms, either by recognition of ubiquitous self-antigens on resident thymic
antigen-presenting cells, or by recognition of peripheral self-antigens presented on
dendritic cell immigrants (Ridge et al., 1996).  It is now clear that a subset of organ-
specific self-antigens are expressed and presented on the thymic antigen-presenting
cells involved in negative selection (Anderson et al., 2002; Hanahan, 1998; Liston,
Lesage, Wilson, Peltonen, & Goodnow, 2003).  However, the delivery of organ-
specific self-antigens to the thymus by dendritic cells that have sampled peripheral
tissues has not been adequately substantiated. It is generally accepted that dendritic
cells travel from tissues to draining lymph nodes via the lymphatic system (Sallusto
& Lanzavecchia, 2000; Scheinecker, McHugh, Shevach, & Germain, 2002).  To
date, there is little evidence to support that they travel through the lymph nodes and
gain access to the circulation system that supplies the thymus, and it has recently
been suggested that thymic dendritic cells develop from precursors within the
thymus (Ardavin, Wu, Li, & Shortman, 1993; Kamath, Henri, Battye, Tough, &
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Shortman, 2002).  How the activation of precursor T cells is regulated in the
presence of danger to result in the preferential activation of foreign-antigen specific
cells in the presence of peripheral “danger” is thus somewhat unclear.
1.3.5. The Two-Step, Two-Signal Model
An alternative model of primary T cell activation that attempts to describe a
mechanism for the preferential activation of foreign-antigen-specific T cells is the
Two-step, Two-signal Model (Bretscher, 1999).  This model differs from the
previous models in that the ultimate gatekeepers of the up-regulation of
costimulatory molecules that lead to the generation of the final activating signals are
antigen-specific immune cells rather than non-discriminatory, antigen-presenting
cells of the innate immune response (Janeway, 1989; Matzinger, 1994).
According to the tenets of this model, the generation of signal 1 by TCR
stimulation, and the generation of a signal 2 by recognition of costimulatory
molecules on non-antigen specific antigen presenting cells, such as dendritic cells,
results only in the initiation of precursor CD4 T cell proliferation (Bretscher, 1999).
This first step, which is all that is required for full naïve CD4 T cell activation in the
previous models, is postulated to only result in the clonal expansion of antigen-
specific T cells.
In order to prevent the generation of autoimmune responses, the Two-step,
Two-signal Model argues that an additional step, involving other antigen-specific
cells of the adaptive immune responses is required for the full activation of expanded
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CD4+ T helper cells (Bretscher, 1999).  The antigen-specific cells required for the
second step of naïve CD4 T cell activation include a population of effector CD4+ T
helper cells, and cognate, antigen-specific B cells acting as antigen presenting cells.
The effector CD4+ T helper cells are required to activate the cognate, antigen-
specific B cells, which in turn, are postulated to deliver the required second
costimulatory signals to recently expanded CD4+ precursor T helper cells (Bretscher,
1999).   The provision of a second set of costimulatory signals and/or cytokines from
B cells rescues recently expanded precursor CD4+ T helper cells from a fate of
apoptotic death or anergy, and results in the full activation of CD4+ T helper cells.
The most obvious question in regards to this model is where do the first foreign
antigen-specific effector CD4+ T helper cells arise.  This question, in addition to the
nature of the particular cells envisaged to be involved in the separate steps of this
model, will be discussed below.
1.3.6. The Cells Participating in the Two-Steps of Primary T Cell
Activation: Dendritic Cells
When they were first identified, dendritic cells were originally described as a
stellate population poor in antigen processing because of their lack of adequate
lysosomes and an apparent inability to phagocytose and present antigen (Kelly,
Balfour, Armstrong, & Griffiths, 1978; Klinkert, LaBadie, & Bowers, 1982;
Steinman, Adams, & Cohn, 1975; Steinman & Cohn, 1973; Wolff & Schreiner,
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1970). These findings were substantiated in a number of systems (Hart & McKenzie,
1988; Pugh, MacPherson, & Steer, 1983; Schuler & Steinman, 1985; Van Voorhis,
Hair, Steinman, & Kaplan, 1982).  Once it was discovered that the ability of
dendritic cells to take up and present antigen is generally a function of maturity, only
immature/un-activated dendritic cells efficiently take up and present antigen in a
manner that is dependent upon MHC class II synthesis, it was quickly realized that
dendritic cells are very potent stimulators of T cell proliferation and cytokine
production (Cella, Sallusto, & Lanzavecchia, 1997; Crowley, Inaba, & Steinman,
1990; Girolomoni, Simon, Bergstresser, & Cruz, 1990; Inaba et al., 1986; Kampgen
et al., 1991; Koch et al., 1995; Pure et al., 1990; Romani et al., 1989; Sallusto et al.,
1995; Schuler & Steinman, 1985; Steinman & Witmer, 1978; Wilson et al., 2003).
On a per cell basis, they are believed to be the most efficient antigen-presenting cells
at stimulating proliferation of both naïve and memory T cells, and as such have been
labeled “nature’s adjuvant” (Banchereau & Steinman, 1998; Cassell & Schwartz,
1994; Crowley et al., 1990; Steinman, 1991; Steinman & Witmer, 1978).
The discovery of Toll-like receptors and the ability of dendritic cells to
respond to inflammatory environments provide support for the position that the
Infectious Non-self and Danger Models of naïve T cell activation describe the
cellular events involved in primary T cell activation (Iwasaki & Medzhitov, 2004).
However, “maturation (of dendritic cells) creates a problem with respect to self/non-
self discrimination” (Steinman & Nussenzweig, 2002) because activation of
dendritic cells results in presentation of both foreign and self-antigens on surface
MHC molecules (Guery & Adorini, 1995).  The discoverer of dendritic cells, R.
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Steinman, has therefore proposed his own model of peripheral tolerance (Hawiger et
al., 2001; Steinman et al., 2003).  He postulates that peripheral self-specific T cells
that encounter antigen on immature/non-activated dendritic cells that have not
encountered infectious non-self or “danger” are subject to deletion, and that such
deletion induces a steady state of peripheral self-tolerance (Steinman et al., 2003).
R. Steinman proposes that these two opposing functions of dendritic cells can be
rationalized by the deletion of self-reactive cells in the steady state, and the
activation of immune cells in the context of inflammation or infection.   In light of
observations showing that dendritic cells need to be activated to induce tolerance in
naïve T cells (Albert et al., 2001), and that CD25+ CD4+ T cell suppression can be
overcome upon dendritic cell activation or the presence of inflammatory cytokines
(Pasare & Medzhitov, 2003; Yang et al., 2004), one again has to ponder the question
of how the activation of peripheral self-specific precursor T cells is prevented when
“stranger” or “dangerous” antigens are presented on dendritic cells that also present
self-derived antigens.
The Two-step, Two-signal Model incorporates the view that the immune
system must contain intricate control mechanisms to regulate the activation of naive
T cells (Bretscher, 1999).  Placing the regulation of naïve T cell activation in the
hands of a non-specific cell, such as the dendritic cell, which has potent stimulatory
capacity, does not provide a way of definitively discriminating self from foreign
antigens (Guery & Adorini, 1995; Steinman et al., 2003), nor a way of ensuring that
only foreign antigens are presented to precursor T cells in a way that results in their
activation, opens up the likelihood that immune responses towards peripheral self
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can be generated and sustained. It must be clarified, however, that the predictions of
this model do not deny the importance of non-antigen specific immune cells, such as
activated dendritic cells, in activation of naïve T cells.  They do however suggest that
the role of dendritic cells is primarily to stimulate the clonal expansion of antigen-
specific T cells (Bretscher, 1999), and provide an antigen-bridge for the helper-
dependent activation of CD8+ cytotoxic T cells. In order to fully rationalize the
stance of this model one must consider the fact that a number of experimental
systems demonstrate that dendritic cells are potent stimulators of naïve T cells,
which are normally separated from previously activated cells via the use of T cell
surface markers (Alpan, Bachelder, Isil, Arnheiter, & Matzinger, 2004; Croft,
Duncan, & Swain, 1992; Steinman & Witmer, 1978). In light of uncertainties in the
reliability of the use of surface T cell activation markers to distinguish naïve T cells
from resting memory cells that have down-modulated expression of such markers
(Ahmadzadeh et al., 2001; Birkeland et al., 1989; Hengel et al., 2003; Murali-
Krishna & Ahmed, 2000), it may be reasonable to question whether the cells
employed as naïve responding T cells in a number of studies are in fact free of
contaminating transitional or resting memory T cells.  The uncertainty as to whether
dendritic cells truly possess the potential to activate naïve T cells in the absence of
other antigen-presenting cells is exemplified by the possibility that the dendritic cells
used in a number of studies may also contain low numbers of other lymphocytes
(Coligan, Kruisbeek, Shevach, & Stober, 1998; Izon et al., 2001 ). Despite optimized
experimental tools and techniques, the following statement previously made by
Ashwell et. al may still hold, “attempts to completely purify these cells
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[macrophages and dendritic cells] away from surface immunoglobulin-positive cells
have so far been only partially successful” (Ashwell, DeFranco, Paul, & Schwartz,
1984).
1.3.7. The Cells Participating in the Two-Steps of Primary T Cell
Activation: The Effector CD4+ T Helper Cells
The effector CD4+ T helper cells, which are postulated to activate cognate
antigen-presenting B cells, are one of the lymphocyte populations believed to
regulate the up-modulation of the final second signal required for full naïve T cell
activation (Bretscher, 1999). Experimental evidence in the literature indirectly
supports the existence of such a cell.  For example, CD4+ T cells that possess
radiation resistant helper effector function, and hence can mediate the generation of
responses without undergoing proliferation, are present in the spleens of normal un-
manipulated mice (Pilarski, 1977). A number of in vivo studies estimate that
radiation resistant CD4+ T cells compose approximately 10% of the peripheral
CD4+ T cell pool (Cederbom, Bandeira, Coutinho, & Ivars, 1998; Pereira, Larsson,
Forni, Bandeira, & Coutinho, 1985; Williams, Patchen, Darden, & Jackson, 1994).
The postulate of a requirement for an effector CD4+ T cell that potentially
regulates the up-modulation of costimulatory molecules critical for the generation
and delivery of signal two, upon challenge with a foreign antigen, generates a
conceptual problem of how the first effector CD4+ T cells arise (Bretscher, 1999).
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As discussed above, evidence to support the functional and phenotypic existence of
such cells is strong (Cederbom et al., 1998; Pereira et al., 1985; Pilarski, 1977;
Williams et al., 1994), but the means by which they are initially activated is purely
speculative.  One possibility is that the initial activation of the effector CD4+ T
helper cells occurs during homeostatic processes.  During homeostatic proliferation,
a fraction of the T cells that proliferate acquire and maintain an activated T cell
phenotype (Cho, Rao, Ge, Eisen, & Chen, 2000; Min et al., 2003; Murali-Krishna &
Ahmed, 2000; Schuler, Hammerling, & Arnold, 2004; Tanchot, Le Campion,
Leaument, Dautigny, & Lucas, 2001).  This proliferation, and subsequent acquisition
of an activated status, of T cells is an IL-7 and CD28 costimulation dependent
phenomenon that is somehow triggered by the lymphopenic environment (Tan et al.,
2001), which is typical of newborns, lethally irradiated mice, or of genetically
modified mice deficient in lymphocytes (Le Campion et al., 2002; Paul, 1999;
Williams et al., 1994).  The Two-step, Two-signal Model postulates that the effector
CD4+ T helper cells that exist, and which may have been activated during
homeostatic proliferation, must be specific for foreign but not self-antigens
(Bretscher, 1999). Because the majority of self-specific CD4+ T cells are subject to
central tolerance mechanisms in the thymus, or are subject to deletion upon the
receipt of signal one in the periphery in the absence of signal two (Bevan et al.,
1994), the number of self-antigen specific effector CD4+ T helper cells is predicted
to be a number that is insufficient to result in the activation of further self-antigen-
specific CD4+ T cells (Bretscher, 1999).
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1.3.8. The Cells Participating in the Two-Steps of Primary T Cell
Activation: The Role of Antigen-specific B Cells as Antigen-
Presenting Cells
As discussed, activated B cells are postulated in the two-step, two-signal
model to play a central role in naive T cell activation (Bretscher, 1999).  They are the
favored antigen presenting cells believed to deliver survival cytokines and/or
costimulatory second signals to recently expanded precursor CD4+ T helper cells
because of their specific means of antigen-uptake/presentation, and CD4+ T helper
cell dependent expression of costimulatory molecules.
Many studies have tried to address whether the generation of immune
responses in vitro and in vivo requires immunoglobulin bearing B cells, but the
conclusions drawn have been contradictory (Cassell & Schwartz, 1994; Chan,
Hannum, Haberman, Madaio, & Shlomchik, 1999; Epstein, Di Rosa, Jankovic, Sher,
& Matzinger, 1995; Greeley et al., 2001; Hayglass, Naides, Scott, Benacerraf, & Sy,
1986; Homann et al., 1998; Janeway, Ron, & Katz, 1987; Kurt-Jones et al., 1988;
Liu et al., 1995; Macaulay, DeKruyff, & Umetsu, 1998; Rivera, Chen, Ron,
Dougherty, & Ron, 2001; Ron & Sprent, 1987; Ronchese & Hausmann, 1993;
Schultz, Klarnet, Gieni, HayGlass, & Greenberg, 1990; Schultz, Paquet, Bader, &
HayGlass, 1995; van der Heyde, Huszar, Woodhouse, Manning, & Weidanz, 1994;
Williams, Oxenius, Hengartner, Benoist, & Mathis, 1998).  The two most widely
used contemporary murine models of in vivo B cell deficiency are the mMT and the
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JhD B cell knockout mouse strains.  The development of B cells has been prevented
in both of these strains of mice by the removal of gene segments essential for
immunoglobulin receptor rearrangement.
Observations from studies employing mMT B cell deficient mice have led to
the conclusion that B cells are not required for the induction of primary cellular and
humoral responses (Epstein et al., 1995; Leef, Elkins, Barbic, & Shahin, 2000;
Rivera et al., 2001).   However, it is now apparent that an abnormal genetic
recombination event in mMT mice, at least on the BALB/c background, enables the
survival of some B cells (Fulcher et al., 1996; Hasan, Polic, Bralic, Jonjic, &
Rajewsky, 2002; Melamed, Miri, Leider, & Nemazee, 2000).  Other studies,
employing a less “leaky” model of B cell deficiency, JhD B cell knock-out mice,
have led to the conclusion that B cells are essential for the activation of T cell
responses (Chan, Hannum et al., 1999; Leef et al., 2000).  These studies suggest that
the involvement of B cells in T cell activation involves a mechanism other than the
production of secreted antibody.  It has been argued that the requirement for B cells
in such studies is either for the development of proper lymphoid architecture, or for
the enhancement of immune responses once established (Croft & Dubey, 1997;
Golovkina, Shlomchik, Hannum, & Chervonsky, 1999; Ngo, Cornall, & Cyster,
2001).
The postulates of the Two-step, Two-signal Model state that B cells, and not
dendritic cells, are the antigen-specific antigen-presenting cells involved in
delivering required cytokines and/or costimulatory signals to naïve T cells during
step two of primary activation of T cells (Bretscher, 1999).  The reason that B cells
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are favored over dendritic cells is their antigen-specificity.  It is well established that
B cells primarily endocytose exogenous antigens via their antigen-specific surface
immunoglobulin receptors in an efficient manner (Lanzavecchia, 1990). They also
primarily present the antigens taken up by receptor-mediated endocytosis on their
surface MHC molecules (Brocke et al., 2003; Bryant & Ploegh, 2004). By contrast,
dendritic cells take up antigen by macropinocytosis or via clathrin-coated pits
utilizing adsorptive endocytosis receptors.  They present all antigens endocytosed in
their immature state indiscriminately on their surface MHC Class II molecules
(Cella, Sallusto et al., 1997).  The combination of the lack of the majority of B cells
with self-specificity, and the ability of B cells to take up and present antigen in an
antigen-specific manner, makes them prime candidates for being the antigen-
presenting cell that delivers the final activating signal two to precursor CD4+ T
helper cells during primary T cell activation.
In summary, the two-step, two-signal model postulates that placing the
regulation of the up-modulation of the final second signal needed for primary T cell
activation in the hands of antigen-specific CD4+ effector T helper cells, and cognate
antigen-specific B cells, both of which are subject to self-tolerance mechanisms,
provides a mechanism whereby primary immune responses can preferentially be
generated against foreign antigens (Bretscher, 1973; Bretscher & Cohn, 1970;
Bretscher, 1999).
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1.4 Theoretical Basis of Thesis Objectives
At the present time, an immunological mechanism to account for the
maintenance of tolerance towards peripheral self during primary CD4+ T cell
activation is not complete.  Several models have been proposed and discussed, and
these include the Infectious Non-self, Danger, and Two-step, Two-signal Models
(Bretscher, 1999; Janeway, 1989; Matzinger, 1994). The preferential activation of
CD4+ T cells that bear ab TCR reactive against foreign antigens, and the subversion
of the activation of those with specificity towards self is essential to the avoidance of
autoimmunity, and must be considered within a model that best describes the events
involved in primary CD4+ T cell activation.
The central question that must be addressed in order to discriminate between the
competing models is can non-specific antigen-presenting cells, such as dendritic
cells, stimulate the generation of immune responses from naïve CD4+ T cells, or is
the presence of an antigen-presenting B cell required?  The experimental work of this
thesis is focused on establishing an experimental system to address this question.
As mentioned previously, a general approach to determine the requirements for
the activation of naïve T cells requires a highly purified population of such cells.
Naïve T cells are typically characterized as CD44low, CD45RBhi, and CD62Lhi and
activated effector T cells as CD44hi, CD45RBlo, and CD62Llo (Dutton et al., 1998).
The use of these markers is useful for the identification of effector T cells, but there
is some uncertainty as to whether a population of CD44low, CD45RBhi, and CD62Lhi
T cells, purified from the secondary lymphoid organs of normal or genetically
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modified TCR transgenic mice, constitutes a population of naïve T cells
uncontaminated with transitional or resting memory T cells (Ahmadzadeh et al.,
2001; Hengel et al., 2003). This uncertainty is exemplified by the possibility that
previously activated T cells possess the potential to revert to, or maintain, the
expression of surface antigens often regarded as defining naïve cells (Blander et al.,
2003).  Impurity in purified T cell populations may lead to misleading observations
on the requirements to activate naïve T cells. Hence, obtaining a population of naïve
responding lymphocytes free of previously activated cells is central to an
experimental approach designed to address whether non-specific antigen-presenting
cells, such as dendritic cells, efficiently stimulate the generation of immune
responses from naïve T cells, or whether the presence of antigen-presenting B cells is
also required.  Attempts were made in this work to study the antigen presenting cell
requirements involved in primary T cell activation employing naïve responding T
cells uncontaminated with previously activated peripheral T cells.  The experimental
system employed will be discussed in full in the beginning of the results section.
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2. Research Objectives
 The objectives of this work were as follows:
(1) To devise an experimental system to test whether the Two-step, Two-signal
Model validly describes the cellular interactions involved in naïve CD4+ T
cell activation.  The primary goal of this Ph.D. thesis is thus to attempt to
understand and delineate the cellular interactions involved in the primary
activation of naïve CD4+ T cells employing such a system, which as for any
experimental system, caveats must be accepted.
(2) According to the model of immune CD4+ T cell activation around which the
hypotheses of this thesis are centered, the Two-step, Two-signal model, an
interaction between a naïve T cell and a non-specific APC, such as a
dendritic cell, is insufficient to result in the primary activation of naive
CD4+ T helper cells.  Such an interaction is likely sufficient to initiate
cellular proliferation, which occurs upon completion of step one of
activation.  Step one, primed CD4+ T cells have to undergo a second cellular
interaction, step two, with other lymphocytes in order for full activation.
One critical lymphocyte population involved in the secondary cellular
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interaction is a naturally acquired reservoir of foreign, antigen-specific
effector CD4+ T helper cells.  Only those with specificity for foreign
antigens are believed to be at numbers sufficient to participate in primary T
cell activation; those specific for self-antigens are postulated to be at
numbers insufficient to result in full naïve T cell activation.  The other
essential lymphocytes envisaged to be required for primary T cell activation
are antigen presenting B cells. Once antigen-specific effector CD4+ T helper
cells activate cognate B cells, they are capable of delivering essential
costimulatory and/or cytokine survival signals to recently expanded step one
primed, CD4+ T helper cells.  Without such a signal from a B cell, a recently
expanded population of precursor CD4+ T helper cells is postulated to
succumb to apoptotic cell death.  Thus, the second objective of this thesis
work is to test whether non-specific antigen-presenting cells, such as
dendritic cells are able/unable to stimulate the generation of primary
immune responses from naïve CD4+ T cells when antigen-specific effector
CD4+ T helper cells and/or cognate B cell antigen-presenting cells are
absent.   It is hypothesized that B cells are the antigen-presenting cells that
deliver essential activation signals to naïve, precursor CD4+ T helper cells.
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(3) Several predictions can be made if the Two-step, Two-signal Model of
primary T cell activation holds true. The primary objectives of this thesis are
not to test the adequacy of these predictions.  However, they warrant
discussion:
a. After naïve T cells encounter specific antigen, a state of antigen-
specific CD4+ and/or CD8+ immune unresponsiveness will be
generated if either one or both of the lymphoid populations involved
in the critical second cellular interaction are absent, the effector
CD4+ T helper cells and/or B cells.
b. The unresponsive state generated in (a) is antigen-specific; immune
responsiveness towards a second antigen will be unaffected by the
generation of unresponsiveness towards the first antigen.
c. The presence of activated, cognate B cells can prevent the
unresponsiveness generated by antigen stimulation with non-specific
antigen presenting cells, such as dendritic cells, if provided within a
sufficient period of time.
d. Alternatively, the unresponsiveness generated by the stimulation of
naïve T cells with non-specific antigen-presenting cells is
preventable by the provision of an analogue of the critical survival
factors normally produced by B cells activated by functional CD4+ T
helper cells.
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3.0. MATERIALS AND METHODS
3.1. Mice
CBA/J (H-2k), C57BL/6 (H-2b), or BALB/c (H-2d) mice were obtained either
from the animal colony of the College of Medicine, University of Saskatchewan
(Canada) or from Charles River (Montreal, Quebec).  Mice were housed under
specific pathogen free conditions.  Routine screening ensured that mice were free of
certain sub-clinical viral and bacterial infections. The mice employed within each
experiment were of the same sex and were typically 5 to 8 weeks of age, unless
otherwise indicated. Thymus donor mice were younger than splenic donors and were
between 4 to 6 weeks of age.  All experiments were performed with ethical approval
from the Canadian Council on Animal Care.
3.2. Media
RPMI 1640 supplemented with L-glutamine and Leibovitz medium (Gibco
Laboratories, Grand Island, NY) were prepared from powdered stocks as per
manufacture’s instructions.  Solutions were sterilized by filtration through 0.22 mm
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filters (Millipore, Molsheim, France) and sterility assessed by overnight incubation
at 37° C.
3.3. Preparation of Single Cell Suspensions
Mice were killed by cervical dislocation and their spleen or thymus aseptically
removed.  Spleens or thymi were placed in 10 mL of Leibovitz media and single cell
suspensions were prepared by gentle disruption and passage through stainless steel
mesh.  Suspensions were left for 2-3 minutes to allow debris to settle, and the
supernatant collected.  Single cell suspensions were then washed twice with
Leibovitz media via centrifugation for 10 minutes at 280-x g.  After the final wash,
splenocytes or thymocytes were resuspended in complete RPMI media (RPMI 1640
supplemented with L-glutamine containing 10% fetal bovine serum, penicillin-
streptomycin (100 U/mL), 0.8 mM sodium pyruvate, and 5 x 10-5 M b -
mercaptoethanol). Viable leukocytes were counted by trypan blue exclusion using a
haemocytometer.  Cells were kept on ice until aliquoted either in culture or in the
ELISPOT plates.  Thymi were harvested from mice less than or equal to 6 weeks of
age.
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3.4. The Generation of Immune Responses against allo-MHC Antigens in
Vitro
CBA/J thymocytes were plated in Falcon 24 well tissue culture plates (Becton
Dickinson & Co., Franklin Lakes NJ, USA) such that 2 x 106 cells/well were
stimulated with 2 x 106 cells/well BALB/c or C57BL spleen cells, which had
received 1500 rads of g irradiation from a Co60 source (Pilarski, 1977).  Similarly
irradiated CBA/J spleens cells were added to the indicated cultures at a number of 1
x 107 cells/well.  For some experiments, 2 x 106 cells/well CBA/J splenocytes were
stimulated with 2 x 106 cells/well irradiated BALB/c or C57BL spleen cells. Five
identical wells of each culture condition were plated and maintained at 37°C and 5%
CO2 for 5-7 days. The generation of CTL and cytokine responses of pooled wells,
representing a standard 1 x 107 input thymocytes, was then determined using the
standard 51Cr CTL assay and a modified ELISPOT assay, respectively.  In some
experiments, the number of thymocytes, the number of stimulators, or the number of
irradiated syngeneic spleen cells were varied as indicated in the respective figures.
For some experiments, different cell subsets were depleted by antibody dependent
complement mediated lysis or separated via procedures to be discussed in the
following sections.  In all experiments where cells that are normally irradiated were
treated or sorted, cells were irradiated following the completion of the treatment.  For
the majority of experiments presented, Thy1.2+ cells were depleted from allogeneic
spleen stimulators by antibody dependent complement-mediated lysis as described in
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section 3.7.1.  Unless otherwise stated, experiments were repeated at least three
times.
3.5. Assessment of the Generation of Immune Responses against Allo-MHC
Antigens in Vitro
3.5.1. Detection of Antigen-Specific CD8+ Cytotoxic T Cells
Specific cytolytic activity was measured using sodium chromate, Na251CrO4,
(Perkin Elmer, Boston, MA) labeled P815 mastocytoma (H-2d) or EL4 lymphoma
(H-2b) target cells (ATCC, Manassas, VA) (Dunkley, Miller, & Shortman, 1974).
Target cells were incubated for 2hrs at 37°C with 200 mCi per 2 x 106 cells after an
equal volume of FCS was added; the desired volume of sodium chromate was
determined separately for each experiment and was corrected for radioactive decay.
Labeled cells were then washed three times and resuspended in warm, complete
RPMI at 1 x 105 cells/mL.
Effector cells were harvested from primary cultures, pooled, washed, and
resuspended in 2 mL of RPMI complete media warmed to 37°C.  To ensure that CTL
responses were normalized for a constant number of input thymocytes, serial
dilutions, starting at 5% of culture by volume or 5 x 105 input thymocytes, were
made in triplicate in 96-well Nunclon flat-bottom micro titer plates (Nalge Nunc
International, Denmark).  For responsive thymocyte cultures given irradiated
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syngeneic spleen cells, 5% of culture corresponds to an approximate effector:target
ratio of 10:1.  Serially diluted cells were incubated with 1 x 104 labeled target
cells/well for 4 hrs at 37°C at 5% CO2.  Maximal release of 51Cr sodium chromate
from the target cells without effectors was induced by the presence of 10% w/v
Sarcosine.  Spontaneous release of the radioactive label from the target cells without
effectors was assessed in the presence of RPMI complete media.   Estimates of
maximal and spontaneous release from the target cells were obtained from the
average of six identical wells. The presence of 51Cr sodium chromate in 0.1 mL of
supernatants was determined using a LS 5000TD Liquid Scintillation System
(Beckman Instruments, Fullerton, CA) after all volume had evaporated, and
scintillation fluid (4 g/L Omnifluor (Packard Instrument Company Inc., Meriden,
CT) in scintillation grade Toluene) was added. The percent specific lysis was
calculated as follows (Coligan et al., 1998):
% lysis = 100 x [(cpm experimental release – cpm spontaneous release)]
              [(cpm maximal release) – (cpm spontaneous release)].                (3.1)
For experiments with multiple experimental conditions, specific lysis values were
converted to lytic unit values in order for linear comparisons to be made.  The
number of lytic units was calculated as follows (Miller & Dunkley, 1974; Sambhara,
Upadhya, & Miller, 1990):
Lytic Units = -100 x [ln (1 – p)]          (3.2)
where p = [(cpm experimental release – cpm spontaneous release)]
                   [(cpm maximal release) – (cpm spontaneous release)].           (3.3)
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3.5.2. Detection of Antigen-Specific Cytokine Producing Cells
Antigen dependent cytokine production was assessed with the ELISPOT
assay (Coligan et al., 1998; Power et al., 1999). Ninety-six-well, unifilter 350
nitrocellulose-flat bottom plates (Whatman-Polyfiltronics, Clifton, NJ, USA) were
prepared as follows:  plates were coated by adding 100 ml/well of purified anti-IFN-g
(R4-6A2), anti-IL-2 (JES6-1A12) or anti-IL-4 (11B11) monoclonal Abs
(Pharmingen, San Diego, CA) at 1.25 mg/ml in 1M bicarbonate buffer at a pH of 9.6.
Coated plates were incubated overnight at 4° C.  The plates were subsequently
washed once with RPMI, and blocked with complete-RPMI for at least 2 h before the
addition of effector cells.
Effector cells were harvested from primary cultures, pooled, washed, and
resuspended in 2 mL of warm RPMI complete media.  After seeding in the CTL
assay, effector cells were resuspended in 2mL of complete RPMI and dead cells were
removed by density gradient centrifugation for 20 minutes at 400-x g on Ficoll “ 400
(Pharmacia Biotech AB, Uppsala, Sweden).  Cells at the interface were harvested and
washed twice with RPMI complete media to remove residual Ficoll “ 400.  CBA/J
thymocyte derived effector cells were resuspended in 1 mL of complete RPMI and
the number of viable cells determined by trypan blue exclusion.  Effector cells were
seeded in the ELISPOT at a concentration of 1 x 104 cells/well with or without 2.5-5
x 105 cells/well irradiated BALB/c or C57BL/6 spleen cells.  At this number of
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irradiated BALB/c or C57BL/6 spleen cells, spots generated in the ELISPOT by
unprimed CBA/J anti BALB/c or C75BL/6 spleen cells are undetectable.
After the addition of cells, ELISPOT plates were incubated overnight at 37°C in
5% CO2.  Cells were then lysed with ddH20, and cellular debris washed away with
PBST.  After at least five PBST washes, 100 ml of biotinylated anti-IFN-g (XMG1.2),
anti-IL-2 (JES6-5H4) or anti-IL-4 (BVD6-24G2) (BD PharMingen (Mississauga,
ON, Canada)) at a concentration of 1.25 mg/ml PBST was added to the appropriate
wells.  ELISPOT plates were then incubated overnight at 4°C, or alternatively for 4
hrs at room temperature.  Biotinylated antibodies were washed away with PBST and
100 ml of alkaline-phosphatase strepavidin at a concentration of 0.2 mg/mL in PBST
was added to each well.  After an incubation period of 1.5 hrs at room temperature,
plates were extensively washed with ddH20 and spots developed by the addition of
100 ml/well of NBT/BCIP Stock Solution (Nitro blue tetrazolium chloride/5-Bromo-
4-Chloro-3-indolyl phosphate, toluidine salt, (Boehringer Mannheim, Germany)
diluted 1:50 in 0.1 M Tris-Hcl, pH 9.5, 0.1 M NaCl, and 0.05M MgCl2).  ELISPOT
plates were allowed to dry and spots were enumerated using a dissecting microscope
with the assistance of an eyepiece grid.
3.6. Monoclonal Antibodies
Monoclonal antibodies were prepared from culture supernatants or ascitis fluid
as described (Coligan et al., 1998).  Hybridomas producing monoclonal antibody
were obtained from the American Type Culture Collection (Rockville, MD) or were
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generous gifts: TIB-207 (GK1.5) anti-CD4, TIB-99 (HO-13-4) anti-Thy1.2, TIB-211
(3.155) anti-CD8, TIB-235 (IM7.8.1) anti-CD44, TIB 146 (RA3-3A/6.1) anti-B220,
HB-253 (GL1) anti-CD86, HB-301 (16-10A1) anti-B7.1, and HB-290 (NLDC-145)
anti-Dec-205 were obtained from ATCC; anti-CD62L (MEL14.D54) and anti-
CD45RB (MB23G2) were gifts from I. Weissman and E. Pure, respectively.
Purified hamster anti-mouse CD40 ligand (CD154, MR1) and anti-mouse CD40
(HM40-3) monoclonal antibodies were obtained from BD PharMingen (Mississauga,
ON, Canada).
3.7. Cell Separation Procedures
3.7.1. Antibody-Dependent Complement Mediated Lysis
Thymocytes or spleen cells were suspended at 107 cells/ml in complete
RPMI. Ascitis fluid containing the anti-Thy-1.2, anti-CD4, or anti-CD8 antibody was
added to the cell suspensions at a dilution previously determined to be optimal for
effective depletion, generally 1/200, and the cells incubated on ice.  Similarly,
effective concentrations of monoclonal antibodies from hybridoma supernatant
containing anti-CD44, anti-CD62L, anti-CD45RB, or anti-B220 were added to cell
suspensions, generally undiluted or 1/2 dilutions of hybridoma supernatants were
employed.  After 1.5 hrs, cells were washed and resuspended in either media for cell
controls, or 1 mL per 107 cells of rabbit complement (Cedarlane Laboratories Ltd,
Hornby, Ontario, Canada) diluted 1:20 in complete RPMI.  Prior to its addition to
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cells, the rabbit complement was passed through a 0.22 mm Nalgene Syringe Filter
(Nalge Company, Rochester, NY, USA), and was subsequently incubated with a
minimum of 2 x 107 thymocytes on ice for 20 min to reduce toxicity. The sterile-
adsorbed complement was centrifuged for 10 minutes at 280-x g and the supernatant
used for antibody dependent complement mediated depletion.  After the addition of
complement, control and antibody tagged cells were incubated at 37°C for 1 hr, with
gentle mixing every 20 minutes.  At this time, cells were washed twice with
complete RPMI and resuspended in fresh medium.  The number of viable white cells
was again determined by trypan blue exclusion to calculate the percentage cell lysis.
In procedures where antibody dependent complement mediated lysis of cells was
performed, cells were added to cultures or the ELISPOT assay based on cell counts
obtained prior to depletion.  The efficiency of antibody-dependent complement
mediated depletion was determined by flow cytometry as described in section 3.9.1.
3.7.2. MACS sorting of CD45R+ (B220+) and CD45R- Cells from
Normal BALB/c Splenocytes
Single cell suspensions were prepared from BALB/c splenocytes and
CD45R+ (B220+) and CD45R- cells (B220-) separated by magnetic cell sorting with
MACs Microbeads (Miltenyi Biotech GmbH, Germany).  B220 is described as a pan
B cell marker (Coffman & Weissman, 1981).  Briefly, after the concentration of
spleen cells was determined by trypan blue exclusion, red blood cells in the desired
number of splenocytes resuspended in 1-2 mL were lysed by a 3 minute incubation
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at room temperature with 5 mL/spleen of 0.2 mm filter sterilized, ACK lysing buffer
(0.15 M NH4Cl, 1.0 mM KHCO3, 0.1mM Na2EDTA in ddH20, pH 7.2-7.4). Cells
were washed once with complete RPMI, resuspended in MACs buffer (5% FCS in
PBS).  Cellular debris was removed by passage through 30 mm nylon mesh.  Filtered
cells were centrifuged for 10 minutes at 280-x g and resuspended in 90 mL MACS
buffer per 107 cells.  Ten mL of MACs CD45R (B220) Microbeads per 107 total cells,
were then added as per the manufacture’s instructions.  Cells were mixed and
incubated at 6-12 °C for 15 minutes.    Cells were washed with 10-20X the labeling
volume of buffer and centrifuged at 280-x g for 10 minutes.  The cell pellet was
resuspended in 1 mL of MACs buffer per 108 cells.  CD45R+/- cells were separated
on washed LS Selection Columns (Miltenyi).  CD45R- cells were collected from the
column effluent while the LS column was in the magnetic field of a MidiMacs
separator magnet (Miltenyi).  CD45R+ cells were collected from the expulsed
column effluent after the column was removed from the magnetic field of the
MidiMacs separator magnet (Miltenyi).   Counts from trypan blue exclusion indicate
that the total cell recovery from the procedure ranged from 60 to 85%.  Results from
flow cytometry that was performed as described in section 3.7.1 indicate that the
purity of the sorted CD45R+ B220+ and CD19+ double positive population was
98%.   It was also confirmed that CD11c expressing cells were absent.
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3.7.3. The Removal of Immunoglobulin Bearing Cells by Panning on
Antibody-Coated Plates
MACs sorted CD45R+ cells from BALB/c mice were depleted of
immunoglobulin bearing cells by panning on antibody-coated Petri plates (Coligan et
al., 1998).  Falcon 100mmx15mm plates (Becton Dickinson & Co.) were coated
overnight at 4°C with 9 mL of 100 mg/mL polyspecific rabbit anti-mouse
immunoglobulin (Cedarlane Laboratories Ltd.).  The following day, the coating
solution was poured off and the plates gently washed 4-5 times with 5ml PBS. Cell
suspensions in complete RPMI were then plated at £ 2x108 cells/plate for 30 minutes
at room temperature.  After 30 minutes, the plates were gently swirled and the
nonadherent immunoglobulin- cells collected and plated onto a second coated and
washed Petri plate.  Cells were allowed to adsorb for another 30 minutes at room
temperature.  The procedure was repeated once more.  Nonadherent
immunoglobulin- cells were collected, washed, and resuspended in complete RPMI.
When cell recovery from the procedure was assessed by trypan blue exclusion, 95%
of the CD45R+ cells were removed. Flow cytometry that was performed as described
in section 3.9.1. confirmed that 95.4% of the B220+ cells were removed.  The cell
counts determined before the panning procedure were used to calculate the number
of BALB/c cells to plate in culture.  Nonadherent, immunoglobulin- BALB/c
splenocytes were also depleted of Thy1.2+ cells by antibody-dependent complement
mediated depletion prior to addition to culture as described in section 3.7.1.  This
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result was again confirmed by flow cytometry that was performed as described in
section 3.9.1, and such treatment removed 97.3% of ab TCR+ cells.
3.8. The Generation and Purification of Dendritic Cells from Bone Marrow,
and their Isolation from Spleen
3.8.1. Generation of Dendritic cells from Proliferating Mouse Bone
Marrow Progenitor Cells
Bone marrow derived dendritic cells were prepared as described (Coligan et
al., 1998) employing a protocol based on a previously described method (Inaba et al.,
1992).  Femurs and tibias were aseptically removed from sacrificed 6-8 week old
female mice.  Muscle tissue was removed and the bones placed in a Falcon
60mmx15mm Petri plates (Becton Dickinson & Co.) containing cold RPMI-1640
(Gibco Laboratories).  Residual tissue was rinsed away with cold RPMI-1640.  Intact
and cleaned bones were sterilized by soaking for 2 minutes in 70% ethanol.
Sterilized femurs and tibias were subsequently washed 3 times with ice-cold RPMI-
1640.
Both epiphyses (bone ends) were separated from femur and tibia shafts with
sterile scissors and transferred to a separate Petri dish.  The ends were minced and
large particles removed by passage through a stainless steel mesh.  Marrow plugs
were flushed from the femur and tibia shafts with an RPMI-1640 containing, latex-
free 10 mL B-D syringe with an attached B-D PrecisionGlide 26-G, 1/2 in. needle
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(Becton Dickinson & Co.).  Bone marrow cells were collected into a 50 mL
centrifuge tube and washed by centrifugation for 10 minutes at 280-x g.  Cells were
resuspended in 2 mL of cold RPMI-1640 and red blood cells lysed by a 3-minute
incubation at room temperature with 5 mL ACK lysing buffer.  Bone marrow cells
were washed twice with 20 mL of RPMI-1640 and resuspended in 10 mL of
complete RPMI media containing 1 ng/mL recombinant mouse GM-CSF (BD
PharMingen).  Cells were counted by trypan blue exclusion to calculate bone marrow
progenitor cell recovery.
After the concentration of cells was determined, bone marrow progenitors
were plated in Falcon 24-well tissue culture plates (Becton Dickinson & Co.)
containing 800 Units/well recombinant mouse GM-CSF (BD PharMingen).  Bone
marrow cells from one mouse were plated in one 24-well tissue culture plate.  Plates
were maintained at 37°C and 5% CO2 for 9-15 days.  Every 48 hrs, the supernatant
was removed and the nonadherent, contaminating lymphocytes were washed away
by the addition and removal of 1-1.5 mL of RPMI-1640 warmed to 37°C.  Fresh,
complete RPMI media containing 800 Units/well of recombinant GM-CSF (BD
PharMingen) was added.  After 9-15 days, dendritic cell aggregates were dislodged
by pipetting and collected.  Dislodged cells were pooled and centrifuged for 10
minutes at 280-x g.  Following centrifugation, dendritic cells were resuspended in
complete-RPMI without GM-CSF and subcultured at 37°C and 5% CO2 for 24 hrs in
Falcon 100mmx15mm Petri plates (Becton Dickinson & Co.) to promote full
differentiation (Coligan et al., 1998).  Nonadherent, nonproliferating differentiated
dendritic cells were collected from the subcultures by gentle collection of the
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supernatant after swirling.  After washing, the number of viable cells was determined
by trypan blue exclusion.
For some experiments, as indicated in the relevant figure legends, bone
marrow derived dendritic cells were exposed to exogenous activation stimuli.
Control bone marrow cultures contained complete RPMI without GM-CSF.
Dendritic cells activated by exogenous stimuli were sub-cultured at 37°C in 5% CO2
for 24, or for 48 hrs in a replicate experiments to confirm efficient dendritic cell
activation, in the presence of complete-RPMI without GM-CSF containing either 2.5
mg/mL anti-CD40 mab (HM40-3, BD PharMingen), or 1 mg/mL LPS (Sigma-
Aldrich, St. Louis, MO).  After activation in the presence of exogenous stimuli,
mature dendritic cells were harvested as described and washed twice to remove
excess anti-CD40 mab or LPS (Coligan et al., 1998; Inaba et al., 1992).   Cells were
resuspended in 2-5 mL of complete RPMI and the number of viable cells determined
by trypan blue exclusion.
For some experiments, the number of dendritic cells added to culture was
varied as indicated.  When the number was not varied, the number of allogeneic
dendritic cells used to stimulate thymocytes was a physiological dose derived from
the number that would normally be found in 2 x 106 BALB/c splenocytes, being 0.1-
0.5% of the total splenocytes (Coligan et al., 1998).  Using the highest percentage,
thymocytes were stimulated with 1 x 104 allogeneic dendritic cells/well.  During the
repetition of some experiments, thymocytes were also stimulated with a two fold
higher number of dendritic cells, 2 x 104 cells/well, representative of 1% of the total
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splenocytes. Similar findings were obtained with both dendritic cell doses, as noted
in the results section.
3.8.2. Antigen Presentation to BALB/c Ovalbumin-Specific CD4+ T cell
Clones by Bone Marrow Derived Dendritic Cells
The ability of mature and activated bone marrow derived dendritic cells to
present antigen to ovalbumin specific CD4+ T cell clones was determined in a
standard proliferation assay (Coligan et al., 1998).  Th1, IFN-g secreting, CD4+ T
cell clones obtained from K.K. McKinstry were plated in 96-well Nunclon flat-
bottom micro titer plates (Nalge Nunc International) at 1x104 cells/well in complete
RPMI in the presence or absence of 1 x 104 cells/well unstimulated, or LPS-
stimulated bone marrow derived dendritic cells. Ovalbumin (Grade V, Sigma-
Aldrich) or Hen Egg Lysozyme (Grade VI, Sigma-Aldrich) was added to the
appropriate wells containing either un-stimulated or 24 hour-LPS stimulated
dendritic cells at a concentration of 1.25 mg/mL, which was previously found by K.
McKinstry to be an optimal concentration of antigen for in vitro expansion and
cytokine elicitation in the ELISPOT assay.
Proliferation was measured by the addition of 1 mCi/well of 3H-thymidine
(Mandel Scientific Co. Ltd., Guelph, ON, Canada) for the last 18 hours of 4-day
culture.   Cells were harvested 18 hrs after the addition of 3H-thymidine using a PHD
Cell Harvester (Cambridge Technology Inc., Cambridge, MA, USA).  The presence
of incorporated 3H-thymidine was determined using a LS 5000TD Liquid
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Scintillation System (Beckman Instruments, Fullerton, CA) after all volume had
evaporated, and scintillation fluid (4 g/L Omnifluor (Packard Instrument Company
Inc., Meriden, CT) in scintillation grade Toluene) was added.  The ability of the
different dendritic cell populations to present antigen was determined from the
amount of 3H-thymidine uptake above the background observed in the absence of
antigen.
3.8.3. Enrichment of Non-T and Non-B Cells by removal of CD45R+ and
Thy1.2+ Cells from BALB/c Splenocytes
Single cell suspensions were prepared from BALB/c splenocytes.  CD45R+
(B220+) and CD45R- (B220-) cells were fractionated by magnetic cell sorting with
MACs Microbeads.  The CD45R- population was collected and depleted of Thy1.2+
T cells by antibody-dependent complement mediated lysis as previously described in
section 3.7.1. The percentage of cells removed by the procedure employed to deplete
CD45R+ and Thy1.2+ cells was determined to be 88% by trypan blue exclusion. To
prevent subsequent proliferation in culture, the CD45R- Thy1.2- cells, which
contains macrophages and most dendritic cell subsets, were exposed to 1500 rads of
g irradiation from a Co60 source, and plated.  The cell counts determined prior to
MACs sorting, adjusted for total cell loss, were used to calculate the concentration of
cells plated in culture.
Separated CD45R+ and CD45R- Thy1.2- cells that had not been exposed to g
irradiation were plated overnight in Corning 25 cm2 Tissue Culture Flasks (Corning
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Glass Works, Corning, NY, USA) containing complete RPMI media supplemented
with 1 ng/mL recombinant mouse GM-CSF (BD PharMingen).  Flow cytometry
performed as described in section 3.9.1 before culture confirmed that unseparated
spleen cell populations contained 1% of cells with low side scatter as described for
dendritic cells (Girolomoni et al., 1990) and were enriched to 9% after the sorting
procedure. CD11c and MHC Class II expressing cells were also found to be present.
The number of cells with dendritic cell morphology after overnight culture derived
from CD45+ and Thy1.2+ T cell depleted spleen was repeatedly 0.2% of the original
number of spleen cells, which is within the range of the expected number of dendritic
cells (Coligan et al., 1998).
3.9. Flow Cytometric Analysis
3.9.1. Identification of Cell Subsets and Characterization of Surface
Marker Expression by Flow Cytometric Analysis
Flow cytometric analysis was performed on normal cell populations
(Butcher, Scollay, & Weissman, 1980), cell populations depleted by antibody-
dependent complement mediated cell lysis, on cell populations positively or
negatively selected by MACs sorting, and on cell populations depleted by anti-
immunoglobulin panning (Coligan et al., 1998). Expression of costimulatory and
dendritic cell markers was also assessed on cells derived from bone marrow cultures
matured in the presence of complete RPMI or those matured in the presence of
additional maturation stimuli.  The indirect detection of cell surface markers was
73
carried out as follows: between 1-10 x 105 cells, in complete RPMI, were centrifuged
for 10 minutes at 280-x g and resuspended in an amount of supernatant previously
determined to be saturating, generally 1 mL of undiluted to 1/2 diluted hybridoma
supernatants.  Cells were stained with antibodies for 1.5 hrs at 4°C and then flooded
with FACs solution (2% FCS in PBS).  Cells were again centrifuged for 10 minutes
at 280-x g and resuspended in 100 ml of FACS solution.  The appropriate FITC
conjugated goat anti-rat, anti-kappa chain, or anti-hamster IgG antibody (Cedarlane
Laboratories Ltd.) or isotype antibody control was then added at the manufacturer’s
recommended concentration, normally 10 ml per sample.  Cells were also directly
stained for expression of CD4 (L3/T4), CD8 (Ly2), Thy1.2 (clone 5a-8), ab TCR
(clone H57-597), B220 (Ly5), or CD19 (B4) with FITC or PE conjugated antibodies
(Cedarlane Laboratories Ltd.).  When cells were stained after antibody dependent
complement mediated depletion, the removal of cells was assessed with FITC
conjugated antibodies that recognize different epitopes than the depleting antibody,
for example FITC anti-mouse CD4+ (RM4-4) (BD PharMingen) was employed
when cells were were tagged with GK1.5 anti-CD4 antibody, or the appropriate
FITC conjugated goat anti-rat IgG, anti-rat kappa chain, or anti-hamster IgG
antibodies were employed to detect antibody tagged cells.  Cells were washed with
FACs solution, resuspended in 100 ml of the same solution, and stained with the
manufacturer’s recommended concentration, normally 2-10 ml, of the appropriate
fluorochrome conjugated antibody.  Labeled cells were incubated in the dark for 30
minutes at 4°C.  In experiments where indirectly stained cells were double stained,
cells were stained sequentially, with a wash in between incubations, with either FITC
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or PE conjugated antibodies. After staining, cells were washed once with 1 mL of
FACS solution and cell pellets were resuspended in 100 mL of FACS solution.  Once
cells were in suspension, an equal volume of fixative (PBS + 2% formaldehyde) was
added.  Stained and fixed cells were analyzed by flow cytometry using a Beckman
Coulter Epics Flow Cytometer, and Expo32v1.2 analysis software (Beckman
Coulter, Mississauga, ON, Canada).
Removal of cell populations by antibody dependent complement mediated
depletion generally resulted in 92-97% depletion of the desired population.  Purity of
sorted CD45R (B220+) cells was found to be 98%.  MACs sorted CD45R (B220-)
cells were found to still contain a population of cells expressing low levels of the B
cell marker B220+ in the range of 5-9%. Panning of Macs sorted CD45R (B220+)
cells on immunoglobulin coated plates resulted in the loss of 94-96% of the B220+
cells.
3.9.2. Detection of Cell Proliferation with 5-(and-6)-carboxyfluorescein
diacetate succinimidyl ester (CFSE)
Proliferation of thymocytes stimulated with irradiated, allogeneic antigen
presenting cells in the absence or presence of syngeneic, irradiated help was assessed
by flow cytometry using CFSE.  CFSE is a stable, intracellular dye that is diluted
two fold with each cell division (Lyons & Parish, 1994).  The number of viable cells
in single cell suspensions in complete RPMI was determined.  Cells were flooded
with PBS and centrifuged for 10 minutes at 280-x g.  A total of 5 x 107 cells/mL,
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resuspended in sterile PBS, was stained with a final concentration of 5 mM CFSE
(Molecular Probes, Eugene, OR, USA).  CFSE powder was dissolved in anhydrous
Dimethyl Sulfoxide (DMSO) to make a 5 mM stock solution that was stored at
–70°C for long term storage, or desiccated at –20° C, as per manufacture’s
instructions.  Cells were stained with CFSE for 30 minutes at 37°C in 5% CO2.  At
this time, cells were washed twice with complete RPMI to remove any residual dye.
After staining, cells were plated and stimulated in culture as described in section 3.4.
Once harvested, dead cells were removed by density gradient centrifugation for 20
minutes at 400-x g on Ficoll “ 400 (Pharmacia Biotech AB). Cell division of single
cells was determined by viable cell expression of CFSE, which was determined by
flow cytometry using a Beckman Coulter Epics Flow Cytometer, and Expo32v1.2
analysis software (Beckman Coulter).
3.10 . In Vitro Generation of CBA/J CD4+ T cell Clones Specific for
BALB/c Alloantigen
CBA/J CD4+ T cell clones were derived from effector cells harvested from
thymocyte cultures stimulated with irradiated BALB/c T cell depleted spleen cells in
the presence of irradiated syngeneic CBA/J splenic helper cells (Coligan et al., 1998;
Sredni, Tse, Chen, & Schwartz, 1981).  Thymocyte derived effector cells were plated
in limiting dilutions ranging from 1 x 104 to 10 cells/well in 96-well Nunclon flat-
bottom micro titer plates (Nalge Nunc International) in complete RPMI containing a
standard amount, 10 Units/mL of recombinant mouse IL-2, which was collected
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from the supernatant of L630 and titrated as described (Coligan et al., 1998).
Effector cells were cultured in the presence or absence of 0.5 x 106 cells/well
irradiated BALB/c spleen cells.  Wells positive for T cell clusters were harvested and
washed by centrifugation for 10 minutes at 280-x g.  Cell pellets were resuspended in
complete RPMI and sub-cultured in Falcon 24 well tissue culture plates (Becton
Dickinson & Co.).  Wells positive for T cell clusters were again harvested and
replated in limiting dilutions in 96-well Nunclon flat-bottom micro titer plates (Nalge
Nunc International).  Alternating rounds of re-stimulation with irradiated BALB/c
splenocytes in the presence or absence of IL-2 resulted in the isolation of T cell
clones.  Alloantigen specificity and the cytokine profile of each cloned line were
determined in the ELISPOT assay as described in section 3.7.2.  The CD4+ T cell
phenotype of each line was determined by flow cytometry as described in section
3.9.1.  Once the phenotype, antigen-specificity, and cytokine profile of each clone
was determined, samples resuspended in complete RPMI with 20% FCS were
prepared for freezing by the slow addition, while mixing in an ice slurry, of 10%
DMSO.  Small aliquots were transferred to cryovials and placed at –70°C for 2 hrs,
after which, the vials were stored in liquid nitrogen.
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4.  RESULTS
4.1. Introduction to the Experimental System
In order to delineate the cell interactions involved in naive T cell activation, we
chose to use an in vitro culture system relying on thymocytes as the responding
lymphocyte population and alloantigen as the stimulating antigen. The former
lymphocyte population was chosen because it was recognized that an incisive study
of the initiation and generation of immune responses by naïve T cells can be
undermined by the presence of previously activated lymphocytes among the
responding naïve T cells. The reliance on the use of an experimental system
employing alloantigen as the stimulating antigen has allowed us to assess the
generation of immune response from naïve thymocytes after primary culture.  While
the frequency of alloreactive cells is higher than that of protein antigen-specific T
cells, in the range of 1/100 to 1/1000 versus 1/104 to 1/105 for other antigen-specific
T cells, this response is still an antigen-specific T cell response; the response
generated upon stimulation with alloantigens is a compilation of a number of T cell
specificities, all of which possess a TCR that can cross-react with the MHC and
peptide complexes presented on allogeneic cells.
Naive T cells can theoretically be isolated from secondary lymphoid organs, such
as lymph nodes and the spleen (Dutton et al., 1998).  However, the reliability of
current separation methods has recently been questioned in light of observations
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showing, for example, that one of the standard surface markers of naïve T cells,
namely CD62L or L-selectin, is also present on resting memory T cells
(Ahmadzadeh et al., 2001; Hengel et al., 2003; Kassiotis & Stockinger, 2004).  An
experimental system relying on the use of thymocytes may be an ideal model for
naïve T cells of the periphery.  It is recognized that some propose thymocytes may
receive additional maturation signals upon emigration into the periphery (Boursalian,
Golob, Soper, Cooper, & Fink, 2004).  Advantages and disadvantages in regards to
the use of thymocytes, and experimental approaches to delineate the potential
differences between competent thymocytes and naïve T cells isolated from the
periphery, will be addressed further in the discussion.
A small fraction of thymocytes found among the mature single positive cells
found in the medullary regions of the thymus, and those mature T cells that have
recently emigrated from the thymus are capable of generating immune responses
(Bennink & Doherty, 1981; Fink, Gallatin, Reichert, Butcher, & Weissman, 1985;
Pilarski, 1977; Ramsdell, Jenkins, Dinh, & Fowlkes, 1991; Scollay, Chen, &
Shortman, 1984; Wagner, Hardt, Bartlett, Rollinghoff, & Pfizenmaier, 1980;
Widmer, MacDonald, & Cerottini, 1981).   Of importance to this thesis work are the
findings of L. Pilarski that the generation of antigen-specific CTL responses from
CBA/J thymocytes stimulated with irradiated, allogeneic BALB/c splenocytes, is
dependent upon the presence of additional CD4+ T helper cells, provided in the form
of irradiated, syngeneic CBA/J splenocytes (Pilarski, 1977). The radiation-resistant
nature of the CD4+ T cell help is important. This property indicates that the helper
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activity of these cells is independent of cell proliferation (Kettman & Dutton, 1971;
Sprent, Anderson, & Miller, 1974).
The initial observations made by L. Pilarski support the proposal that effector
CD4+ T helper cells that can “help” in the generation of immune responses from
naïve thymic T cells exist in the spleens of normal, un-primed mice (Pilarski, 1977).
She also demonstrated, employing spleen cells from CBA/J into CBA/J X BALB/c
chimeras, that the CD4+ T cell in the irradiated spleen that “helps” thymocytes
generate allo-MHC specific CTL responses is tolerant towards self; spleen cells from
such mice fail to “help” in the generation of responses against BALB/c MHC-
antigens but do “help’ in the generation of responses against third party MHC-
antigens (Pilarski, 1977; Pilarski et al., 1980).  The latter findings provide strong
evidence that the radiation resistant effector CD4+ T cells found in the spleens of
normal mice are tolerant to self and are antigen specific. Radiation-resistant CD4+
effector T helper cells generated in vitro from normal spleen cells similarly display
allo-MHC specificity (Baum & Pilarski, 1978).
We have devised a simpler, but similar, experimental system to the one of L.
Pilarski to delineate the cell interactions involved in naive T cell activation.  Her
major experimental observations that the activation of thymocytes, to generate allo-
MHC specific CTLs, is dependent upon radiation-resistant syngeneic spleen cells
have been repeated.
In addition to the generation of CTLs, the generation of cytokine producing cells
from thymocytes has been assessed. In the experiments discussed, unless otherwise
indicated, the irradiated-allogeneic spleen used to stimulate thymocytes has been
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depleted of Thy1.2+ T cells, because the presence of such cells may not allow a clear
analysis of the cellular events involved in the generation of immune responses, as we
shall show.
4.2. The Basic Experimental System
The experimental conditions required to generate optimal responses from
thymocytes were determined via titration of the number of thymocytes, and the
number of irradiated syngeneic spleen cells, using the findings of L. Pilarski as a
starting point.   Employing conditions giving rise to consistent responses,
experiments were carried out to determine the kinetics of the in vitro generation of
allo-MHC specific CTL and cytokine producing cells from thymocytes stimulated
with alloantigen in the presence of irradiated syngeneic spleen cells.  Using the
standard chromium release assay to assess CTL activation and the ELISPOT assay to
enumerate alloantigen-specific cytokine producing cells (Dunkley et al., 1974; Power
et al., 1999), the generation of alloantigen-specific CTL, and cytokine producing
cells from thymocytes has been found to depend upon the presence of irradiated-
allogeneic spleen cells, see Figures 4.2.1 and 4.2.2.  The generation of IFN-g- and
IL-2- producing cells peaks on day 4 of culture and thereafter, on day 5, cytotoxic
activity is evident.  The cell that possesses CTL activity has been determined to be
an antigen-specific, CD8+ T cell, see Figure 4.2.3. The phenotype of the IFN-g and
IL-2 producing cells has also been determined.  They have been found to be CD8+
and CD4+ T cells, respectively, see Figure 4.2.4. Additionally, the detection of both
cytokine producing cells has been demonstrated to be dependent upon both the
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number of thymocyte derived effector phase cells seeded, and the number of
irradiated BALB/c spleen cells used to re-stimulate the effectors in the ELISPOT
assay, see Figure 4.2.5.
The observations that the generation of allo-MHC specific CD8+ CTL and IFN-g
producing, and CD4+ IL-2 producing cells from thymocytes are dependent upon
syngeneic irradiation resistant “helper” cells confirms previous experimental
findings (Pilarski, 1977), and also provides experimental support for the choice of
using competent thymocytes as responding naïve T cells in vitro to delineate the
cellular interactions involved in naive T cell activation
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Figure 4.2.1.  The Kinetics of the Generation of CTLs from Thymocytes Stimulated
with Allo-MHC Spleen Cells in the Presence of Syngeneic Irradiated Spleen Cells.
CBA/J thymocytes were stimulated with irradiated, T cell depleted, BALB/c spleen
cells in the absence or presence (o, n, respectively) of irradiated CBA/J spleen cells
as described in section 3.4. The response of the syngeneic irradiated spleen cells
stimulated with BALB/c spleen cells is represented by the hatched square, and lysis
of the BALB/c syngeneic target was < 3% upon incubation with all corresponding
fractions of the culture.   The generation of CTLs was assessed on the indicated days
using the standard 51Cr CTL assay against P815 (H-2d) target cells as described in
section 3.5.1.
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Figure 4.2.2. The Kinetics of the Generation of IFN-g and IL-2 Producing
Cells from Thymocytes Stimulated with Allo-MHC Spleen Cells in the
Presence of Syngeneic Irradiated Spleen Cells. CBA/J thymocytes were
stimulated with irradiated, T cell depleted BALB/c spleen cells in the absence
or presence (open and filled symbols, respectively) of irradiated CBA/J spleen
cells as described in section 3.4.  Cytokine producing cells were detected on
the indicated days in the ELISPOT assay as described in section 3.5.2. The
error bars represent the standard deviation of the number of antigen dependent
spots.  The detection of a low number of antigen-dependent IL-2 producing
cells from thymocyte cultures stimulated with allogeneic spleen cells in the
absence of irradiated syngeneic spleen was found to be erratic and the highest
number detected from replicate experiments is shown.
84
0
1 0 0 0
2 0 0 0
3 0 0 0
4 0 0 0
A
nt
ig
en
 d
ep
en
de
nt
 
sp
ot
s 
pe
r 
10
7  
un
pr
im
ed
 t
hy
m
oc
yt
es
Day of Culture
 3 4 5
0
1 0 0
2 0 0
3 0 0
4 0 0
 3 4 5
INF-g I L - 2IFN-g
85
Figure 4.2.3. The Allo-MHC Specific CTL is a CD8+ T cell. CBA/J
thymocytes, T, were stimulated with irradiated, T cell depleted, BALB/c
spleen cells in the absence or presence of irradiated CBA/J spleen cells or H-
Help as described in section 3.4. Prior to seeding in the CTL assay, T cell
subsets were depleted from day 6 effector phase cells by antibody dependent
C’-mediated depletion.  Cells were untreated, treated (Rx) with C’ alone, or
with C’ and anti-CD4 (GK1.5), or anti-CD8 (TIB 211), or anti-Thy1.2 (TIB
99) hybridoma supernatants as described in section 3.7.1. Adjustments were
not made to cell numbers to compensate for cell loss.  The presence of CTLs
was assessed on day 6 using the standard 51Cr CTL assay against P815 (H-2d-
left panel) or EL-4 (H-2b- right panel) target cells as described in section
3.5.1. The response of the syngeneic irradiated spleen cells stimulated with
BALB/c spleen cells against both targets represented by the hatched square
was < 5% upon incubation with all corresponding fractions of the culture and
is hidden by the other symbols.
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Figure 4.2.4. The CD4/CD8 Phenotype of the Allo-MHC Specific IFN-g and
IL-2 Producing Cells. IFN-g and IL-2 producing cells generated as described
in section 3.4 by stimulation of thymocytes, T , with irradiated, T cell
depleted, BALB/c spleen cells in the absence or presence of irradiated CBA/J
spleen cells or H-help, were detected in the ELISPOT assay as described in
3.5.2.  Before seeding, T cell subsets were depleted from day 5 effector phase
cells by antibody dependent C’-mediated depletion as described in section
3.7.1.  Cells were untreated (1, 2, 7), treated (Rx) with C’ alone (3), treated
with C’ and anti-CD4 (GK1.5), anti-CD8 (TIB 211), or anti-Thy1.2 (TIB 99)
hybridoma supernatants (4-6, respectively).  Adjustments were not made to
cell numbers to compensate for cell loss. The average percentage of single
positive CD4+ and CD8+ T cells present in cultures as assessed by flow
cytometry performed as described in section 3.9.1 on Day 0 were 8.7 and
3.8%, respectively, and on Day 5, for responsive cultures (T+H), 26.8 and
22.1%, respectively.  The error bars represent the standard deviation of the
number of antigen dependent spots.  Similar results were obtained in three
separate experiments.
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Figure 4.2.5. The Number of Antigen Dependent IFN-g and IL-2 Producing
Cells Detected in the ELISPOT Assay is Dependent upon the Number of
Effector Cells and Allo-MHC Stimulators Plated. CBA/J thymocytes were
stimulated with irradiated, T cell depleted, BALB/c spleen cells in the
presence of irradiated CBA/J spleen cells as described in section 3.4.  The
ability to detect the generation of IFN-g (upper row) or IL-2 (lower row)
producing cells in the ELISPOT assay was assessed by varying either the
number of day 6 effector phase cells (left panels) or the number of irradiated
BALB/c stimulating spleen cells plated (right panels). The ELISPOT assay
was performed as described in section 3.5.2.  The error bars represent the
standard deviation of the number of antigen dependent spots.  Similar results
were obtained in three separate experiments.
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4.3. Dependence of the In Vitro Generation of Primary Immune Responses
from Thymocytes upon the Density of Thymocytes and “Initiator T
Helper” Cells
To ensure optimal sensitivity for subsequent depletion studies, the number of
thymocytes or number of irradiated syngeneic spleen cells added to culture was
varied and the generation of CTL and cytokine producing cells from thymocytes
upon stimulation with alloantigen, in either the absence or presence of irradiated
syngeneic spleen cells, assessed.
It is evident that when the density of thymic precursors is varied, and the
number of irradiated syngeneic spleen cells and stimulators held constant, the
generation of allo-MHC specific CD8+ CTLs is dependent upon the number of
thymocytes plated as one would expect, see the left panel of Figure 4.3.1.  When the
density of thymocytes and irradiated stimulators were constant, and the density of
irradiated syngeneic spleen cells varied, the generation of allo-MHC specific CD8+
CTLs is similarly dependent upon the number of irradiated syngeneic spleen cells
plated, see right panel of Figure 4.3.1.
A cooperative trend for the generation of antigen-dependent IFN-g producing
cells from thymocytes is evident from the normalized cytokine responses, see Figure
4.3.1.  Cytokine responses were normalized to consider the varied number of
responding cells present at the initiation of culture.  A comparison of the efficiency
with which responses are generated at different cell densities must take account of
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the different number of precursor cells present under different conditions.  We
therefore compared the responses generated after correcting for the differences in
responder cell density.  Normalization or expressing responses per constant number
of input cells/precursors ensures that different efficiencies in the generation of
responses reflects density dependence, and not differences in the number of
responding lymphocytes present at the onset of culture.   The cooperative trend that
is evident for the generation of IFN-g producing cells from thymocytes is not evident
for the generation of CTLs when the density of thymocytes is varied.  It is difficult to
validly assess the presence or absence of a cooperative effect for the generation of
CTLs within this experiment because of the need to rely on low specific lysis values.
However, if the generation of CTLs from thymocytes is in fact a non-cooperative
phenomenon, as is indicated from the horizontal line of normalized lytic responses
and the results to be discussed in section 4.4, the discrepancy between the generation
of CTLs and IFN-g producing cells may be related to the independent regulation of
cytotoxicity and IFN-g secretion in CD8+ T cells (Snyder et al., 2003).  Enumeration
of the number of cytolytic and IFN-g releasing cells simultaneously, as is possible in
the LYSISPOT assay (Snyder et al., 2003), may be required to adequately assess
whether cooperation among thymocytes is involved in the generation of CTLs.
The influence of the presence of T cells in the stimulating BALB/c
alloantigen was determined in a separate experiment, in which the number of
radiation-resistant CBA/J spleen cells and allogeneic stimulators were again
constant, and the number of thymocytes plated in culture varied five-fold.  The
number of radiation-resistant CBA/J spleen cells used in this experiment, 4 x 106
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cells/well, differed from that normally used, 1 x 107 cells/well, in that it was a
number known to be limiting for providing “help” under these conditions.  When T
cells are present in the allogeneic stimulators, high numbers of thymocytes generate
CTL responses in a manner not critically dependent on the presence of radiation-
resistant CBA/J spleen cells, see the left panel of Figure 4.3.2, whereas a lower
number of thymocytes is dependent upon the presence of irradiated spleen cells for
the generation of CTL responses. When T cells are depleted from the allogeneic
stimulators by antibody dependent complement mediated lysis, only cultures
containing a high number of thymocytes support the generation of CTL responses in
a manner that is partially dependent upon the presence of radiation-resistant CBA/J
spleen cells, see the left panel of Figure 4.3.2.  It is possible that a small population
of approximately 3 to 5% residual T cells that normally escape antibody dependent
complement mediated depletion as assessed by flow cytometry are present in the
irradiated allogeneic stimulators, and that this residual population contains cells that
can participate in the generation of responses when a sufficient number of
responding thymocytes is present.  To minimize the influence of the residual T cells
in the allogeneic stimulators in preceding experiments, a density of thymocytes, 2 x
106 cells/well, that fails to generate CTL and IFN-g responses unless an optimal
number of irradiated spleen cells, 1 x 107 cells/well, are provided was employed.
We conclude from our findings that a threshold number of cooperative T cell
interactions must occur between thymocytes and radiation-resistant CBA/J spleen
cells for the efficient generation of primary CTL and IFN-g immune responses when
thymocytes are cultured at lower densities and are stimulated with allogeneic spleen
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cells depleted of T cells by antibody dependent complement mediated depletion.
Some experimental evidence supports the suggestion that T cell cooperation between
CD4+ T cells is required to generate responses in vivo and in vitro (Bretscher, 1979,
1986; Gerloni et al., 2000; Ismail & Bretscher, 2001; Strutt & Bretscher, 2005;
Tucker & Bretscher, 1982).  The thymocyte cells involved in the cooperative
interactions with radiation-resistant CBA/J spleen cells will be explored further in
the following section.
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Figure 4.3.1. The Generation of CTL and IFN-g Producing cells from
Thymocytes Stimulated with Allo-MHC Stimulators in the Presence of
Syngeneic Irradiated Spleen Cells is Dependent upon both the Thymocyte and
Syngeneic Spleen Cell Number. CBA/J thymocytes were stimulated with
irradiated, T cell depleted, BALB/c spleen cells in the absence or presence
(open and filled symbols, respectively) of irradiated CBA/J spleen cells as
described in section 3.4.  Either the number of thymocytes (left panel) or the
number of irradiated syngeneic helper cells (right panel) plated in culture was
varied as follows:  Thymocytes (left panel), t- 0.25 x 106 cells/well; l - 0.50
x 106 cells/well; s  - 1.0 x 106 cells/well; and n  - 2.0 x 106 cells/well all
stimulated in the presence of 1.0 x 107 irradiated spleen cells; or Splenocytes
(right panel): 2 x 106 thymocytes/well stimulated in the presence of t- 0.4 x
107 cells/well; l- 0.6 x 107 cells/well; s - 0.8 x 107 cells/well; n - 1.0 x 107
cells/well irradiated syngeneic spleen cells.  The generation of CTLs was
assessed on day 6 using the standard 51Cr CTL assay against P815 (H-2d)
target cells as described in section 3.5.1.  The corresponding number of
antigen-dependent IFN-g producing cells/107 input thymocytes given “help”
detected in the ELISPOT performed as described in section 3.5.2 for each
condition is also presented ± the standard deviation.  The normalized CTL
response of 1.25 x 104 input stimulated thymocytes given irradiated syngeneic
help is also shown. Similar observations were obtained in three separate
experiments.
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Figure 4.3.2.  The Generation of CTL Responses from Thymocytes Stimulated
with Allo-MHC Stimulators is not Critically Dependent on Syngeneic
Irradiated Spleen Cells at High Thymocyte Densities when the Allo-MHC
Stimulators Contain Thy1.2+ T cells. A high number, n - 1x 107 cells/well, or
a moderate number, l  - 2x 106 cells/well, of CBA/J thymocytes was
stimulated with irradiated BALB/c spleen cells in the absence or presence
(open and filled symbols, respectively) of a limiting number, 4 x 106
cells/well, of irradiated CBA/J spleen cells as described in section 3.4.  The
BALB/c stimulator cells were either untreated (left panel) or depleted of
Thy1.2+ T cells (right panel) by antibody dependent complement mediated
depletion prior to addition to culture as described in section 3.7.1.
Adjustments were not made to cell numbers to compensate for cell loss.  The
generation of CTLs was assessed on day 6 using the standard 51Cr CTL assay
against P815 (H-2d) target cells as described in section 3.5.1. The response of
the syngeneic irradiated spleen cells stimulated with BALB/c spleen cells
against syngeneic targets is represented by the hatched square and was < 5%
upon incubation with all corresponding fractions of the culture and is hidden
by the other symbols. The numbers to the right of each symbol represent the
normalized percent specific lysis of the different conditions per 5 x 104 input
thymocytes. Similar observations were obtained in two separate experiments.
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4.4. CD4+ T cell Cooperation in the Generation of Primary Immune
Responses In Vitro
The experimental findings just described indicate that a threshold number of
T cell cooperative events are potentially involved in the generation of primary
immune responses.  Cooperative interactions may occur between CD4+ T cells and
intermediary antigen-presenting cells.  For example, it is possible that the radiation-
resistant, effector CD4+ T helper cells present in the irradiated syngeneic spleen
provides “help” for thymocyte precursor CD8+ CTLs by interacting with and
activating an antigen presenting cell (Bennett et al., 1998; Lutz & Fitch, 1979; Ridge
et al., 1998). It is also conceivable that the effector CD4+ T helper cells present in
the irradiated syngeneic spleen are cooperating with, and activating or licensing
antigen-presenting cells that then activate a population of naive precursor CD4+
thymocyte T helper cells, which also participate in “helping” in the generation of
CD8+ CTL and cytokine responses (Alpan et al., 2004; Creusot et al., 2003).
Two different experiments were performed to discriminate between the two
possibilities.  In the first, the effect of removing different thymocyte T cell subsets
was determined.  CD4+, CD8+, or Thy1.2 positive cells were depleted from CBA/J
thymocytes by antibody dependent complement mediated lysis before the onset of
culture, and the ability of the different thymocyte populations to generate CTL and
cytokine responses was assessed upon stimulation with alloantigen or allogeneic
spleen cells depleted of T cells in the presence of radiation-resistant CBA/J spleen
cells. CTLs and IFN-g producing cells fail to be generated in the absence of cells
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bearing CD8+ and Thy1.2+ surface markers, see Figures 4.4.1. a and b.  The
generation of IL-4 producing cells was increased by the removal of CD8+ cells, see
Figure 4.4.1 b.  This increase in the detection of IL-4 producing cells may be the
result of increased CD4+ T cell expansion, which may favor the generation of Th2
type responses, or alternatively, an element that suppresses IL-4 production may be
absent. When CD4+ T cells were removed from the responding thymocytes before
the onset of culture, IL-4 producing cells were no longer generated, and a slight
decrease in both the generation of CTLs and IFN-g producing cells was evident,
again see Figures 4.4.1 a and b.
In the second experiment, complement treated and CD4 depleted thymocytes
were cultured at different densities and stimulated with allogeneic spleen cells
depleted of T cells in the presence of sufficient numbers of irradiated syngeneic
spleen cells to ascertain the influence of CD4+ thymocytes on the generation of CTL
and normalized cytokine responses.  The generation of CD8+ CTLs was found to
decrease when thymocyte cultures are devoid of CD4+ T cells, see Figure 4.4.2. a.
As was indicated in previous experiments, the generation of CTLs from thymocytes
appears to be a non-cooperative phenomenon, and supports the suggestion that the
different effector functions of CD8+ T cells are independently regulated (Snyder et
al., 2003).  The generation of IFN-g producing cells was also markedly lower in
cultures that were devoid of CD4+ thymocyte precursor T helper cells, see Figure
4.4.2. b.   As one would expect from the CD4+ phenotype of the IL-2 producing
cells, the removal of CD4+ T cells before cell culture abolished the ability to detect
the generation of IL-2 producing cells.
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We conclude from these findings that thymocyte CD4+ precursor T helper
cells can act in conjunction with radiation-resistant CBA/J spleen cells in the
generation of antigen-specific CTL and IFN-g producing cells.  CD4+ precursor
thymocytes can potentially “help” in the generation of responses from CD8+
thymocytes by either directly licensing additional APC, and/or by providing
additional growth cytokines, such as IL-2 and/or IL-4.  Naïve CD4+ thymocytes,
therefore, possess the potential, if appropriately stimulated, to “help” in the in vitro
generation of antigen-specific immune responses.
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Figure 4.4.1. a.  The Generation of CTLs from Thymocytes after the Removal of
different T cell Subsets at the Initiation of Culture.    A standard number of male
CBA/J thymocytes, T, were stimulated with irradiated, T cell depleted, female
BALB/c spleen cells in the absence or presence of irradiated male CBA/J spleen
cells or H-Help as described in section 3.4. At the initiation of culture, T cell subsets
were depleted from input thymocytes by antibody dependent C’-mediated depletion
as described in section 3.7.1.  Cells were untreated, treated (Rx) with C’ alone, or
with C’ and anti-CD4 (GK1.5), or anti-CD8 (TIB 211), or anti-Thy1.2 (TIB 99)
hybridoma supernatants.  Adjustments were not made to cell numbers to compensate
for cell loss.  The generation of CTLs was assessed on day 6 using the standard 51Cr
CTL assay against P815 (H-2d) target cells as described in section 3.5.1. The
response of the syngeneic irradiated spleen cells stimulated with BALB/c spleen
cells against syngeneic targets is represented by the hatched square was < 5% upon
incubation with all corresponding fractions of the culture and is hidden by the other
symbols.  Similar observations were obtained in two independent experiments in
which male CBA/J mice, the only mice available at the time, were employed.
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Figure 4.4.1 b. The Generation of Allo-MHC Specific IFN-g, IL-2, and IL-4
Cytokine Producing Cells from Thymocytes after the Removal of Different T
cell Subsets at the Initiation of Culture. CBA/J thymocytes, T , were
stimulated with irradiated, T cell depleted, BALB/c spleen cells in the absence
or presence of irradiated CBA/J spleen cells or H-Help as described in section
3.4.  At the initiation of culture, T cell subsets were depleted from thymocytes
by antibody dependent C’-mediated depletion as described in section 3.7.1.
Cells were untreated (1, 2, 7), treated (Rx) with C’ alone (3), treated with C’
and anti-CD4 (GK1.5), anti-CD8 (TIB 211), or anti-Thy1.2 (TIB 99)
hybridoma supernatants (4-6, respectively).  Adjustments were not made to
cell numbers to compensate for cell loss. The number of IFN-g and IL-4
producing cells generated by day 6 was enumerated in the ELISPOT Assay as
described in section 3.5.2.  The error bars represent the standard deviation of
the number of antigen dependent spots.  Similar observations were obtained in
two independent experiments.
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Figure 4.4.2. a.  CD4+ Thymic Precursor T Helper Cells act in Conjunction
with the Syngeneic Irradiated Spleen Cells in the Generation of Allo-MHC
Specific CTLs. CBA/J thymocytes were stimulated with irradiated, T cell
depleted, BALB/c spleen cells in the absence or presence (open and filled
symbols, respectively) of irradiated CBA/J spleen cells as described in section
3.4. At the initiation of culture, input thymocytes were either n - C’-treated,
or l - depleted of CD4+ cells by antibody dependent complement mediated
depletion as described in section 3.7.1. Adjustments were not made to cell
numbers to compensate for cell loss.  Thymocytes were plated at the indicated
densities, and on day 6, the generation of CTLs was determined using the
standard 51Cr CTL assay against P815 (H-2d) or EL-4 (H-2b- inset) target cells
as described in section 3.5.1. Similar observations were obtained in two
independent experiments.  The normalized CTL response of 5 x 104 input
thymocytes is also shown.
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Figure 4.4.2. b. CD4+ Thymic Precursor T Cells act in Conjunction with the
Syngeneic Irradiated Spleen Cells in the Generation of Allo-MHC Specific
IFN-g, and IL-2 Cytokine Producing Cells. CBA/J thymocytes, T, were
stimulated with irradiated, T cell depleted, BALB/c spleen cells in the absence
or presence of irradiated CBA/J spleen cells or H-Help as described in section
3.4. At the initiation of culture, thymocytes were either C’-treated (filled
bars), or depleted of CD4+ cells (open bars) by antibody dependent
complement mediated depletion as described in section 3.7.1.  Adjustments
were not made to cell numbers to compensate for cell loss. Thymocytes were
plated at the indicated densities, and on day 6, the number of IFN-g and IL-2
producing cells generated was enumerated in the ELISPOT Assay as
described in section 3.5.2.  The error bars represent the standard deviation of
the number of antigen dependent spots. Similar observations were obtained in
two independent experiments.
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The inference that CD4+ thymocyte precursor T helper cells participate in the
generation of primary allo-MHC specific CTL and cytokine responses would be
further validated by the demonstration that an allo-MHC specific effector CD4+ T
helper cell is generated from naïve thymocytes.  It has been previously demonstrated
by L. Pilarski with mice with disparate Thy1 alleles, but shared MHC haplotypes,
that the CTLs generated upon stimulation of thymocytes with allo-MHC antigens in
vitro, in the presence of irradiated syngeneic spleen, are derived from the thymocyte
precursors (Pilarski, 1977).  She was also able to show that effector CD4+ T cells
generated in vitro from thymocytes possess the ability to “help” in an antigen-
specific manner in the generation of CTL responses, albeit at a lower efficiency than
irradiated syngeneic spleen cells (Pilarski & McKenzie, 1985).
Experiments were performed to elaborate upon these findings.  Thymocyte
derived effector populations were harvested and used as a source of irradiated-
syngeneic “help” for additional thymocyte cultures.  The ELISPOT assay, being a
more sensitive than the CTL assay, was employed to determine if the in vitro
generated effector CD4+ thymocytes could “help” in the generation of CD8+ IFN-g
producing cells from thymocytes upon stimulation with alloantigen.  Irradiated-
thymocytes harvested from cultures stimulated with alloantigen in the absence of
irradiation-resistant syngeneic spleen cells could not “help” in the generation of
cytokine producing cells, whereas, irradiated effector thymocytes generated by
stimulation with alloantigen in the presence of irradiated syngeneic spleen “helped”
thymocytes generate CD8+ IFN-g producing cells (data not shown).
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Thymocyte derived, CD4+ effector T helper cell clones were generated from
the stimulated cultures discussed in the previous paragraph.  Thymic effector phase
cells were repeatedly stimulated with irradiated BALB/c spleen cells, with alternate
rounds of stimulation in the presence of recombinant IL-2.  All of the thymocyte
derived effector T cell clones isolated, including the clones C4 and F6 used in the
experiments presented below, express CD4, and primarily produce IL-4 upon
stimulation with allo-MHC antigens in the ELISPOT assay, see Table 1.
Experiments were performed to determine whether the thymocyte derived,
CD4+ T cell clones generated could operationally provide radiation resistant
syngeneic “help”, and whether the “help” provided is mediated in an antigen-specific
manner.  Such a demonstration would indicate that the effector CD4+ T cell clones
express antigen-specific TCRs.  Separate CBA/J thymocyte cultures were stimulated
with either irradiated BALB/c or C57BL/6 spleen cells in the absence or presence of
normal irradiated syngeneic CBA/J spleen cells, CBA/J thymocyte derived clone C4,
or clone F6.  The number of irradiated cloned T cells required to “help” in the
generation of responses from thymocytes was previously determined (data not
shown).  The results in Figure 4.4.3 a and b show the thymocyte derived effector
CD4 T cell clones preferentially “help” thymocytes generate CTL and cytokine
responses against BALB/c allo-MHC antigens, the allo-MHC antigen employed for
their derivation.  Similar results were obtained in separate experiments where the
ability of CBA/J thymocyte derived clone C4 to “help” thymocytes generate allo-
MHC specific responses was assessed in the presence of both irradiated BALB/c and
C57BL/6 spleen cells, see Figure 4.4.3. c and d.  While these observations suggest
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that, the thymocyte derived CD4+ T cell clones operationally provide antigen-
specific “help” for thymocytes, the exact nature of this “help” remains to be
determined. Nevertheless, these findings allow one to infer that CD4+ thymocyte
precursor T helper cells possess the potential to differentiate into functional CD4+ T
helper cells.
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Table 1.   Characterization of the Cytokine Profile and Specificity of CBA/J Thymocyte
Derived CD4+ T cell Clones C4 and F6 in the ELISPOT Assay*.
Clone
Antigen Stimulation in ELISPOT
              None                           BALB/c                   C57BL/6
C4 - IFN-g -, IL-2 –,
IL-4 ++
IFN-g -, IL-2 –,
IL-4 +
F6 - IFN-g -, IL-2 –,
IL-4 ++
-
    
*CBA/J T cell clones were generated as described in section 3.10 and cytokine production was assessed
in the ELISPOT as described in section 3.5.2. –  and + symbols refer to the absence and presence of
detectable cytokine producing cells, respectively.  The percentage of cloned T cells plated that produce
cytokines ranged from 3-5%.  Cytokine production of each clone was assessed in three separate
experiments.
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Figure 4.4.3. a. Thymocyte Derived Effector CD4+ T Helper Cell Clones Help
Thymocytes Generate Allo-MHC Specific CTL Responses. A standard number of
CBA/J thymocytes were stimulated with irradiated, T cell depleted, BALB/c (left
panel) or C57BL/6 (right panel) spleen cells in the absence (open symbols) or
presence of irradiated CBA/J spleen cells (n), 1 x 104 cells/well irradiated CBA/J
CD4+ T cell Clone C4 (    ), or Clone F6 (   ) as described in section 3.4.  The
generation of CTLs was assessed on day 6 using the standard 51Cr CTL assay against
P815 (H-2d- left panel) target cells or EL-4 (H-2b- right panel) target cells as
described in section 3.5.1. Similar observations were obtained in two independent
experiments.
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Figure 4.4.3. b.  Thymocyte Derived Effector CD4+ T Helper Cell Clones
Help Thymocytes Generate Allo-MHC Specific IFN-g, IL-2, and IL-4 Cytokine
Producing Cells. CBA/J thymocytes, T, were stimulated with irradiated, T
cell depleted, BALB/c (filled bars) or C57BL/6 (open bars) spleen cells in the
absence or presence of irradiated CBA/J spleen cells, Spl H-Help, or 1 x 104
cells/well irradiated CBA/J CD4+ T cell Clone C4 or Clone F6 as described
in section 3.4. The number of IFN-g, IL-2, and IL-4 producing cells generated
by Day 6 was enumerated in the ELISPOT Assay as described in section
3.5.2.  The error bars represent the standard deviation of the number of
antigen dependent spots.  Similar observations were obtained in two
independent experiments.
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Figure 4.4.3. c.  Thymocyte Derived Effector CD4+ T Helper Cell Clones
Help Thymocytes Generate Allo-MHC Specific CTL Responses in an Antigen-
Specific Manner.  CBA/J thymocytes were stimulated with irradiated BALB/c
(left panel), C57BL/6 (middle panel), or a combination of both (right panel)
spleen cells in the absence (open symbols) or presence of 5 x 104 cells/well
irradiated CBA/J CD4+ T cell Clone C4 (n) as described in section 3.4.  The
generation of CTLs was assessed on Day 6 using the standard 51Cr CTL assay
against P815 (H-2d) target cells or EL-4 (H-2b) target cells as described in
section 3.5.2.  Lysis of third party target cells by cells harvested from cultures
stimulated with either BALB/c or C57BL/6 spleen cells is represented by the
squares with Xs. The response of the syngeneic irradiated clones stimulated
with irradiated, T cell depleted, BALB/c or C57BL/6 spleen cells against
syngeneic targets is represented by the hatched square was < 5% upon
incubation with all corresponding fractions of the culture and is hidden by the
other symbols.
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Figure 4.4.3. d. Thymocyte Derived Effector CD4+ T helper Cell Clones Help
Thymocytes Generate Allo-MHC Specific IFN-g, IL-2, and IL-4 Cytokine
Producing Cells in an Antigen-Specific Manner.  CBA/J thymocytes, T, were
stimulated with irradiated, T cell depleted, BALB/c (filled bars), C57BL/6
(open bars), or a combination of both (hatched bars) spleen cells in the
absence or presence of 1 x 105 cells/well irradiated CBA/J CD4+ T cell Clone
C4 Help or H as described in section 3.4. The number of IFN-g, IL-2, and IL-
4 producing cells generated by day 6 was enumerated in the ELISPOT Assay
as described in section 3.5.2.  The error bars represent the standard deviation
of the number of antigen dependent spots.
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The demonstration that a cell that can act as a radiation resistant helper cell
can be generated from thymocyte precursor cells supports the possibility that the
radiation resistant CD4+ T spleen cells in normal mice that can “help” thymocytes
generate alloresponses are of thymic origin.  The demonstration that mice
thymectomized within 24 hours of birth lack peripheral radiation resistant CD4+ T
cells that can “help” thymocytes generate responses in an antigen specific manner
would further support this position.
The observation that effector CD4+ T cell clones that primarily produce the
Th2 associated cytokine IL-4 “help” in the generation of cellular responses from
naïve thymocytes is in accord with previous observations that IL-4 or T cell clones
that posses the potential to help B cells produce antibody can support the
differentiation of CD4+ and CD8+ T cells into competent alloreactive cells (Bagley,
Sawada, Wu, & Iacomini, 2000; Pfeifer et al., 1987; Ramarli, Parodi, Fabbi, Corte,
& Lanzavecchia, 1984), and leaves open the possibility that the effector CD4+ T
cells present in the periphery of normal mice could be Th0, Th1, or Th2 in character.
The CD4+ T cell phenotype of the radiation-resistant effector helper cell has
been described previously (Pilarski, 1977; Pilarski et al., 1980).  Results obtained
with bone marrow chimeras discussed previously show that this cell is a CD4+ T cell
that displays antigen-specificity and self-tolerance (Pilarski, 1977).  The radiation-
resistant nature of “helper activity” of the effector CD4+ T cells indicates that these
cells are activated T cells that provide helper signals and/or cytokines without prior
proliferation; g-irradiation induces lethal DNA damage that will result in cell death
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upon engaging in the process of proliferation (Kettman & Dutton, 1971; Sprent et al.,
1974).
Experiments were performed to further characterize the activation status of
the radiation resistant effector CD4+ T helper cells.  To expand upon the findings of
L. Pilarski, the syngeneic irradiated CBA/J spleen cells were depleted of CD4+,
CD8+, and Thy1.2+ positive cells by antibody dependent complement mediated
lysis, and to further characterize the activation status, the syngeneic spleen cells were
also depleted of cells expressing either T cell surface markers typically associated
with naïve and resting memory T cells or surface markers associated with activated T
cells before irradiation and assessment of their “helper” activity. The removal of
cells expressing high levels of CD62L or CD45RB is expected to deplete naïve or
resting memory cells, whereas, the removal of cells expressing high levels of CD44
is expected to result in the depletion of activated cells (Dutton et al., 1998). The
number of irradiated spleen cells added to thymocytes was determined before
depletion and cell numbers were not adjusted to compensate for cell loss.  High
expression of the latter T cell surface marker, CD44, has to date been the most
reliable marker to characterize activated, or blasting, T cells.
The ability of the “helper” spleen cell populations, after depletion by
antibody dependent complement mediated depletion, to provide “help” for
thymocytes to produce CTLs and cytokine-producing cells was assessed.  In
agreement with the findings of L. Pilarski examining the generation by thymocytes
of CTL responses (Pilarski, 1977), the removal of CD4+ T cells from the syngeneic
spleen by antibody dependent complement mediated depletion significantly reduces
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the in vitro generation of CD8+ CTLs and IFN-g producing cells, and CD4+ IL-2
producing cells from thymocytes upon stimulation with allo-MHC antigens, see
Table 2 and Figure 4.4.4. a.  When cells expressing high levels of the effector
memory T cell/activation marker CD44, which is up modulated in the late stages of
T cell activation (Swain, 1999), were removed by antibody dependent complement
mediated depletion, the generation of CD8+ CTLs and IFN-g producing cells was
also markedly decreased, whereas the generation of CD4+ IL-2 producing cells was
only partially affected.  It is reasonable to speculate that some of the intermediate
expressing CD44+ CD4+ T cells are in a transitional phase of CD44 expression.  The
presence of residual cells may be sufficient to result in the generation of IL-2
producing cells or the generation of some IL-2 producing cells may require these
cells.  It is less easy to explain in the latter case why the generation of IL-2
producing CD4+ T cells from thymocytes is dependent upon radiation resistant
CD4+ Thy1.2+ cells in the spleen cell population.
By contrast, the removal of cells expressing high levels of markers
characteristic of naïve and resting memory T cells, namely CD62L or CD45RB
(Dutton et al., 1998), failed to decrease the ability of the irradiated syngeneic CBA/J
spleen cells to provide thymocytes with “help” upon stimulation with alloantigen.
Rather, the generation of CD8+ CTL and IFN-g responses was enhanced by the
removal of these cells.  The enhancement may be the result of the removal of
CD62Lhigh or CD45RBhigh expressing NK cells, which could lead to the more
prolonged presence of irradiated stimulators in culture (Moretta, 2002; Nikolic,
Cooke, Zhao, & Sykes, 2001). Alternatively, the enhanced responses may be the
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result of the removal of a subset of suppressor cells, which express surface markers
either associated with naïve/resting memory cells or activated cells (Huehn et al.,
2004; Szanya, Ermann, Taylor, Holness, & Fathman, 2002).
The heterogeneity of the expression profiles of the relevant surface markers
on un-stimulated, normal, and for comparison purposes on un-stimulated DO11.10
TCR transgenic Thy1.2+ cells that should contain a higher proportion of naïve T
cells, are presented in Figures 4.4.4. b and c.  High, intermediate and low expression
of CD44 is not as obvious on total Thy1.2 cells as it is for CD4+ T cells, see Figure
4.4.4.b.  The expression profiles of the relevant markers on thymocytes presented in
4.4.4 c conform to the profiles already established in the literature (Lee et al., 2001).
It has been suggested that the heterogeneous expression of such markers on T cells
that emerge from the thymus, and potentially also activated T cells that emerge from
tissues, is more related to a commitment to different migration patterns and/or
reversible adaptation to anatomical microenvironments, respectively, than definitive
markers of previous activation status (Kassiotis & Stockinger, 2004; Lee et al.,
2001).
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Table 2 Characterization of the CD4+ T cells present in irradiated CBA/J spleen that
helps thymocytes
Culture Syngeneic Spleen
Cell Treatment
Lytic Units*
T None 0 ± 0
T + H None       143 ± 15
T + H Complement       129 ± 24
T + H Anti-CD4 and C”        2.4 ± 1.2
T + H Anti-CD8 and C”       120 ± 30
T + H Anti-Thy1.2 and C”           0 ± 0
T + H Anti-CD44 and C”         10 ± 1.0
T + H Anti-CD45RB and C”       175 ± 8.0
T + H Anti-CD62L and C”       180 ± 7.6
H None 0 ± 0
* The errors represent the standard deviation of the LU values.  Cultures were set up as
described in section 3.4.  Cell populations were depleted by antibody dependent complement
mediated depletion as described in section 3.7.1.  The generation of CTLs was assessed in
the CTL assay as described in section 3.5.1.  Similar findings were obtained in three separate
experiments for all markers and two additional experiments for the removal of CD44 cells.
In one replicate experiment, the trend of results was identical, but LU values were low due to
a Lot of rabbit complement that was abnormally toxic for thymocytes.  Values ranged from 0
± 0 for T, to 47± 3.4 LU for anti-CD45RB and C” Rx T + H.  In experiments where the
removal of CD44 expressing cells was assessed as a function of hybridoma supernatant
dilution, the percentage of Low, Intermediate, and High expressing CD44+ CD4+ cells as
defined (Wang & Mosmann, 2001) was determined by flow cytometry as described in
section 3.9.1. to be: C” treated (Rx), L:62.4%, I:27.7%, H:8.9; C” and undiluted anti-CD44
ab Rx, L:65.3%, I:25.5%, H:0.6%; C” and 1/2 diluted anti-CD44 ab Rx, L: 65.6%, I:24.9%,
H:0.5%; and lastly C” and 1/4 diluted anti-CD44 ab Rx, L:65.5%, I:25.7%, H:0.9%.
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Figure 4.4.4. a. The Syngeneic Radiation Resistant Spleen Cells that Help
Thymocytes Generate IFN-g and IL-2 Cytokine Producing Cells upon
Stimulation with Allo-MHC Stimulators are CD44hi, CD45RBlow and CD62Llow
CD4+ Thy1.2+ Cells.  Thymocytes, T, were stimulated with irradiated, T cell
depleted, BALB/c spleen cells in the absence or presence of irradiated CBA/J
spleen cells or H-help as described in section 3.4. Standard culture conditions
were employed.  Before irradiation and culture, T cell subsets were depleted
from CBA/J spleen cells by C’-mediated depletion as described in section
3.7.1.  Cells were untreated (1, 2, 10), treated (Rx) with C’ alone (3), with C’
and anti-CD4 (GK1.5, 4), anti-CD8 (TIB 211, 5), anti-Thy1.2 (TIB 99, 6),
anti-CD44 (IM7.8.1,7), anti-CD62L (MEL14.D54, 8), or anti-CD45RB
(MB23G2, 9) hybridoma supernatants. Analysis of the degree of depletion is
described in section 3.9.1 and in the legend of Table 2 for the removal of
CD44 expressing cells.  Adjustments were not made to cell numbers to
compensate for cell loss. The ability of the treated syngeneic spleen cells to
help in the generation of IFN-g and IL-2 producing cells was assessed on Day
6 with the ELISPOT Assay as described in section 3.5.2.  The error bars
represent the standard deviation of the number of antigen dependent spots.
Similar results were obtained in three separate experiments for all markers,
and two additional experiments where the removal of CD44 expressing cells
was assessed independently.
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Figure 4.4.4. b. The Expression Profile of T Cell Activation Markers on
Normal and TCR Transgenic Splenocytes. The expression profile of CD44,
CD62L, and CD45RB on normal (upper row) and D011.10 TCR Transgenic
(lower row) gated on Thy1.2+ splenocytes was assessed directly ex vivo by
flow cytometry as described in section 3.9.1.  The heterogeneous expression
of CD44 is more evident on CD4+ gated cells. The approximate positions of
Low, Intermediate, and High gates are presented.
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Figure 4.4.4. c. The Expression of T Cell Activation Markers on Immature and
Mature Normal and TCR Transgenic Thymocytes. The expression profile of CD44,
CD62L, and CD45RB on gated populations of immature Thy1.2high (æ) and mature
Thy1.2low (æ ) normal (upper row) and D011.10 TCR Transgenic (lower row)
thymocytes was assessed by flow cytometry as described in section 3.9.1.
Background staining is represented as a shaded histogram.
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4.5. Nature of the Antigen Presenting Cell Involved in Primary T Cell
Activation: Stimulatory Capacity of Dendritic Cells
Experimental evidence has been presented that shows conditions can be
established under which the generation of allo-MHC specific CTLs and cytokine
responses from thymocytes upon stimulation with allogeneic spleen cells depleted of
T cells involves radiation resistant CD4+ T spleen cells syngeneic with the
thymocytes.  Precursor CD4+ thymocyte T helper cells can also participate in the
generation of these responses.  CD4+ T helper cells are restricted to MHC Class II
antigens (Goldrath & Bevan, 1999).  Their TCRs must therefore recognize antigenic
peptides in the context of MHC Class II complexes in order to license/activate
antigen-presenting cells that then can activate MHC Class I restricted, CD8+ T cells
(Bennett et al., 1998; Bennett et al., 1997; Ridge et al., 1998). Competing models of
primary T cell activation predict that different kinds of antigen-presenting cells are
centrally involved in initiating the activation of naïve T cells (Bretscher, 1999;
Janeway, 1989; Matzinger, 1994).
The proponents of the Infectious Non-Self and Danger models of naïve T cell
activation propose that non-specific antigen-presenting cells, such as dendritic cells,
under the correct circumstances, stimulate naïve CD4+ T cells to become activated
cells that can help B cells produce antibody and/or help in CD8+ T cell activation
(Janeway, 1989; Matzinger, 1994).  The Two-step, Two-signal Model of primary
CD4+ T cell activation states that non-specific antigen presenting cells, such as
dendritic cells, are important for stimulating the proliferation of naïve CD4+ and
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CD8+ T cells, but that such cells are unable to deliver the critical costimulatory
signals and/or cytokines required for full naïve T cell activation (Bretscher, 1999).
The latter model proposes that a critical signal needed for primary T cell activation,
termed the second signal of step two, must be delivered in an antigen specific
manner.  The antigen-specific delivery of the second step second signal is postulated
to occur upon recognition of cognate antigen presented on activated B cells, whose
activation is dependent upon effector CD4+ T helper cells.
Experiments were performed to delineate which antigen-presenting cell(s) in
the allogeneic BALB/c spleen cell population depleted of T cells are necessary for
stimulating the generation of allo-MHC specific CTL and cytokine producing cells
from thymocytes when irradiation resistant spleen cell “help” is provided.  The
allogeneic spleen cell populations depleted of T cells used to stimulate thymocytes
were further depleted of different cell populations by antibody dependent
complement mediated lysis and assessed for their ability to stimulate alloresponses.
The stimulatory capacity of irradiated T cell depleted BALB/c spleen cells, T cell
depleted BALB/c spleen also depleted of B220+ cells, and graded numbers of
dendritic cells derived from the bone marrow of BALB/c mice were assessed.  It is
evident from the results presented in Table 3 that the removal of B220+ cells from
the allogeneic stimulator spleen by antibody dependent complement mediated
depletion decreased the generation of allo-MHC specific CTLs by three-fold.  In
comparison to the response generated upon stimulation with T cell depleted BALB/c
spleen cells, a marked decrease in the generation of CD8+ CTL and IFN-g producing
cells, as well as CD4+ IL-2 producing cells, was evident when irradiated bone-
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marrow derived dendritic cells were used to stimulate thymocytes, see Table 2 and
Figure 4.5.1.  When high numbers of bone marrow-derived dendritic cells were used
to stimulate thymocytes, marginal CTL responses, in comparison to the control
cultures, were evident.  Possible reasons for the generation of the latter response are
discussed below.
Low numbers of B cells that escape anti-B220 antibody dependent
complement mediated depletion are inevitably present in the former treated
allogeneic spleen population that was also depleted of T cells.  The presence of
residual B cells may explain the inability to dramatically affect the generation of
responses from thymocytes if B cells are required to generate responses, or
alternatively the generation of such responses may not require B cells.  It is pertinent
in assessing the plausibility of the two possibilities that some activated B cells have
been reported to down regulate B220 expression (McHeyzer-Williams, Cool, &
McHeyzer-Williams, 2000).  The presence of B220- B cells in the treated allogeneic
stimulator cells might also explain the inability to markedly affect the generation of
responses from thymocytes by the depletion of B220+ cells from the BALB/c spleen
cells.  Low numbers of B cells may also be present in the bone marrow derived
dendritic cell populations because B cells and dendritic cells can both develop from
an early B-lineage precursor population found in adult mouse bone marrow (Coligan
et al., 1998; Inaba et al., 1992; Izon et al., 2001).  To minimize the presence of B
cells in the bone marrow derived dendritic cells employed in all subsequent
experiments, bone marrow cultures were extensively washed to remove
contaminating cells.  The efficiency of the removal of contaminating cells from bone
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marrow derived dendritic cells was confirmed by flow cytometry and is discussed in
the next section.  The issue of whether B cells are required for the generation of
immune responses from thymocytes, and whether the dendritic cells generated from
BALB/c bone marrow are in fact conventional dendritic cells is not resolved and will
be considered further in the next sections and as well as the discussion.
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Table 3: The Efficiency of Different Allogeneic APC at Stimulating the Generation of
CTLs from Thymocytes.
Culture Stimulator
Number of Stimulator
Cells per Culture Lytic Units1
T a Thy1.2 Rx Spleen 2 x 106 0 ± 0
T + H a Thy1.2 Rx Spleen 2 x 106 320 ± 11
T + H a Thy1.2 , a B220 and
Ad-  Rx spleen
2 x 106 110 ± 2
T + H BMDC 1 x 102 0 ± 0
T + H BMDC 1 x 103 0 ± 0
T + H BMDC 1 x 104 1 ± 0
T + H BMDC 1 x 105 35 ± 3
H a Thy1.2 Rx Spleen 2 x 106 0 ± 0
  1 The errors represent the standard deviation of the LU values.  Similar observations were obtained in
three separate experiments.  Cultures were set up employing standard culture conditions of 2 x 106
cells/well thymocytes and 1.0 x 107 cells/well irradiated spleen cells as described in section 3.4 and
CTL assays were performed as described in section 3.5.1.  Adherent cells (Ad) were removed by
incubation of spleen cells in plastic Petri plates at 37°C for 2 hrs as described (Coligan et al., 1998).
Bone marrow derived dendritic cells were prepared as described in section 3.8.1. and were sub cultured
in the absence of exogenous activation stimuli.
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Figure 4.5.1.  Efficiency of Different Allo-MHC Bearing APC in Stimulating
the Generation of IFN-g and IL-2 Producing Cells from Thymocytes in the
presence of Irradiated Syngeneic Spleen. CBA/J thymocytes, T , were
stimulated with different irradiated T cell depleted BALB/c spleen cells in the
absence or presence of irradiated CBA/J spleen cells or H-Help employing
standard conditions as described in section 3.4. The irradiated BALB/c spleen
cells employed were Thy1.2 depleted spleen (Spl), spleen that was further
depleted of adherent and B220+ cells, (Spl, *), or graded numbers of bone
marrow derived dendritic cells (DC) that were generated from BALB/c bone
marrow as described in section 3.8.1.  Cell populations were depleted of cell
populations by antibody dependent complement mediated depletion as
described in section 3.7.1.  Adjustments were not made to cell numbers after
antibody dependent complement mediated depletion to compensate for cell
loss.  The number of IFN-g and IL-2 producing cells generated by Day 6 was
enumerated in the ELISPOT Assay as described in section 3.5.2.  The error
bars represent the standard deviation of the number of antigen-dependent
spots.  Similar results were obtained in three independent experiments.
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One could argue from the observations just described that the dendritic cells
derived from murine proliferating bone marrow progenitor cells are inherently
inefficient at stimulating the generation of CTL and cytokine producing cells from
naïve thymocytes because they are functionally immature or alternatively are
unconventional dendritic cells (Bonifaz et al., 2002; Girolomoni et al., 1990;
Hawiger et al., 2001; Inaba et al., 1986; Jonuleit et al., 2000; Steinman et al., 2003).
Experiments in which CBA thymocytes or splenocytes were stimulated with bone
marrow derived dendritic cells matured/activated by exposure to different maturation
stimuli for 24 hrs were performed to assess the stimulatory capacity of the in vitro
generated dendritic cells.  The bone marrow derived dendritic cells were sub-
cultured in the presence of complete media, in the presence of media containing anti-
CD40 mab, or complete media containing LPS.   The latter two stimuli have been
extensively documented to trigger the activation of dendritic cells (Banchereau &
Steinman, 1998).  The results presented in the right panels of Figures 4.5.2. a and b
show that CBA splenocytes readily generate CTL responses upon stimulation with
irradiated allogeneic bone marrow derived dendritic cells, with those matured in the
absence of exogenous maturation stimuli and subsequently matured by the allogeneic
T cells in culture and those matured in the presence of anti-CD40 ligation stimulating
the generation of comparable responses.  The bone marrow derived dendritic cells
matured in the presence of LPS stimulated the generation of more vigorous CTL and
IFN-g responses.  The ability of LPS-matured dendritic cells to stimulate more
vigorous responses from thymocytes may be directly related to their increased
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production of IL-12 upon such stimulation.  In contrast to the responses generated
from CBA splenocytes, CBA thymocytes failed to generate responses when
stimulated with any of the matured dendritic cells, even though an adequate number
of irradiated syngeneic spleen cells were present, see the left panels of Figure 4.5.2. a
and Figure 4.5.2 b.  The same thymocytes, however, readily generated CTL and
cytokine producing cells upon stimulation with irradiated, T cell depleted, BALB/c
splenocytes when irradiated syngeneic spleen is provided.  The latter finding
indicates that the inability to detect the generation of responses from thymocytes
upon stimulation with allogeneic dendritic cells is unlikely to be due to an inherent
inability of thymocytes to generate immune responses.
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Figure 4.5.2. a. Activated Bone Marrow Derived Dendritic Cells Stimulate
the Generation of CTL Responses by Responding Splenocytes, but Fail to
Stimulate Responses from Thymocytes in the Presence of Syngeneic Irradiated
Spleen. CBA/J thymocytes were stimulated with irradiated T cell depleted
BALB/c spleen cells in the absence or presence of irradiated CBA/J spleen
cells (o or n, respectively) employing standard conditions as described in
section 3.4.  Separate CBA/J thymocyte cultures that contained irradiated
syngeneic spleen cells (left panel) or CBA/J splenocyte cultures (right panel)
were stimulated with 1 x 104 cells/well irradiated DCs derived from the bone
marrow of BALB/c mice as described in sections 3.4 and 3.8.1.   Before the
addition to cultures, bone marrow derived DCs were sub-cultured for 24 hours
in the presence of media (l), anti-CD40 monoclonal antibody (s), or 1ug/ml
LPS (t).   The generation of CTL responses was assessed on Day 6 against
labeled P815 (H-2d) target cells or against labeled third party targets, EL-4 (H-
2b- inset) in the standard 51Cr CTL assay as described in section 3.5.1. The
percent specific lysis of thymocytes stimulated with all matured dendritic cells
in the presence of irradiated syngeneic spleen cells, and irradiated spleen cells
stimulated with T cell depleted BALB/c spleen cells was < 2%.  Similar
observations were obtained in three independent experiments.
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Figure 4.5.2. b.  Activated Bone Marrow Derived Dendritic Cells Stimulate
the Generation of IFN-g, and IL-2 Cytokine Producing Cells from Responding
Splenocytes, but Fail to Stimulate Responses from Thymocytes in the Presence
of Syngeneic Irradiated Spleen. CBA/J thymocytes, T, were stimulated with
irradiated, T cell depleted, BALB/c spleen (Spl) cells in the absence or
presence of irradiated CBA/J spleen cells or H-Help.  Standard culture
conditions as described in section 3.4 were employed.  Separate CBA/J
thymocyte cultures that contained irradiated syngeneic spleen or CBA/J
splenocyte cultures (insets) were stimulated with 1 x 104 cells/well irradiated
DCs derived from the bone marrow of BALB/c mice that were generated as
described in section 3.8.1.  Standard culture conditions were also employed
for CBA/J splenocyte cultures.   Prior to the addition to cultures, bone marrow
derived DCs were sub-cultured for 24 hours in the presence of the following
maturation stimuli (MS): media (1), anti-CD40 monoclonal antibody (2), or
1mg/ml LPS (3). The number of IFN-g and IL-2 producing cells generated by
Day 6 was enumerated in the ELISPOT Assay as described in section 3.5.2.
The error bars represent the standard deviation of the number of antigen
dependent spots.  Similar observations were obtained in three independent
experiments.
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The inability to detect the generation of CTL and cytokine responses from
thymocytes upon stimulation with bone marrow derived cells could, in principle, be
due to the generation of a cell other than a dendritic cell from the proliferating bone
marrow progenitor cells that inhibits the generation of responses, though no
precedence has been documented.   To assess whether the cells generated from the
proliferating bone marrow progenitors are in fact dendritic cells, the expression of
known costimulatory and dendritic cell antigens, in addition to the antigen presenting
capacity of the bone marrow derived cells (Inaba et al., 1992) was examined.  The
increased expression of the B7 and CD40 costimulatory molecules, and the stable
expression of the dendritic cell marker DEC-205 (Bonifaz et al., 2002; Bonifaz et al.,
2004; Coligan et al., 1998; Hawiger et al., 2001; Inaba et al., 1992), upon Toll-like
receptor ligation support the suggestion that the bone marrow derived cells are in fact
dendritic cells, see Figure 4.5.3.
The latter observations are further supported by the finding that only bone
marrow derived cells sub-cultured in the absence of exogenous activation stimuli
retain the capacity to efficiently endocytose and subsequently present antigen to
BALB/c ovalbumin-specific CD4+ T cell clones, see Figure 4.5.4.  This finding
agrees with previous observations that matured and activated dendritic cells down
modulate both macropinocytosis and their antigen processing machinery upon
activation, which was discussed previously in the Introduction, see section 1.3.6.
(Delamarre et al., 2003; Kampgen et al., 1991; Koch et al., 1995; Pure et al., 1990;
Romani et al., 1989; Sallusto et al., 1995; Steinman, 1991; Wilson et al., 2003).
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While it has been reported that LPS activated dendritic cells retain the capacity to
endocytose antigens by receptor-mediated endocytosis, such as 0.5-mm latex beads
or anti-adsorptive endocytosis receptor antibody complexes, in matured and
activated dendritic cells these internalized complexes reportedly fail to reach
lysosomal compartments (Engering et al., 2002; Kamath et al., 2000).  Antigens
internalized in such a manner have been reported to reside in small organelles called
early endosomes that are located in proximity to the cell surface and have a neutral
pH (Engering et al., 2002).
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Figure 4.5.3.   Bone Marrow Derived Cells Up Regulate Costimulatory Molecules
upon Stimulation with LPS and Express the DEC-205 Dendritic Cell Surface
Marker. The expression of B7.2, B7.1, CD40, DEC-205, B220, or ab TCR on bone
marrow derived cells that were generated as described in section 3.8.1 was assessed
by flow cytometry that was performed as described in section 3.9.1. Expression
profiles after 24 hr maturation with media (æ) or with LPS (æ ) stimulation is
shown.  Background staining is represented as shaded histograms.
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Figure 4.5.4.  Bone Marrow Derived Cells Present Antigen to BALB/c
Ovalbumin (OVA) Specific CD4+ T cell Clones in a Manner Indicative of
Dendritic Cells. Bone marrow derived DC were prepared as described in
section 3.8.1 and were sub-cultured for 24 hrs in the presence of media or
media containing 1 mg/mL of LPS.   Sub-cultured DCs were subsequently
used as APC in a standard proliferation assay and their ability to acquire and
present antigen assessed.  1 x 104 BALB/c Th1, IFN-g secreting OVA-
Specific CD4+ T cell clones were stimulated with 1 x 103 DC in the presence
of no antigen, 1.25 mg/mL OVA, or Hen Egg Lysozyme (HEL) in 96-well
trays.  The ability of the DC to stimulate the proliferation of the BALB/c
OVA-specific T cell clones was determined via the amount of 3H uptake
during the last 18hrs of a 3-day culture as described in section 3.8.2.
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In light of these observations, we can suggest that the cells derived from
BALB/c bone marrow progenitors are in fact conventional dendritic cells.  The
inability of thymocytes to generate significant CTL and T cells producing cytokines
upon stimulation with bone marrow derived dendritic cells, because the dendritic
cells are inefficient at up modulating costimulatory molecules, is unlikely because
CBA/J spleen cells generate alloresponses upon stimulation with these cells, with
LPS activated dendritic cells stimulating the most vigorous responses.  The
difference in the generation of CTL and cytokine responses from unseparated
splenocytes upon stimulation with the differentially activated dendritic cells,
specifically that between CD40 and LPS activated dendritic cells, is most likely the
result of a combination of the higher levels of MHC class II expression and increased
secretion of IL-12 from dendritic cells upon stimulation with LPS, (Edwards et al.,
2002; Kelleher & Beverley, 2001; Maxwell, Ruby, Kerkvliet, & Vella, 2002; Reis e
Sousa et al., 1997).
The requirement for additional antigen-presenting cell-naive T cell
interactions to achieve full T cell activation is at odds with reports in the literature
(Banchereau & Steinman, 1998).  Dendritic cells are renowned for their ability to
stimulate the proliferation and activation of T cells, especially those that have been
activated by exposure to maturation stimuli (Banchereau & Steinman, 1998; Bonifaz
et al., 2002; Bonifaz et al., 2004; Cella et al., 1996; Grohmann, Fallarino, Silla et al.,
2001; Hawiger et al., 2001; Schuurhuis et al., 2000; Steinman & Witmer, 1978;
Tough, Sun, & Sprent, 1997).  Another group has demonstrated that separated
normal CD8+ T cells isolated from the spleen fail to generate responses against
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ovalbumin-pulsed, LPS activated bone marrow derived dendritic cells when CD4+ T
cell signals such as CD40L-CD40 ligation are absent (Kelleher & Beverley, 2001).
Ligation of CD40 restores the responsiveness of the normal CD8+ T cells. In our
experimental system, naïve thymic CD4+ and CD8+ T cells fail to give rise to T cell
responses upon stimulation with dendritic cells even though irradiated syngeneic
splenic cells or CD40 ligation, both of which have been widely reported to activate
dendritic cells, are present.  In light of these observations, it may be reasonable to
speculate that the potent capacity of dendritic cells to act as stimulators for T cells
(Croft, Bradley, & Swain, 1994), is the result of the presence of previously activated
T cells in the responding lymphocyte populations.  The experimental data presented
supports the possibility that additional cellular interactions, in addition to those with
bone marrow derived dendritic cells, are necessary to stimulate the generation of
CTL and cytokine responses from naïve CD4+ and CD8+ thymocytes.
In order to determine how CD4+ and CD8+ T cells respond to stimulation
with allogeneic dendritic cells, experiments were performed to assess whether
stimulation influences the expression of costimulatory ligands on T cells
(Banchereau et al., 1994), and whether stimulation triggers the initiation of T cell
proliferation.  The expression of CD40L and stimulation of proliferation at the single
cell level were assessed by flow cytometry.
CD40L expression is known to peak at very early time points after T cell
stimulation, and is maintained at low levels on Th1 CD4+ T cells thereafter (Jaiswal
et al., 1996; Lee et al., 2002).  The results presented in Figure 4.5.5 show that on Day
5 of culture, when responses have been established, thymocytes stimulated with
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dendritic cells in the absence or presence of irradiated syngeneic CBA/J spleen cells
express CD40L.  Expression is at a high level for thymocytes stimulated in the
absence of help, and is down-modulated to a low level for thymocytes stimulated in
the presence of help.  Thymocytes stimulated with allogeneic spleen cells express
only low levels of CD40L, as is expected for Th1 responses (Lee et al., 2002). We
are currently exploring the kinetics of peak CD40L expression in the differentially
stimulated thymocyte populations.
The proliferation of CBA/J thymocytes was also assessed upon stimulation
with either irradiated allogeneic, bone marrow derived dendritic cells or T cell
depleted spleen cells.  The results presented in Figure 4.5.6 show that thymocytes
stimulated with BALB/c dendritic cells, matured by the presence of irradiated
syngeneic CBA/J spleen cells, divide.  Division of thymocytes is evident from the
loss of CFSE intensity over time (Lyons & Parish, 1994).  The proliferation of
thymocytes stimulated by dendritic cells in the presence of irradiated CBA/J spleen
cells is comparable to that seen when thymocytes are stimulated with irradiated
BALB/c, T cell depleted, spleen cells in the presence of irradiated CBA/J spleen
cells.  As discussed previously, only the latter cultures of thymocytes stimulated in
the presence of “help”, generate allo-MHC specific CD8+ CTL and IFN-g producing
cells, and CD4+ IL-2 or IL-4 producing cells.
In summary, the results presented indicate that dendritic cells derived from
proliferating bone marrow progenitor cells are conventional dendritic cells that
possess the capacity to stimulate the naïve T cells present among thymocytes to
increase expression of CD40L, and progress into cell cycle.  However, in the absence
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of further cellular interactions, the proliferating CBA/J thymocytes fail to
differentiate into functional CTLs and T cells producing cytokines.  In marked
contrast, such stimulation of CBA/J splenocytes, which contain both naïve and
previously activated T cells (Dutton et al., 1998), results in the generation of CTL
and cytokine responses.
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Figure 4.5.5. Thymocytes Stimulated with Allogeneic Bone Marrow Derived
Dendritic Cells or Allogeneic Spleen Cells Up-Regulate the Costimulatory Molecule
CD40L (CD154). CBA/J thymocytes were stimulated with 1 x 104 cells/well
irradiated DC derived from the bone marrow of BALB/c mice (left panel) or with
irradiated, T cell depleted, BALB/c spleen cells (right panel) in the absence (æ) or
presence (æ ) of irradiated CBA/J spleen cells.  Standard culture conditions as
described in section 3.4 were employed.  The expression of the costimulatory ligand
CD40L (CD154) on stimulated thymocytes was performed by flow cytometry as
described in section 3.9.1 on day 5.  Background staining is indicated by the shaded
histogram.  Similar results were obtained in two independent experiments.
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Figure 4.5.6.  Thymocytes Stimulated with Allogeneic Bone Marrow Derived
Dendritic Cells in the Presence of Syngeneic Irradiated Spleen are Stimulated
to Divide. CBA/J thymocytes, T, were stimulated with 2 x 104 cells/well
irradiated DCs derived from the bone marrow of BALB/c mice or with
irradiated, T cell depleted, BALB/c spleen cells in the absence or presence of
irradiated CBA/J spleen cells or H-Help.  Standard culture conditions as
described in section 3.4 were employed.  Before the addition to culture,
responding CBA/J thymocytes were labeled with CFSE as described in
section 3.9.2.  Single cell division was assessed at 24 hr intervals on Days 2
(æ), 3 (---), and 4 (æ) by the loss of CFSE fluorescence intensity after the
removal of dead cells by Ficoll density centrifugation.  Background
fluorescence of unlabelled and stimulated thymocytes is indicated by the
shaded histogram.  Similar observations were obtained in three independent
experiments.
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4.6. Nature of the Antigen Presenting Cell Involved in Primary T Cell
Activation: Stimulatory Capacity of B cells
We have shown that allogeneic bone marrow derived dendritic cells fail to
stimulate thymocytes to generate CTLs and cytokine producing cells, even after they
have been exposed to maturation signals such as CD40 ligation or exposure to LPS,
and when radiation-resistant effector CD4+ T helper cells are provided.  Thymocytes
stimulated with allogeneic dendritic cells up-regulate CD40L and proliferate, but fail
to differentiate into competent effector cells.  The two-step, two-signal model
predicts that the inability of thymocytes to generate significant CTL and cytokine
producing cells upon dendritic cell stimulation in the presence of “help” is due to the
absence of antigen-specific B cells that act as antigen-presenting cells (Bretscher,
1999).
Indirect experimental evidence, such as the ability of the BALB/c T cell depleted
spleen to stimulate thymocytes to generate immune responses in the presence of
irradiated syngeneic CBA/J help, and the reduction in the stimulatory capacity of the
BALB/c splenocytes after the removal of both Thy1.2 and B220+ cells, support the
possibility that B cells may participate in the delivery of activation signals to naïve T
cells that have initiated clonal expansion.
Experiments were performed to obtain more conclusive evidence that B cells are
capable of stimulating the generation of CTL and cytokine producing cells from
naïve cells obtained from the thymus.  B cells, as operationally defined as CD45RA
(B220+) cells (Coffman & Weissman, 1981), were purified from BALB/c
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splenocytes using MACs beads.  The ability of the purified B220+ cells, which are
predominately B cells, to stimulate the generation of responses from thymocytes was
assessed in either the absence or presence of irradiated, syngeneic CBA/J spleen
cells.  The results presented in Figure 4.6.1 a and b show that thymocytes readily
generate allo-MHC specific CTL and cytokine responses against irradiated B220+
cells when irradiated syngeneic spleen cells are provided.
We next examined the capacity of combined bone marrow derived dendritic cells
and MACs sorted B220+ cells, which are predominately B cells, to stimulate the
generation of allogeneic responses from thymocytes.  Responses similar to that
generated upon stimulation with B220+ cells alone were generated when both B220+
cells and bone marrow derived dendritic cells were present in culture, which
indicates that the cells in the bone marrow derived dendritic population or any
cytokine they may produce, are not inhibiting the generation of responses from
thymocytes.  However, when the B220+ cells in the latter stimulators were depleted
of immunoglobulin-bearing cells (Ig), thymocytes failed to produce CTL and T cells
producing cytokines upon stimulation with allo-MHC bearing dendritic cells, see the
left panels of Figure 4.6.2. a and b, as well as Figure 4.6.2. c, even though irradiated
syngeneic spleen cell “help” was provided. This result appears to be very “clean”,
and provides strong support for the possibility that allogeneic B220+ Ig+ B cells are
required in this system to generate responses.
 Both allogeneic antigen presenting cell populations, the purified B220+ cells and
the bone marrow derived dendritic cells, stimulate CBA/J spleen cells to generate
CTL and cytokine producing cells, see the left panels of Figure 4.6.2 a and b, with
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B220+ B cells stimulating more optimal CTL and cytokine responses when both
stimulator cell populations are employed at physiological cell numbers.
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Figure 4.6.1.a. MACs Sorted CD45R (B220+) Allo-MHC Bearing Spleen
Cells Stimulate the Generation of CTLs from Thymocytes in the Presence of
Syngeneic Irradiated Spleen. CBA/J thymocytes were stimulated with
irradiated B220+ cells that were isolated from the spleens of BALB/c mice as
described in 3.7.2.  The number of T cell depleted, BALB/c spleen cells was
determined before sorting.  In order to accommodate for cell loss during the
sorting procedure, a standard number of thymocytes were stimulated with 2 x
106 cells/well (u), 4 x 106 cells/well (l), or 8 x 106 cells/well (n) stimulators
as enumerated before sorting.  Stimulated thymocytes were cultured either in
the absence (left panel) or presence (right panel) of a standard number of
irradiated CBA/J spleen cells as described in section 3.4. The response of
irradiated CBA/J spleen cells stimulated with sorted B220+ cells in the
absence of responding thymocytes is represented by the open triangle.  The
generation of CTL responses was assessed on Day 6 using a standard 51Cr
CTL assay against labeled P815 (H-2d) target cells or against labeled third
party EL-4 (H-2b- inset) targets as described in section 3.5.1.  Similar results
were obtained in two independent experiments.
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Figure 4.6.1. b. MACs Sorted CD45R (B220+) Allo-MHC Bearing Spleen
Cells Stimulate the Generation of IFN-g, IL-2, and IL-4 Producing Cells from
Thymocytes in the Presence of Syngeneic Irradiated Spleen.  CBA/J
thymocytes, T, were stimulated with irradiated B220+ cells that were isolated
from the T cell depleted spleens of BALB/c mice as described in section 3.7.2.
The number of stimulator cells was determined before sorting.  In order to
accommodate for cell loss during the sorting procedure, thymocytes were
stimulated with 2 x 106 cells/well (1), 4 x 106 cells/well (2), or 8 x 106
cells/well (3) as enumerated before sorting.  Stimulated thymocytes were
cultured employing standard conditions as described in section 3.4 in either
the absence or presence of irradiated CBA/J spleen cells or H-Help. The
number of IFN-g, IL-2, and IL-4 producing cells generated by day 6 was
enumerated in the ELISPOT Assay as described in section 3.5.2.  The error
bars represent the standard deviation of the number of antigen dependent
spots.  Similar results were obtained in two independent experiments.
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Figure 4.6.2.a. The MACs Sorted CD45R (B220+) Allo-MHC Bearing Spleen
Cell that Stimulates the Generation of CTLs from Thymocytes in the Presence of
Syngeneic Irradiated Spleen also Bears Surface Immunoglobulin. CBA/J
thymocytes were stimulated with combinations of irradiated T cell depleted
BALB/c cells in the absence or presence of irradiated CBA/J spleen cells (open
and filled symbols, respectively) employing standard conditions as described in
section 3.4.  DCs were derived from bone marrow, and B220+ cells were isolated
from the spleens of BALB/c mice using MACs beads as described in sections
3.8.1 and 3.7.2, respectively.  Immunoglobulin bearing cells were removed from
the sorted B220+ cells by panning on Ig coated plates as described in section
3.7.3.  Thymocytes (left panel) were stimulated with 1 x 104 DC/well alone (n),
DC plus 1 x 106 Ig+ B220+ cells/well (l), DC plus 0.5 x 106 Ig+ B220+
cells/well (s), DC plus 1 x 106 B220+ cells/well depleted of Ig+ cells (:), or
with 1 x 106 Ig+ B220+ cells/well alone (u).  CBA/J thymocytes stimulated in
the absence of irradiated spleen cells were stimulated with DC plus 1 x 106 Ig+
B220+ cells/well (®) and the hatched circle, which is hidden under the square,
represents similarly stimulated irradiated CBA/J spleen cells without
thymocytes.  CBA/J spleen cells (right panel) were also stimulated with either 1
x 104 DC/well (n ) or 1 x 106 Ig+ B220+ cells/well (u).  The ability of the
different APCs to support the generation of CTLs was determined on day 7
against labeled P815 (H-2d) in the standard 51Cr CTL assay as described in
section 3.5.1.  Similar observations were obtained in three separate experiments.
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Figure 4.6.2.b. The MACs Sorted CD45R (B220+) Allo-MHC Bearing Spleen
Cell that Stimulates the Generation of IFN-g, IL-2, and IL-4 Producing Cells
from Thymocytes in the Presence of Syngeneic Irradiated Spleen also Bears
Surface Immunoglobulin. CBA/J thymocytes, T, were stimulated with
combinations of irradiated BALB/c APC in the absence or presence of
irradiated CBA/J spleen cells or H –help employing standard conditions as
described in section 3.4.  DCs were derived from bone marrow, and B220+
cells were isolated from the spleens of BALB/c mice using MACs beads as
described in sections 3.8.1 and 3.7.2, respectively.  Thymocytes were
stimulated with 1 x 104 DC/well alone, DC plus 1 x 106 Ig+ B220+ cells/well,
DC plus 0.5 x 106 Ig+ B220+ cells/well, DC plus 1 x 106 B220+ cells/well
depleted of Ig+ cells, or with 1 x 106 Ig+ B220+ cells/well alone. The +* in
the B220 row represents 0.5 x 106 Ig+ B220+ cells/well, and +/- represents 1 x
106 B220+ cells/well depleted of Ig+ cells. CBA/J spleen cells (S) were also
stimulated with either 1 x 104 DC/well, or 1 x 106 Ig+ B220+ cells/well. The
ability of the different APCs to support the generation of cytokine producing
cells was determined on day 7 in the ELISPOT assay in the absence or
presence of BALB/c re-stimulation as described in section 3.5.2. The error
bars represent the standard deviation of the number of antigen dependent
spots.  Similar observations were obtained in three independent experiments.
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Figure 4.6.2. c. The MACs Sorted CD45R (B220+) Allo-MHC Bearing Spleen
Cell that Stimulates the Generation of IFN-g Producing Cells from
Thymocytes in the Presence of Syngeneic Spleen also Bears Surface
Immunoglobulin. CBA/J thymocytes, T, were stimulated with combinations of
irradiated BALB/c APCs in the absence or presence of irradiated CBA/J
spleen cells or H –help employing standard conditions as described in section
3.4.  DCs were derived from bone marrow, and B220+ cells were isolated
from the spleens of BALB/c mice using MACs beads as described in sections
3.8.1 and 3.7.2, respectively. Thymocytes were stimulated with 1 x 104
DC/well alone, DC plus 1 x 106 Ig+ B220+ cells/well, DC plus 0.5 x 106 Ig+
B220+ cells/well, DC plus 1 x 106 B220+ cells/well depleted of Ig+ cells, or
with 1 x 106 Ig+ B220+ cells/well alone. The +* in the B220 row represents
0.5 x 106 Ig+ B220+ cells/well, and +/- represents 1 x 106 B220+ cells/well
depleted of Ig+ cells.  The ability of the different APCs to support the
generation of IFN-g producing cells was determined on day 7 in the ELISPOT
assay in the absence or presence of BALB/c re-stimulation as described in
section 3.5.2. Effector phase cells were seeded in the ELISPOT at a
concentration of 1 x 104 effectors/well with or without 2.5 x 105 irradiated
BALB/c spleen cells/well. Similar observations were obtained in three
independent experiments.
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In order to assess in another context a requirement for Ig+ B220+ B cells in
primary thymic T cell activation, and ensure that the inability of the bone marrow
derived dendritic cells to stimulate the generation of CTL and cytokine responses is
not a unique property of the dendritic cells generated from proliferating bone marrow
progenitor cells, B220+ cells and B220- cells were isolated from normal BALB/c
splenocytes depleted of T cells by MACs sorting.  The sorted B220+ and B220- cells
were used to stimulate CBA/J thymocytes and spleen cells.  Thymocytes were
stimulated in either the absence or presence of irradiated syngeneic CBA/J spleen
cells.  The results presented in Figure 4.6.3. a and b show that unsorted BALB/c
spleen depleted of T cells and sorted B220+ spleen cells readily stimulate
thymocytes to generate CTL and cytokine producing cells when “help” is provided,
whereas sorted B220- cells, which contain macrophages and the majority of the
different dendritic cells subsets found in the spleen, fail to optimally stimulate the
generation of allo-MHC specific CTL and IFN-g cytokine producing cells, but do
stimulate the generation of IL-2 and IL-4 producing cells.  The control CBA/J spleen
cell cultures readily generate potent CTL and cytokine responses against both the
B220+ and B220- cells sorted from BALB/c spleen, see the left panels of Figure
4.6.3. a and b.
FACs analysis on the sorted B220+ and B220- spleen cells is shown in
Figure 4.6.3.c.  The B220+ cells sorted using MACs beads were 98% pure B220+
CD19+ B cells.  The B220- fraction, was less pure, and was found to still contain a
small population of cells expressing a low level of B220.  The presence of this small
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population in addition to any memory B cells that have completely down regulated
B220 (McHeyzer-Williams et al., 2000) may explain the residual generation of IL-2
and IL-4 cytokine producing cells from thymocytes stimulated with Thy1.2- B220-
allogeneic spleen cells.  In preliminary experiments where residual immunoglobulin
cells were removed via MACs sorting, the residual generation of IL-2 cytokine
producing cells from thymocytes was abrogated (data not shown).
171
Figure 4.6.3. a.  MACs Sorted CD45R (B220-) Allo-MHC Bearing Spleen
Cells Stimulate the Generation of CTLs from CBA/J Splenocytes, but Fail to
Optimally Stimulate the Generation of CTL Responses from CBA/J
Thymocytes Stimulated in the Presence of Syngeneic Irradiated Spleen.
CBA/J thymocytes were stimulated with combinations of irradiated BALB/c
APCs in the absence or presence of irradiated CBA/J spleen cells (open and
filled symbols, respectively) employing standard conditions as described in
section 3.4. B220+ and B220- cells were isolated from T cell depleted spleens
of BALB/c mice using MACs beads as described in section 3.7.2 and 3.8.3.
Thymocytes (left panel) were stimulated with 2 x 106 unsorted anti-Thy1.2
treated spleen cells/well (n), 1 x 106 B220+ spleen cells/well (s), or 1 x 106
anti Thy1.2 treated B220- spleen cells/well (l).  CBA/J spleen cells (right
panel) were also stimulated with 2 x 106 anti-Thy1.2 treated spleen cells/well
(n), 1 x 106 B220+ cells/well (s), or 1 x 106 anti Thy1.2 treated B220- spleen
cells/well (l).  The ability of the different APCs to support the generation of
CTLs was determined on day 7 against labeled P815 (H-2d) and EL-4 (H-2b)
target cells as described in section 3.5.1.  Specific lysis of third party EL-4
target cells by effector cells generated by stimulation with anti-Thy1.2 treated
spleen stimulators is shown by the hatched square. The specific lysis of
irradiated CBA/J spleen cells stimulated with T cell depleted BALB/c spleen
cells was < 2% and is hidden by the other symbols in the left panel.  Similar
observations were obtained in three independent experiments.
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Figure 4.6.3. b.  MACs Sorted CD45R (B220-) Allo-MHC Bearing Spleen
Cells Stimulate the Generation of IFN-g, IL-2, and IL-4 Producing Cells from
Responding Splenocytes, but Fail to Optimally Stimulate the Generation of
IFN-g Responses from Thymocytes Stimulated in the Presence of Syngeneic
Irradiated Spleen. CBA/J thymocytes, T, were stimulated with combinations
of irradiated BALB/c APCs in the absence or presence of irradiated CBA/J
spleen cells or H-Help employing standard conditions as described in section
3.4. B220+ and B220- cells were isolated from the spleens of T cell depleted
BALB/c spleen cells using MACs beads as described in section 3.7.2.
Thymocytes (left panels) were stimulated with 2 x 106 unsorted anti-Thy1.2
treated (Rx) spleen cells/well (anti-Thy1.2 Rx Ag), 1 x 106 B220+ spleen
cells/well, or 1 x 106 anti-Thy1.2 treated B220- spleen cells/well.  CBA/J
spleen (S) cells (right panels) were also stimulated with 2 x 106 anti-Thy1.2
treated B220+ spleen cells/well, or 1 x 106 anti Thy1.2 treated B220- spleen
cells/well. The ability of the different APCs to support the generation of
cytokine producing cells was determined on day 7 in the ELISPOT assay in
the absence or presence of BALB/c re-stimulation as described in section
3.5.2. The error bars represent the standard deviation of the number of antigen
dependent spots.  Similar results were obtained in three independent
experiments.
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Figure 4.6.3. c.  CD45R (B220) and CD19 Expression on Normal Spleen and on
CD45R (B220+) and CD45R (B220-) MACs Sorted Cells. The expression profiles of
B220 and CD19 on normal (upper row) and MACs sorted BALB/c spleen cells
(lower row) were assessed by flow cytometry as described in section 3.9.1.
Expression profiles of MACs sorted B220+ (æ), or B220- (æ) cells are shown.
Background staining is represented as shaded histograms.
Normal BALB/c Splenocytes
MACs Sorted BALB/c Splenocytes
Background B220 CD19
B220 CD19
Events
Fluorescence Intensity
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4.7. Stimulation of Naïve Thymic T cells with Dendritic Cells in the Absence
of B cells Appears to result in a State of Antigen-Specific CTL
Unresponsiveness
Experimental evidence has been presented that shows that thymocytes, the naïve
precursors of the peripheral T cell pool, fail to generate CTL and cytokine-producing
T cells upon stimulation with allogeneic bone marrow derived dendritic cells
matured by maturation stimuli, such as CD40 ligation or exposure to LPS, even
when irradiated syngeneic spleen cell “help” is provided.  To determine if a state of
allo-MHC specific tolerance follows the cellular proliferation initiated by stimulation
with activated, allogeneic dendritic cells as has been documented for fetal thymic
cells (Matzinger & Guerder, 1989), stimulated thymocytes were re-stimulated after 5
days with either T cell depleted allogeneic spleen cells of the same MHC haplotype
of the primary LPS activated DC stimulators, or with those of an alternate MHC
haplotype, in either the absence or presence of irradiated syngeneic spleen cell
“help”.  To avoid disturbing the initial cultures, irradiated syngeneic spleen cells and
T cell depleted allogeneic spleen cells were added to thymocyte cultures after the
careful removal of half of the culture media (1mL for a 2 mL culture).  The ability of
the re-stimulated thymocytes to generate CTL against both allo-MHC antigens was
assessed after 6 days.
The findings presented in Figure 4.6.1 show that the ability of thymocytes to
generate allo-MHC specific CTL responses against cells bearing the same allo-MHC
antigens as dendritic cells used as stimulators in primary culture, is significantly
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reduced, even though irradiated syngeneic spleen cell “help” was provided with the
T cell depleted allogeneneic spleen cell stimulators.  By contrast, the generation of
alternate allo-MHC specific CTLs in restimulated cultures is minimally affected by
previous exposure to dendritic cells of a different MHC haplotype.  A reduction in
the response generated against stimulators that share MHC antigens with the primary
stimulating dendritic cells is more dramatic for the response against BALB/c MHC-
antigens than for C57BL/6. It is possible that the kinetics of tolerance induction
against the different allogeneic cells varies, for example thymocytes stimulated with
C57BL/6 dendritic cells may still be “rescue-able” on Day 5 but not on Day 6.
Future experiments will thoroughly analyze the kinetics of the proliferative potential
of the C57BL/6 allogeneic dendritic cell stimulated thymocytes as well as the
kinetics of tolerance induction and rescue of differentially stimulated CBA/J
thymocytes.
The corresponding cytokine data (data not shown) reveals some interesting
differences in the ability of thymocytes to generate cytokine-producing cells upon
secondary stimulation.  Thymocytes stimulated with allogeneic spleen cell
stimulators in the presence of irradiated syngeneic spleen cell “help” after a pre-
exposure to allogeneic bone marrow derived dendritic cells appear to only generate
cytokine producing cells against non-dendritic cells alloantigens present on non-
Thy1.2 + allogeneic spleen cells as revealed by a comparison of spleen-dependent
and dendritic cell dependent development of spots in the ELISPOT assay.  These
findings are preliminary and warrant further examination.
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A number of reports in the literature argue that the provision of the growth factor
IL-2, which is normally produced by CD4+ T helper cells, can rescue CD8+ T cells
from activation induced cell death (Smith, 1984; Teh & Teh, 1980).  Experiments
were performed to determine if the addition of this cytokine prevents the induction of
allo-MHC specific CTL and cytokine unresponsiveness, and thereby helps
thymocytes generate allo-MHC specific CTLs and cytokine producing cells.  The
results presented in Figure 4.6.2 a and b show that thymocytes do generate allo-MHC
specific CTL and IFN-g producing cells, which in this experimental system derive
from CD8+ thymic precursors, upon stimulation with irradiated, LPS-activated,
allogeneic dendritic cells when exogenous IL-2 is provided and irradiated syngeneic
spleen cells are absent.  Provision of IL-2, which is normally produced in large
amounts by CD4+ T cells (Harris et al., 2000; Swain, Weinberg, & English, 1990),
can therefore bypass the cellular requirements normally involved in the primary
activation of CD8+ T cells.  It is interesting to note that B cells have been
demonstrated to stimulate CD4+ T cells to produce more IL-2 than other antigen-
presenting cells (Harris et al., 2000).
In summary, the observations presented provide supportive experimental
evidence that naive thymic T cell activation upon stimulation with conventional
allogeneic bone marrow derived dendritic cells can be dependent upon costimulatory
signals and/or cytokines provided by activated, cognate, allogeneic B cells.  In the
absence of such cells, thymic naïve T cells appear to fail to become fully activated
upon stimulation with bone marrow derived dendritic cells. At least for CD8+ CTLs,
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the induction of antigen-specific tolerance is preventable by the presence of high
levels of the CD4+ T helper cell derived cytokine, IL-2.
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Figure 4.7.1.   Exposure of Thymocytes to Activated Dendritic Cells in the
Absence of Effector CD4+ T Helper Cells and B220+ B cells Results in
Antigen Specific Immune Unresponsiveness. CBA/J thymocytes, 2 x 106
cells/well, were stimulated for 5 days with either 2 x 104 cells/well irradiated
BALB/c (left panel) or C57BL/6 (right panel) LPS-activated, bone marrow
derived DCs as described in section 3.4 and 3.8.1, respectively.   On Day 5,
separate DC-pretreated cultures were stimulated with irradiated anti-Thy1.2
and C” treated (Rx) BALB/c (n) or C57BL/6 (l) spleen cells in absence or
presence of irradiated CBA/J spleen cells (open and filled symbols,
respectively).  The latter cells were added to cultures in situ at standard
numbers as described in section 3.4.  The ability of the different DC pretreated
thymocytes to generate CTL responses was assessed six days after re-
stimulation using the standard 51Cr CTL assay against labeled P815 (H-2d)
target cells or against labeled third party targets, EL-4 (H-2b) as described in
section 3.5.1.  The specific lysis of pre-treated thymocytes stimulated with T
cell depleted BALB/c or C57BL/6 spleen cells without “help”, and the
specific lysis of irradiated CBA/J spleen cells stimulated with T cell depleted
BALB/c or C57BL/6 spleen cells in the absence of thymocytes was < 2% and
are hidden by the other symbols in the appropriate panels.  Similar
observations were obtained in three independent experiments. Similar
observations were obtained in two independent experiments.
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Figure 4.7.2. a. High Levels of IL-2 Prevent the Antigen-Specific CTL
Unresponsiveness Generated by Exposure of Thymocytes to Dendritic Cells.
Varied numbers of CBA/J thymocytes were stimulated for 6 days with 1 x 104
cells/well LPS-activated, irradiated BALB/c bone marrow derived DCs in the
absence or presence of 10 Units of recombinant IL-2.   Thymocyte cultures
and bone marrow derived dendritic cells were prepared as described in
sections 3.4 and 3.8.1.  Irradiated, syngeneic CBA/J spleen cells were not
added to any cultures.  The numbers of CBA/J thymocytes seeded in culture
were as follows: 1 x 106 (o ), 2 x 106 (! ), 4 x 106 (° ), and 8 x 106 (—)
cells/well.  The ability of the DCs to stimulate the generation of CTL
responses was assessed on Day 6 using the standard 51Cr CTL assay against
labeled P815 (H-2d) target cells as described in section 3.5.1.  The specific
lysis of the varied numbers of thymocytes represented by the above symbols
in the absence of IL-2 was < 2% lysis and the corresponding symbols are
hidden under the o .  Similar results were obtained in two independent
experiments.
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Figure 4.7.2. b. High Levels of IL-2 “Help” Thymocytes Generate the
Antigen-Specific IFN-g Producing cells upon Stimulation with Bone Marrow
Derived Dendritic Cells. Varied numbers of CBA/J thymocytes were
stimulated with 1 x 104 cells/well, LPS-activated, irradiated BALB/c bone
marrow derived DCs in the absence or presence of 10 Units of recombinant
IL-2. Thymocyte cultures and bone marrow derived dendritic cells were
prepared as described in sections 3.4 and 3.8.1.  Irradiated, syngeneic CBA/J
spleen cells were not added to any cultures.  The numbers of CBA/J
thymocytes seeded in culture were as follows 1 x 106 (1), 2 x 106 (2), 4 x 106
(3), and 8 x 106 (4) cells/well. The ability of DCs to support the generation of
IFN-g producing cells was determined on Day 7 in the ELISPOT assay in the
absence or presence of BALB/c re-stimulation as described in section 3.5.2.
The error bars represent the standard deviation of the number of antigen
dependent spots.  Similar results were obtained in two independent
experiments.
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5. GENERAL DISCUSSION
5.1. Prologue
CD4+ T cells play an essential role in the body’s defense against infectious
pathogens.  They orchestrate the antigen specific immune responses that provide
both primary and secondary immunological protection against infection (Abbas et
al., 2000). In order to ensure that the appropriate type of immune response is
generated upon antigenic challenge, and to ensure that immune responses against self
are subverted, the activation of naïve CD4+ T helper cells must be regulated.
The need to regulate the activation of immune cells to prevent the generation
of autoimmune responses or “horror autotoxis” has been evident since the days of
Ehrlich (Ehrlich, 1900).   As discussed in the Introduction, an immunological
mechanism to account for the regulation of peripheral self-reactive T cells, which
escape central tolerance in the thymus, during the primary activation of naïve,
foreign antigen-specific T cells remains to be established. Several models of naive T
cell activation that attempt to describe how tolerance towards peripheral self occurs
during the activation of foreign antigen specific cells have been discussed in the
Introduction.  These include the Infectious Non-Self, the Danger, the Two-Step,
Two-Signal, and the Steady State Models, which may or may not also involve
CD25+ CD4+ T regulatory cells (Bretscher, 1999; Janeway, 1989, 2001; Matzinger,
1994; Sakaguchi, 2004; Steinman & Nussenzweig, 2002).  The major goal of this
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thesis was to establish an experimental system that would allow one to begin to
delineate which model most validly describes the cellular interactions required for
generation of primary immune responses from naïve T cells.
5.2. The Generation of Primary Immune Responses from the Naïve T
Cells present among Thymocytes Requires the Presence of Effector
CD4+ T helper Cells
In order to delineate the cellular interactions involved in naive T cell
activation, we chose to use an in vitro culture system in which thymocytes are the
responding naïve lymphocytes (Pilarski, 1977). The use of thymocytes as responding
naïve T cells has enabled us to study the cellular interactions required for naive T
cell activation in a manner uncomplicated by the presence of any partially or
previously activated T cells. A number of studies have demonstrated that mature
thymocytes harvested from mice at time periods 24 hours after birth, or thymic
emigrants that have recently exited the thymus are immunocompetent cells (Bennink
& Doherty, 1981; Claman et al., 1968; Claman et al., 1966a; Fink et al., 1985;
Pilarski, 1977; Ramsdell et al., 1991.  In fact, thymocytes were the lymphocyte
population employed by Claman in the landmark experiments that suggested that
antibody-producing cells derived from bone marrow and thymus dependent
lymphocytes interact with one another for the efficient generation of antibody
responses (Claman, 1966 #1492; Scollay et al., 1984; Wagner et al., 1980; Widmer
et al., 1981).  Of particular interest to this work is the demonstration that the
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frequency of CTL precursors reactive against either alloantigens or viruses amongst
thymocytes does not vary dramatically from frequency of CTL precursors isolated
from the secondary lymphoid organs (Bennink & Doherty, 1981; Fink et al., 1985;
Widmer et al., 1981).   However, it must be acknowledged that some propose that
thymocytes receive additional maturation signals in the periphery, and that
thymocytes, particularly CD4+ T cells, are therefore functionally different from
naïve T cells isolated from the periphery (Boursalian et al., 2004; Lutz, 1981). At the
present time, it is difficult to distinguish whether differences in the activation
requirements of thymic T cells in comparison to peripheral naïve T cells reflects
inherent differences in the functional capacity of the two T cell populations or
whether the cellular requirements for their activation are truly different, as will be
discussed later in this discussion.
Employing an in vitro system similar to the one established by L. Pilarski in
the 1970’s (Pilarski, 1977), we were able to reliably stimulate the generation of
primary antigen-specific IL-2 CD4+ and IFN-g CD8+ cytokine producing cells and
CD8+ CTL immune responses from the naïve, competent T cells present among
thymocytes.  We have confirmed and extended previous observations in that we have
found that not only the generation of CTL responses but cytokine producing cells
from thymocytes upon stimulation with allogeneic spleen cells is dependent upon the
presence of a sufficient number of irradiated spleen cells syngeneic to the responding
thymocytes (Pilarski, 1977).  The cells in the irradiated syngeneic spleen that are
required to “help” in the activation of naïve T cells present among thymocytes have
previously been shown to be CD4+ T cells (Pilarski, 1977; Pilarski et al., 1980).  We
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have found that these radiation resistant CD4+ T cells can act in conjunction with
thymic CD4+ T cells to activate naïve CD8+ effector cells.
Our findings show that effector CD4+ T helper cells are required to activate
naïve, thymic, precursor CD4+ T helper cells. However, the requirement for effector
CD4+ T helper cells for the activation of thymocytes could conceivably be due to
thymic CD4+ T cell functional immaturity (Boursalian et al., 2004; Lutz, 1981).
Conclusive experimental evidence that thymocytes behave the same as naïve T cells
isolated from the periphery remains a topic for future investigation that will be
addressed in the Future experiments section.
5.3. The Surface Marker Phenotype and Antigen Specificity of the
Radiation resistant, Effector CD4+ T helper Cells
A number of studies have lead to the estimate that 5-10% of peripheral CD4+
T cells survive in vivo after lethal irradiation (Cederbom et al., 1998; Pereira et al.,
1985; Williams et al., 1994). The ability of a fraction of splenic CD4+ T cells to
provide “help” for thymocytes after exposure to gamma irradiation indicates that
these surviving cells are activated cells that can provide “help” independently of
having to go through some divisions before being able to provide such help. In
agreement with previous findings characterizing the surface marker phenotype of the
CD4+ T cells that survive lethal doses of irradiation (Cederbom et al., 1998; Pereira
et al., 1985), our results, employing a functional assay, indicate that the radiation
resistant cell that “helps” thymocytes generate CTL and cytokine responses is a
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CD4+ T cell that expresses surface markers normally associated with activated T
cells (Dutton et al., 1998).  The removal of cells expressing high levels of a surface
molecule normally associated with recently activated cells, namely CD44 (Budd et
al., 1987), abrogates the ability of the irradiated syngeneic spleen to provide “help”
for the in vitro generation of CTL and cytokine producing cells from thymocytes.
By contrast, the removal of cells bearing high levels of surface markers normally
associated with naïve T cells or resting memory cells, for example CD62L or
CD45RB (Birkeland et al., 1989; Gallatin et al., 1983), fails to abrogate the ability of
the irradiated syngeneic spleen to provide help for thymocytes. The radiation
resistant effector CD4+ T helper cell is thus an activated CD44hi, CD62Llo, and
CD45RBlo T cell.
Previous experiments, in which the spleen cells from CBA/J into CBA/J X
BALB/c bone marrow chimeric mice were employed as a source of “help” for
thymocytes, have demonstrated that the radiation resistant “helper” cells display
tolerance towards self-antigens and specificity towards foreign antigens (Pilarski,
1977).  Spleen cells from such chimeric mice fail to provide CBA/J thymocytes with
radiation resistant “help” for the generation of allospecific CTL responses against
BALB/c MHC antigens, but do provide help for the generation of alloresponses
against third party allogeneic spleen cells. Effector CD4+ T helper cells expanded in
vitro also display specificity.  Using spleen cells from normal un-manipulated F1
mice, L. Baum was able to expand up a population of radiation resistant effector
CD4+ T cells that fail to provide “help” for the generation of responses against both
parent MHC antigens, but do provide “help” for the generation of responses against
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the third party allogeneic spleen cells (Baum & Pilarski, 1978). Using effector CD4+
T cells clones derived from responsive thymocyte cultures as “helper cells”, we have
shown that thymocytes are capable of generating cells that can function as radiation
resistant “helper” cells for other thymocytes.  The thymocyte-derived clones are able
to “help” thymocytes generate significantly greater responses against the allogeneic
spleen cells for which they are specific than for third party allogeneic spleen cells.
In conjunction with previously published findings (Baum & Pilarski, 1978; Pilarski,
1977), these observations indirectly support the suggestion that the irradiation
resistant, effector CD4+ T cells that “help” thymocytes generate primary responses
are thymus dependent lymphocytes, which bear antigen-specific ab T cell receptors.
If the requirement for effector CD4+ T helper cells is general, their presence
could determine whether the generation of immune responses occurs. The Two-step,
Two-signal Model hypothesizes that the effector CD4+ T helper cells that are present
in the periphery of normal, un-manipulated mice, primarily bear T cell receptors that
recognize foreign antigens, and that those with self-specificity do not exist in the
periphery (Bretscher, 1999).  This model hypothesizes that self-specific CD4+ T
helper cells are deleted as they are generated, and that such deletion results in the
peripheral population of effector CD4+ T helper cells with specificity for foreign
antigens. According to this model, it is the presence of effector CD4+ T cells that
determines, in part, the ability to generate responses against foreign or self-antigens,
and not the “stranger” or “danger” signals the antigens may or may not induce
(Bretscher, 1999; Janeway, 1989; Matzinger, 1994).
192
Findings obtained in an unrelated experimental system also provide support
for the postulate that effector CD4+ T cells with self-specificity are lacking in the
periphery of normal mice.  These results come from studies analyzing the T cell
receptor specificity of peripheral T cells that have undergone homeostatic driven
proliferation upon transfer into lymphopenic mice (de Souza et al., 2002). After T
cell hybridomas were generated from such cells, it was determined that the small
minority of CD4+ T cells, which proliferated, and acquired an activated surface
marker phenotype, primarily bear TCR with specificity for foreign antigens as
assessed by the lack of responsiveness towards autologous cells (de Souza et al.,
2002). While the ontogeny of effector CD4+ T helper cells requires further and
direct examination, the possibility that the lymphopenic environment of the
developing immune system supports the initial activation of foreign antigen-specific,
effector CD4+ T helper cells is potentially supported by the previous study (Cho et
al., 2000; Min et al., 2003; Murali-Krishna & Ahmed, 2000; Schuler et al., 2004;
Tanchot et al., 2001).
5.4. The Nature and Role of the Antigen Presenting Cells Involved in the
Primary Activation of Naïve Thymic T Cells in Vitro
The discussed requirement for effector CD4+ T helper cells is a plausible
mechanism whereby the immune system decides to preferentially generate immune
responses against foreign antigens, whilst maintaining a state of unresponsiveness
towards peripheral self.  The Two-step, Two-signal Model postulates that effector
193
CD4+ T cells are required to activate cognate antigen-specific B cells to up modulate
the expression of the costimulatory ligands that collectively lead to the generation
and delivery of signal two to naïve CD4+ T helper cells (Bretscher, 1999).  The other
models of primary T cell activation discussed propose that non-specific antigen
presenting cells, such as dendritic cells that express pattern recognition receptors for
“dangerous” or “stranger” signals, are the cells that deliver signal two to naïve T
cells during T cell activation (Janeway, 1989; Matzinger, 1994; Steinman &
Nussenzweig, 2002).  While the requirement for effector CD4+ T cells for the
activation of naïve thymic T cells supports certain predictions of the Two-step, Two-
signal Model, the determination of whether such a requirement also applies to
peripheral naïve T cells remains a topic for investigation.  In light of this uncertainty,
other issues must be resolved to determine which model of primary T cell activation,
if any, most validly describes the activation of naïve CD4+ T cells.  A major
prediction that distinguishes between the competing models is that dendritic cells can
activate naïve T cells.
We designed a number of in vitro experiments to address whether dendritic
cells are capable of stimulating the generation of immune responses from the
competent naïve T cells present among thymocytes, realizing that separation of
different antigen-presenting cells into separate populations may never be absolute.
Our results show that when bone marrow derived dendritic cells (Inaba et al., 1992),
which were thoroughly washed to remove the majority of contaminating B cells, are
employed as allogeneic stimulator cells the generation of CTL and cytokine
responses from naïve thymic T cells occurs minimally if at all, even when radiation
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resistant effector CD4+ T cell “help” is present. The same bone marrow derived
dendritic cells that fail to stimulate the generation of responses from thymocytes
readily stimulate the generation of allo-MHC specific cytokine and CTL responses
from splenic T cells. The latter observation leads us to suggest that the inability of
dendritic cells to stimulate the generation of responses from thymocytes is unlikely
to be due to the release of inhibitory cytokines and/or by the expression of inhibitory
ligands, which are down-modulated upon CD40 ligation (Cella, Dohring et al., 1997;
Grohmann, Fallarino, Bianchi et al., 2001; Grohmann, Fallarino, Silla et al., 2001;
Powell, Jenkins, Hattori, & MacPherson, 2003).  The possibility that thymocytes fail
to respond because they are lacking competent CD4+ T helper cells is also unlikely
because functional “help”, in the form of irradiated syngeneic spleen cells, was
present (Boursalian et al., 2004; Lutz, 1981).
Under the appropriate circumstances, other allogeneic spleen cells, in contrast
to purified dendritic cells, readily stimulate the generation of alloresponses from
thymocytes when radiation resistant CD4+ effector T helper cells are present.  This
discrepancy in the ability of allogeneic bone marrow derived dendritic cells, in
comparison to allogeneic spleen cells depleted of T cells, to stimulate the generation
of competent CD4+ and CD8+ effector cells from thymocytes prompted us to
examine the fate of the differentially stimulated thymocytes.  We therefore assessed
whether stimulation with allogeneic bone marrow derived dendritic cells results in
thymocyte proliferation, and whether T cell costimulatory molecule receptors, such
as CD40L, are up modulated (Banchereau et al., 1994; Croft & Dubey, 1997).  Both
allogeneic spleen and dendritic cell stimulator populations stimulate thymocytes to
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cycle and up-regulate the expression of CD40L. However, only thymocytes
stimulated with allogeneic spleen cells depleted of T cells appear to differentiate into
competent effector cytokine producing cells and CTLs. It is reasonable to speculate,
given our observations, that stimulation of competent thymocytes with allogeneic
bone marrow derived dendritic cells in the absence of allogeneic B cells and/or
effector CD4+ T helper cells induces activation induced cell death (Schwartz, 2003;
Wells et al., 1999).
According to the tenets of the Two-step, Two-signal Model, the discrepancy
in the ability of the two allogeneic populations to stimulate the generation of
responses from thymocytes is most likely a consequence of the absence of B cells in
the former, and their presence in the latter (Bretscher, 1999). Our initial findings
with T cell depleted allogeneic spleen cell stimulators, further depleted of B220+
cells, which are predominately B cells, by antibody dependent complement mediated
lysis indicate that the generation of responses can be reduced when such cells are
removed.  In order to more conclusively examine whether B cells are necessary to
stimulate the generation of responses from naïve T cells, we sorted B220+ and B220-
cells from the T cell depleted allogeneic spleen by magnetic cell sorting, and used
the separate fractions as allogeneic stimulators for CBA/J thymocytes and
responding splenocytes.   The T cell depleted, BALB/c spleen cell fraction devoid of
B220 expressing cells, which harbors macrophages and the majority of splenic
dendritic cell subsets, failed to optimally stimulate the generation of significant CTL
and IFN-g cytokine producing cells from competent thymocytes given irradiated
“help”, but did stimulate the generation of such responses from spleen cells.  By
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contrast, the B220+ cells stimulated the generation of responses from both
thymocytes and responding splenocytes in a manner very similar to that generated
upon stimulation with irradiated, T cell-depleted spleen.
To determine if the presence of B220+ cells can restore the responsiveness of
thymocytes stimulated with bone marrow derived dendritic cells, we again sorted
B220+ cells from the T cell depleted BALB/c spleen by magnetic cell sorting and
assessed the ability of combined allogeneic populations to stimulate the generation of
responses when CD4+ T cell “help” in the form of irradiated syngeneic spleen was
present.    We also removed immunoglobulin bearing cells (Ig) from the sorted
B220+ cell fraction via panning on immunoglobulin coated plates to ensure that the
B220+ cell necessary for stimulating the generation of responses is in fact a B cell.
Stimulation of thymocytes with combined bone marrow derived dendritic cells, and
Ig+ B220 cells restored the generation of cytokine producing cells and CTLs from
thymocytes when irradiated syngeneic spleen cell “help” was present. The removal
of Ig+ cells abrogated the ability of the combined allogeneic cells to stimulate the
generation of alloresponses from thymocytes. Thus, in regards to the question of
whether allogeneic, bone marrow derived dendritic cells can activate naïve thymic T
cells in the absence of B cells, we conclude that the in vitro generation of
alloresponses from the competent naïve T cells present among thymocytes requires
the presence of an additional cell, which is an immunoglobulin bearing allogeneic B
cell.  According to the postulates of the Two-step, Two-signal Model, the potential
requirement for a B cell for the generation of immune responses, which possesses the
potential to specifically acquire and present protein antigens to naïve T cells
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(Hodgkin & Basten, 1995; Lanzavecchia, 1990; Rush & Hodgkin, 2001), adds a
level of control over the generation of immune responses that is lacking if the
delivery of signal two occurs from a non-antigen specific antigen-presenting cell.
The specific acquisition and presentation of antigens to T cells by B cells is not
easily addressed in in vitro systems.  However, in our experimental in vitro system,
which relies on the use of alloantigens, cognate allo-MHC bearing B cells can be
required for the generation of responses from naïve thymic T cells.
5.5. In vivo evidence to support the postulate that B cells are required
for the activation of naïve antigen-specific CD4+ T cells
Literature to support the suggestion that B cells are required for the in vivo
generation of primary Th1- and Th2-type immune responses dates back to the days
of Burnet (N. L. Warner, A. Szenberg, & F. M. Burnet, 1962).  At that time, it was
commonplace to generate B cell deficient chickens via the early administration of
testosterone (Szenberg, 1970).   Such hormonal treatment blocks the development of
the Bursa, and subsequently blocks B cell development (Glick et al., 1956).  In his
experiments, Burnet found B cell deficient chickens to lack both cell-mediated, DTH
and anti-viral responses, as well as antibody responses (N. L. Warner et al., 1962).
Before the appearance of genetically modified mice, the generation of B cell
deficient mice required the continuous administration of anti-IgM immunoglobulin
(Gordon, 1979).  This treatment results in the depletion of all B cells.   In some
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instances, this regime was commenced immediately after birth.  Findings obtained
with mice treated in this manner largely support the position that B cells play an
essential role in the generation of primary immune response against protein and
infections antigens (Hayglass et al., 1986; Janeway et al., 1987; Kurt-Jones et al.,
1988; Ron & Sprent, 1987; Schultz et al., 1990; Schultz et al., 1995).  However, the
demonstration that uMT genetically modified B cell deficient mice generate primary
Th1 and Th2 responses, in vitro and in vivo, against a broad array of antigens, cast
considerable doubt on the proposition that B cells participate in the primary
activation of naïve T cells (Epstein et al., 1995; Leef et al., 2000).  The influence of
the continuous administration of anti-IgM immunoglobulin on the ability to generate
functional T cell responses in the previous studies became subject to question, and
Burnet’s findings appear to have been forgotten (Epstein et al., 1995; N. L. Warner
et al., 1962).
While the uMT model of B cell deficiency appears ideal, considerable
controversy developed over the use of such mice.  This is primarily due to the
variable ability of these mice to generate T cell responses (Epstein et al., 1995;
Greeley et al., 2001; Leef et al., 2000). The finding that uMT B cell deficient mice,
on backgrounds other than the original C57BL/6 strain in which they were
developed, possess serum immunoglobulin of isotypes other than IgM led to the
realization that genetic recombination events can occur that allow for the survival of
a small number of B cells (Hasan et al., 2002; Melamed et al., 2000; Rivera et al.,
2001).  The ability to generate responses in such mice against some antigens and not
others may therefore be the result of a randomly altered B cell repertoire.
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A more complete model of B cell deficiency is the JhD B cell deficient
mouse (Liu et al., 1995).  Immunoglobulin recombination is not possible in JhD mice
because a gene segment necessary for genetic recombination, the joining region, is
missing.  The generation of Th1 and Th2 immune responses, and the maintenance of
memory CD4+ T helper cells, is severely impaired in these mice (Chan, Madaio, &
Shlomchik, 1999; Leef et al., 2000; Linton, Harbertson, & Bradley, 2000; Liu et al.,
1995; Macaulay et al., 1998).  Repopulation of the B cell compartment in JhD B cell
deficient mice with B cells that are either capable or incapable of secreting
immunoglobulin restores immune responsiveness (Chan, Hannum et al., 1999; Chan,
Madaio et al., 1999), which supports the suggestion that there is a role for B cells in
primary T cell activation.  The inability of passively administered immunoglobulin
from responsive mice to restore the ability to generate T cell responses in JhD mice
supports the latter argument (Chan, Hannum et al., 1999; Leef et al., 2000).
However, the JhD in vivo model of B cell deficiency may also have
limitations.  According to Cyster, the requirement for B cells in the generation of
Th1 and Th2 immune responses in B cell deficient mice, is indirect, and is unrelated
to B cell antigen presenting functions (Golovkina et al., 1999; Ngo et al., 2001).  He
suggests that B cells are necessary in vivo for the development of proper lymphoid
architecture (Cyster, 2003).  While B cells may be essential for proper lymphoid
development in vivo, our in vitro findings support the position that B cells also play
an essential antigen-presenting role in the primary activation of naïve T cells.
The cellular requirements for primary T cell activation in vitro may not be
directly applicable to the cellular requirements in vivo.  However, studies analyzing
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the in vivo traffic of T cells undergoing T cell activation support the possibility that
the two rare antigen specific cells the Two-step, Two-signal Model predicts to be
involved in the generation of signal two in the second step, effector CD4+ T cells
and cognate antigen-specific B cells (Bretscher, 1999), interact during the generation
of cellular and humoral responses (Attanavanich & Kearney, 2004; Garside et al.,
1998; Moser, Schaerli, & Loetscher, 2002; Schaerli, Loetscher, & Moser, 2001). For
example, B cells that encounter their specific antigen migrate from the B cell areas of
lymphoid organs to the marginal zones to come into close contact with T cells
(Attanavanich & Kearney, 2004; Garside et al., 1998). Conversely, uncommitted
CD4+ T cells producing IL-2, which express the chemokine receptor CCRX5, that
have encountered antigen on antigen presenting cells such as dendritic cells, migrate
from the T cell zones of the lymphoid organs into the B cell areas (Moser et al.,
2002; Schaerli et al., 2001).  These CD4+ T cells subsequently differentiate into
either Th1 or Th2 effector T helper cells.
Collectively, in vivo observations support the possibility that B cells are
centrally involved in the activation of naïve T cells.  Conclusive experimental
observations that B cells are directly required for the in vivo activation of naïve
CD4+ T cells rather than for the development of the architecture of lymphoid organs
necessary to support immune responses, is not yet available.  We are currently in the
process of establishing a system to address the in vivo requirement for B cells in
primary CD4+ T cell activation.
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5.6. Is there evidence that dendritic cells stimulate the activation of
naïve antigen-specific CD4+ T cells?
Presently, the arguments that B cells are essential antigen presenting cells
that participate in primary T cell activation, in vitro and in vivo, are controversial,
and most believe that dendritic cells are the most potent activators of naïve T cells
(Banchereau & Steinman, 1998; Steinman, 1991).  To understand how support for
the role of dendritic cells in primary T cell activation arose, one must review the
discovery of dendritic cells and consider the experimental techniques employed to
study their stimulatory capacity.
The belief that dendritic cells are, on a per cell basis, the most potent
activators of naïve T cells emanated from a number of in vitro studies published
shortly after the discovery that antigen-presentation by dendritic cells is maturation
dependent (Cella, Sallusto et al., 1997; Girolomoni et al., 1990; Kampgen et al.,
1991; Kelly et al., 1978; Klinkert et al., 1982; Koch et al., 1995; Pure et al., 1990;
Romani et al., 1989; Sallusto et al., 1995; Schuler & Steinman, 1985; Steinman et al.,
1975; Steinman & Cohn, 1973; Steinman & Witmer, 1978; Wilson et al., 2003;
Wolff & Schreiner, 1970). It was demonstrated that allogeneic dendritic cells are 100
times more efficient at clustering and initiating the proliferation of splenic T cells
than allogeneic B cells or macrophages (Steinman & Witmer, 1978).
At this time, the separation of naïve T cells from those previously activated
by antigen encounter was uncommon, and the surface markers discriminating
between naïve/resting memory cells and activated T cells were unknown (Dutton et
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al., 1998).  The procedures to purify the desired lymphoid populations, in particular,
dendritic cells, were also somewhat elemental (Steinman, Kaplan, Witmer, & Cohn,
1979).  Even current protocols to purify dendritic cells state that 65% purity may be
acceptable for most assays (Coligan et al., 1998). Most importantly, at the time the
stimulatory capacity of dendritic cells was first being analyzed, it is not clear
whether a disassociation was being made between stimulation of T cell proliferation
and full activation as it is today (Cunningham & Lafferty, 1974; Hawiger et al.,
2001; Heckford et al., 1986; Hernandez, Aung, Marquardt, & Sherman, 2002; Kurts
et al., 2001; Kurts, Kosaka et al., 1997; Townsend & Goodnow, 1998).
The advance of experimental techniques, and the realization that fractionated
lymphocyte populations are not as pure as was once hoped, has led to a re-
examination of a number of experimental findings regarding primary T cell
activation.  In most current studies, these experiments rely on the use of genetically
modified mice.  The use of TCR transgenic mice, knockout mice deficient in genes
of immunological interest, or knockout mice lacking whole lymphocyte subsets, has
become standard because of the ease by which desired lymphoid populations can be
studied.  Genetically modified mice are extremely valuable experimental tools.
However, one must keep in mind a number of confounding issues that may influence
the experimental outcome obtained when using such animals.  These include a
marked increase in the precursor frequency of mono-specific cells, or endogenous
TCRa chain rearrangement in TCR transgenic mice that harbor wild-type Rag1 and
Rag2 recombination genes, and, as is evident from the models of B cell deficiently,
the inadvertent alteration of developmental process in gene knockout mice
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(Golovkina et al., 1999; Legrand & Freitas, 2001; Radu, Noben-Trauth, Hu-Li, Paul,
& Bona, 2000; Smiley & Grusby, 1997; Zhou et al., 2004).  Generally, also, most
molecules of immunological interest that we know of have multiple functions, and so
the latter gene knockout mice are intrinsically complicated.
The general consensus resulting from studies employing such mice as
experimental tools appears to be that dendritic cells are the most potent stimulators
of naïve T cell proliferation and activation (Croft et al., 1992; Langenkamp et al.,
2002; Levin, Constant, Pasqualini, Flavell, & Bottomly, 1993; Liu, Kanzler,
Soumelis, & Gilliet, 2001).  The most convincing experimental finding to support the
argument that dendritic cells are capable of stimulating the generation of primary
immune responses from naïve T cells comes from a study in which both TCR
transgenic and knockout mice were employed (Lemos, Fan, Lo, & Laufer, 2003).  In
this study, the generation of primary immune responses from peripheral TCR
transgenic CD4+ T cells was examined in an adoptive transfer system in which mice
believed to be deficient in Class II expression on all antigen-presenting cells except
dendritic cells were employed as host animals. Upon antigenic challenge, the
responding TCR transgenic CD4+ T cells generate cytokine and DTH responses
efficiently, even though the B cells present in the host mice lack MHC Class II
expression and, in theory, cannot interact with the TCR transgenic CD4+ T cells
(Lemos et al., 2003). These observations at face value appear to demonstrate that
presentation by dendritic cells alone can result in T cell activation and thus appear to
invalidate the postulates of the Two-step, Two-signal Model and the potential
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significance of the findings described in this thesis.  However, two confounding
issues brought about by the use of genetically modified mice require consideration.
First, similar to the majority of studies using TCR transgenic T cells, the
naivety of the responding T cells in the latter study is uncertain (Smiley & Grusby,
1997). The TCR transgenic mice from which the responding CD4+ T cells were
isolated harbor the Rag recombination genes.  Thus, endogenous TCRa chain
rearrangement is possible, and leads to the possibility that the transgenic CD4+ T
cells express the desired transgenic receptor, and a hybrid receptor containing an
endogenously rearranged TCRa chain and the transgene encoded b chain.  Hence,
the idea that the TCR transgenic CD4+ T cells are naïve because they have not been
deliberately exposed to antigen can in theory be questioned because the potential
exists that the hybrid T cell receptor has encountered environmental antigens (Croft
et al., 1992; Zhou et al., 2004).  The generation of T cells producing cytokines and
DTH responses in the experimental mice may, therefore, have been obtained by
activating T cells primed in the donor, which has B cells and activated T cells
(Lemos et al., 2003).
Second, knowledge gained from studies of T cell proliferation under
lymphopenic conditions leads one to question the completeness of the Class II
deficiency in the in vivo model employed (Martin, Bourgeois, Dautigny, & Lucas,
2003).  Using similar, I-Abb -/- Class II deficient mice on the C57BL/6 background,
which are naturally deficient in I-E MHC class II expression because of the lack of a
functional Ea chain, it has been shown that homeostatic driven proliferation of
adoptively transferred CD4+ T cells still occurs, albeit less efficiently (Martin et al.,
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2003).  Homeostatic driven proliferation of adoptively transferred CD4+ T cells can
be prevented by backcrossing the I-Abb -/- host mice to mice engineered to also be
deficient in the I-Eb chain.  While the chains encoded by the I-A or the I-E regions of
the MHC complex normally associate with their respective b chains, it has been
suggested that a normally rare association of I-Aa and I-Eb chains to form a
functional class II MHC antigen occurs at a higher frequency in the I-Abb -/- mice
(de Souza et al., 2002).  Expression of a hybrid I-Aa and I-Eb MHC class II molecule
on B cells in I-Abb -/- mice is thus possible.  Hence, whether the delivery of signal
two occurs after interaction with dendritic cells or whether it occurs after encounter
with antigen-specific B cells is uncertain.
The possibility that the naïve CD4+ TCR transgenic cells contain previously
activated cells, in addition to the possibility that the B cells of the I-Abb -/- mice may
express a hybrid class II MHC molecule, opens up the possibility that more than
recognition of “danger” or “stranger” signals by non-antigen-specific dendritic cells
is required for the primary activation of naïve, precursor CD4+ T helper cells
(Lemos et al., 2003).  While modern experimental tools have broadened our
understanding of the cells that mediate immune responses, the delineation of the
cellular requirements necessary for primary T cell activation in vivo remain
enigmatic.
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6. CONCLUDING REMARKS AND FUTURE DIRECTIONS
The major goal of this thesis was to establish and utilize an experimental
system that would allow one to begin to delineate which model of immune T cell
activation most validly describes the cellular interactions required for generation of
primary immune responses from naïve CD4+ T cells, whilst the generation of
immune responses towards self antigens is avoided. We have obtained experimental
evidence that additional cellular interactions involving B220+ Ig+ B cells can be
required for full activation of naïve thymic T cells in vitro after encounter with
antigen presented by non-specific antigen-presenting cells, as represented by
dendritic cells derived from bone marrow progenitors.  While the latter antigen
presenting cells are efficient at stimulating the proliferation of naïve T cells, our
findings show that such stimulation fails to result in the acquisition of full effector
functions.  We have also obtained some experimental evidence, which warrants
further examination, that suggests that naïve thymic T cells, more specifically CD8+
T cells, can be rendered tolerant in an antigen specific manner by exposure to MHC-
alloantigens presented by non-specific antigen presenting cells, such as bone marrow
derived dendritic cells when effector CD4+ T helper cells and cognate B cells are
absent.
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Our results thus favor the predictions of the Two-step, Two-signal Model of
T cell activation, which postulates that T cell-T cell cooperation and antigen-specific
B cells are involved in the generation and delivery of the critical activation signals to
precursor CD4+ T helper cells (Bretscher, 1999).
While our in vitro findings are supportive of this model, in vivo confirmation
of these cellular requirements with peripheral naïve T cells and sorted antigen
presenting cell populations is required before one can definitively state that the Two-
step, Two-signal model most validly describes the cellular events involved in
primary T cell activation, and the means by which immune responses towards
peripheral self are avoided.
We are currently in the process of establishing an in vivo system to test
whether the cellular requirements predicted by this model apply to the in vivo
activation of naïve T cells.  We plan to use a murine adoptive transfer system with
lethally irradiated host animals to address whether the same antigen presenting and
effector CD4+ T helper cell requirements apply to the in vivo activation of
transferred naïve thymic T cells.  Preliminary observations obtained from
collaborative experiments with K.K. McKinstry are supportive of the t ro
observations presented in this thesis that B220+ cells, which are predominately B
cells, are necessary for the generation of IFN-g and IL-4 producing cells from
thymocytes when mice are challenged with sheep red blood cells (SRBCs).  We plan
to employ this system, rather than the in vitro system that relies on the use of allo-
MHC antigens, to assess whether antigen-specific B cells are in fact required to
initiate the generation of immune responses (Rivera et al., 2001).
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Confirmation of a requirement for B cells in primary T cell activation in such
an in vivo system will provide support for the re-examination of the generation of
primary immune responses from TCR transgenic CD4+ T cells in an in vivo system
where MHC class II expression is restricted to defined subsets of antigen-presenting
cells (Lemos et al., 2003).  The use of TCR transgenic mice on a Rag-deficient
background as naïve CD4+ T cell donors, and C57BL/6 mice as host animals that are
I-Abb -/- and I-Eb -/- deficient on all antigen presenting cells except dendritic cells
(Martin et al., 2003), will allow for a valid assessment of whether B cells are in fact
required for primary T cell activation in vivo.  Such a system will also allow for a
distinction between whether the requirement for B cells in vivo is directly related to
the delivery of the critical signals needed for the generation of immune responses or
whether their role is indirectly related to the development of lymphoid architecture
(Bretscher, 1999; Ngo et al., 2001).
In closing, such experiments may allow for a determination of whether the
Two-step, Two-signal Model, does in fact, validly describe the cellular requirements
for naïve T cell activation.
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